Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Irritable Bowel Syndrome, January 2025

Free Subscription


Abstracts

Retrieve all available abstracts of the following 810 articles:
HTML format


 

Single Articles

  1. MANIPIS K, Cronin P, Street D, Church J, et al
    Examination of Methods to Estimate Productivity Losses in an Economic Evaluation: Using Foodborne Illness as a Case Study.
    Pharmacoeconomics. 2025 Jan 4. doi: 10.1007/s40273-024-01458.
    Abstract

  2. FASSOV J, Hoyer KL, Lundby L, Laurberg S, et al
    Long-term efficacy and safety of sacral neuromodulation for diarrhoea-predominant and mixed irritable bowel syndrome.
    Tech Coloproctol. 2025;29:41.
    Abstract

  3. WANG Y, Zhao Z, Wang R, Hu X, et al
    Genetic Links Between Gastrointestinal Disorders and Kidney Stone Disease: Insights from Genome-Wide Cross-Trait Analysis.
    Kidney360. 2025 Jan 3. doi: 10.34067/KID.0000000689.
    Abstract

  4. WARNER MM, Soliman OM, Crichton M, Marshall S, et al
    Systematic Review: Integrated Models of Care for Managing Irritable Bowel Syndrome.
    Neurogastroenterol Motil. 2025 Jan 3:e14989. doi: 10.1111/nmo.14989.
    Abstract

  5. ZHANG Q, Xu Y, Guo D, He H, et al
    Classification of Irritable Bowel Syndrome Using Brain Functional Connectivity Strength and Machine Learning.
    Neurogastroenterol Motil. 2025 Jan 3:e14994. doi: 10.1111/nmo.14994.
    Abstract

  6. ZAJAC DJ, Xu J, Cheng F
    Basic Science and Pathogenesis.
    Alzheimers Dement. 2024;20 Suppl 1:e092389.
    Abstract

  7. WAN X, Wang L, Wang Z, Wan C, et al
    Toll-like receptor 4 plays a vital role in irritable bowel syndrome: a scoping review.
    Front Immunol. 2024;15:1490653.
    Abstract

  8. SARNOFF RP, Hreinsson JP, Kim J, Sperber AD, et al
    Sex Differences, Menses-Related Symptoms and Menopause in Disorders of Gut-Brain Interaction.
    Neurogastroenterol Motil. 2025 Jan 2:e14977. doi: 10.1111/nmo.14977.
    Abstract

  9. YANG J, Yue K, Sun J, Pan C, et al
    Altered functional network topology properties to detect anxiety and depression caused by Crohn's disease and disease severity.
    Brain Res Bull. 2024 Dec 31:111187. doi: 10.1016/j.brainresbull.2024.111187.
    Abstract

  10. GOZDZIEWSKA M, Lyszczarz A, Kaczoruk M, Kolarzyk E, et al
    Relationship between SIBO and other bowel diseases and a common eating pattern for them. Part III.
    Ann Agric Environ Med. 2024;31:322-328.
    Abstract

  11. CHANGELA S, Ashraf S, Lu JY, Duong KE, et al
    New-onset gastrointestinal disorders in COVID-19 patients 3.5 years post-infection in the inner-city population in the Bronx.
    Sci Rep. 2024;14:31850.
    Abstract

  12. SCHMIDT S, Loef M, Ostermann T, Walach H, et al
    Treatment Effects in Pharmacological Clinical Randomized Controlled Trials are Mainly Due to Placebo.
    J Clin Epidemiol. 2024 Dec 27:111658. doi: 10.1016/j.jclinepi.2024.111658.
    Abstract

  13. FAN Z, Shao C, Kou Z, Xie F, et al
    The Role of Sex Hormones and Sex Hormone-binding Globulin in Functional Gatrointestinal Disorders: A Bidirectional Two-sample Mendelian Randomization Study.
    J Gastrointestin Liver Dis. 2024;33:474-481.
    Abstract

  14. TEGEGNE HA, Savidge TC
    Leveraging human microbiomes for disease prediction and treatment.
    Trends Pharmacol Sci. 2024 Dec 27:S0165-6147(24)00248.
    Abstract

  15. GASIOROWSKA A, Romanowski M, Walecka-Kapica E, Kaczka A, et al
    Efficacy and Safety of a Mixture of Microencapsulated Sodium Butyrate, Probiotics, and Short Chain Fructooligosaccharides in Patients with Irritable Bowel Syndrome-A Randomized, Double-Blind, Placebo-Controlled Study.
    J Clin Med. 2024;14:6.
    Abstract

  16. GARCIA MANSILLA MJ, Rodriguez Sojo MJ, Lista AR, Ayala Mosqueda CV, et al
    Exploring Gut Microbiota Imbalance in Irritable Bowel Syndrome: Potential Therapeutic Effects of Probiotics and Their Metabolites.
    Nutrients. 2024;17:155.
    Abstract

  17. GIAMMONA A, Galuzzi BG, Imperia E, Gervasoni C, et al
    Chronic Gastrointestinal Disorders and miRNA-Associated Disease: An Up-to-Date.
    Int J Mol Sci. 2025;26:413.
    Abstract

  18. HOYER KL, Dahl Baunwall SM, Kornum DS, Klinge MW, et al
    Faecal microbiota transplantation for patients with diabetes type 1 and severe gastrointestinal neuropathy (FADIGAS): a randomised, double-blinded, placebo-controlled trial.
    EClinicalMedicine. 2024;79:103000.
    Abstract

  19. AYDEMIR C, Al Saidi R, Choi JS, Ahmed MH, et al
    Bariatric surgery and HIV: Joint venture between family, primary care, and HIV physicians.
    J Family Med Prim Care. 2024;13:5920-5923.
    Abstract

  20. SINGH S, Srivastava NK, Yadav R, Paul S, et al
    Acute gastrointestinal and post-acute COVID-19 gastrointestinal syndrome assessment on the Gastrointestinal Symptom Rating Scale scoring system: A questionnaire-based survey.
    J Family Med Prim Care. 2024;13:5787-5798.
    Abstract

  21. DELLSCHAFT N, Murray K, Ren Y, Marciani L, et al
    Assessing Water Content of the Human Colonic Chyme Using the MRI Parameter T1: A Key Biomarker of Colonic Function.
    Neurogastroenterol Motil. 2025 Jan 10:e14999. doi: 10.1111/nmo.14999.
    Abstract

  22. HAMID N, Kueh YC, Muhamad R, Zahari Z, et al
    Complex and Bidirectional Interplay Between Marital Quality, Catastrophizing, Psychological Dysfunction, and Quality of Life in Married Malay Women With Disorder of Gut-Brain Interactions.
    Neurogastroenterol Motil. 2025 Jan 9:e15000. doi: 10.1111/nmo.15000.
    Abstract

  23. HAEDRICH J, Huber R
    Crohn's disease, irritable bowel syndrome, and chronic fatigue: the importance of communication and symptom management-a case report.
    J Med Case Rep. 2025;19:9.
    Abstract

  24. KRYNICKA P, Kaczmarczyk M, Skonieczna-Zydecka K, Cembrowska-Lech D, et al
    The burden of irritable bowel syndrome and functional dyspepsia in Poland: a cross-sectional study from West Pomeranian Voivodship.
    BMC Gastroenterol. 2025;25:8.
    Abstract

  25. CHENG S, Xiao W, Shi F, Zhao Z, et al
    A Bifunctional "Two-in-One" Array for Simultaneous Diagnosis of Irritable Bowel Syndrome and Identification of Low-FODMAP Diets.
    J Agric Food Chem. 2025 Jan 9. doi: 10.1021/acs.jafc.4c08690.
    Abstract

  26. HOLM IM, Lorentzen SCS, Carlsen MH, Valeur J, et al
    Evaluation of dietary quality in patients with functional gastrointestinal symptoms: a Norwegian single centre study.
    Food Nutr Res. 2024;68.
    Abstract

  27. IQBAL M, Hira S, Saeed H, Shahid S, et al
    Efficacy of Amitriptyline in Irritable Bowel Syndrome: A Systematic Review and Meta-analysis.
    J Neurogastroenterol Motil. 2025;31:28-37.
    Abstract

  28. LI X, Li X, Xiao H, Xu J, et al
    Meta-analysis of gut microbiota alterations in patients with irritable bowel syndrome.
    Front Microbiol. 2024;15:1492349.
    Abstract

  29. TANG R, Jin Y, Xu K, Wu L, et al
    Aberrant functional connectivity patterns in the pregenual anterior cingulate cortex and anterior midcingulate cortex of patients with irritable bowel syndrome accompanied by depressive symptoms.
    Brain Imaging Behav. 2025 Jan 7. doi: 10.1007/s11682-024-00964.
    Abstract

  30. FRASER K, James SC, Young W, Gearry RB, et al
    Characterisation of the Plasma and Faecal Metabolomes in Participants with Functional Gastrointestinal Disorders.
    Int J Mol Sci. 2024;25:13465.
    Abstract

  31. HAGHBIN H, Hasan F, Gangwani MK, Zakirkhodjaev N, et al
    Efficacy of Dietary Interventions for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
    J Clin Med. 2024;13:7531.
    Abstract

  32. ZHAO Y, Zhu S, Dong Y, Xie T, et al
    The Role of Gut Microbiome in Irritable Bowel Syndrome: Implications for Clinical Therapeutics.
    Biomolecules. 2024;14:1643.
    Abstract

  33. BELL L, Fordham B, Mumtaz S, Yaman R, et al
    Using Natural Language Processing and Social Media Data to Understand the Lived Experience of People with Fibromyalgia.
    Healthcare (Basel). 2024;12:2511.
    Abstract

  34. SOEBY M, Clausen L, Richelsen B, Gribsholt SB, et al
    Patterns of Medical Diagnoses Before and After a Diagnosis of Anorexia Nervosa: A Danish Nationwide Cohort Study.
    Int J Eat Disord. 2025 Jan 6. doi: 10.1002/eat.24340.
    Abstract

  35. VERMEIJDEN NK, de Silva L, Manathunga S, Spoolder D, et al
    Epidemiology of Pediatric Functional Abdominal Pain Disorders: A Meta-Analysis.
    Pediatrics. 2025 Jan 7:e2024067677. doi: 10.1542/peds.2024-067677.
    Abstract

  36. SAHA S, Schnabl B
    Modulating the microbiome in chronic liver diseases- current evidence on the role of fecal microbiota transplantation.
    Expert Rev Gastroenterol Hepatol. 2025 Jan 6. doi: 10.1080/17474124.2025.2450707
    Abstract

  37. LENOVER MOYER MB, Jasani K, Waldman AB, Chinchilli VM, et al
    The Developmental Origins of Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Am J Hum Biol. 2025;37:e24209.
    Abstract

  38. WANG Q, Liu X, Song D, Wang Q, et al
    Exploring the mechanism and effective compounds of Changan Granule on diarrhea-predominant irritable bowel syndrome via regulating 5-hydroxytryptamine signaling pathway in brain-gut axis.
    Phytomedicine. 2024;136:156350.
    Abstract

  39. HAZAN S, Bao G, Vidal A, Sfera A, et al
    Gut Microbiome Alterations Following Oral Serum-Derived Bovine Immunoglobulin Administration in the Management of Dysbiosis.
    Cureus. 2024;16:e75884.
    Abstract

  40. JOHNSON T, Jahnke AR, Reindel K
    Using Osteopathic Manipulative Therapy to Treat Irritable Bowel Syndrome and Severe Refractory Gastroesophageal Reflux Disease: A Case Report.
    Cureus. 2024;16:e75811.
    Abstract

  41. ALLAM DMM, Ali Abdel Ghaffar H, Mostafa Elshamy A, Abdelmotaal Safa M, et al
    Effect of Pilates exercises on symptoms of irritable bowel syndrome in women: a randomized controlled trial.
    Arch Physiother. 2024;14:170-181.
    Abstract

  42. AKRAM U, Rehman OU, Fatima E, Nadeem ZA, et al
    The Efficacy of Lubiprostone in Patients of Constipation: An Updated Systematic Review and Meta-Analysis.
    JGH Open. 2025;9:e70070.
    Abstract

  43. SZCZEPANKOWSKA AK, Cukrowska B, Aleksandrzak-Piekarczyk T
    Complete genome sequence of Bifidobacterium animalis subsp. lactis BI040, a probiotic strain with multiple health benefits from the NORDBIOTIC collection.
    Microbiol Resour Announc. 2025 Jan 17:e0111724. doi: 10.1128/mra.01117.
    Abstract

  44. BARBARO MR, Bianco F, Cremon C, Marasco G, et al
    Lactiplantibacillus plantarum (CECT7484 and CECT7485) and Pedioccoccus acidilactici (CECT7483) enhance actin cytoskeleton and CYP1A1 expression restoring epithelial permeability alterations induced by irritable bowel syndrome mediators.
    Gut Microbes. 2025;17:2452235.
    Abstract

  45. KUMAR A, Vallabhaneni P
    Anxiety disorders presenting as gastrointestinal symptoms in children - a scoping review.
    Clin Exp Pediatr. 2025 Jan 13. doi: 10.3345/cep.2024.01732.
    Abstract

  46. BEGRE S, Fox M, Jordi SBU, Misselwitz B, et al
    [Functional disorders in chronic inflammatory bowel disease: the gut-brain axis].
    Inn Med (Heidelb). 2025 Jan 14. doi: 10.1007/s00108-024-01832.
    Abstract

  47. DING H, Jiang Y, Sun Q, Song Y, et al
    Integrating genetics and transcriptomics to characterize shared mechanisms in digestive diseases and psychiatric disorders.
    Commun Biol. 2025;8:47.
    Abstract

  48. QUIGLEY EM
    Small intestinal bacterial overgrowth: from malabsorption to misinterpretation.
    Minerva Gastroenterol (Torino). 2025 Jan 13. doi: 10.23736/S2724-5985.24.03781.
    Abstract

  49. ZHOU S, Zi J, Hu Y, Wang X, et al
    Genetic correlation, pleiotropic loci and shared risk genes between major depressive disorder and gastrointestinal tract disorders.
    J Affect Disord. 2025;374:84-90.
    Abstract

  50. VALITUTTI F, Mennini M, Monacelli G, Fagiolari G, et al
    Intestinal permeability, food antigens and the microbiome: a multifaceted perspective.
    Front Allergy. 2025;5:1505834.
    Abstract

  51. STEIN T, Collins S, St Louis J
    The prevalence of hypermobile Ehlers-Danlos syndrome at a gender-affirming primary care clinic.
    SAGE Open Med. 2025;13:20503121251315021.
    Abstract

  52. YING J, Zhang MW, Wei KC, Wong SH, et al
    Influential articles in autism and gut microbiota: bibliometric profile and research trends.
    Front Microbiol. 2025;15:1401597.
    Abstract

  53. TABA N, Fischer K, Estonian Biobank Research Team, Org E, et al
    A novel framework for assessing causal effect of microbiome on health: long-term antibiotic usage as an instrument.
    Gut Microbes. 2025;17:2453616.
    Abstract

  54. WEI JJ, Zhang PH, Yang ZY, Liu LP, et al
    Colonoscopic administration of probiotics to treat irritable bowel syndrome with predominant diarrhea: a randomized placebo-controlled clinical trial.
    Surg Endosc. 2025 Jan 23. doi: 10.1007/s00464-025-11542.
    Abstract

  55. DING L, Duan J, Yang T, Yuan M, et al
    Efficacy of fermented foods in irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Front Nutr. 2025;11:1494118.
    Abstract

  56. PAN B, Pan Y, Huang YS, Yi M, et al
    Efficacy and safety of gut microbiome-targeted treatment in patients with depression: a systematic review and meta-analysis.
    BMC Psychiatry. 2025;25:64.
    Abstract

  57. BLACK CJ, Ford AC
    An evidence-based update on the diagnosis and management of irritable bowel syndrome.
    Expert Rev Gastroenterol Hepatol. 2025.
    Abstract

  58. LI M, Zhuo X, Liu Y, You J, et al
    PPARgamma activation attenuates neonatal CRD-induced visceral pain sensitization and anxiety in male rats by alleviating oxidative stress.
    BMC Gastroenterol. 2025;25:22.
    Abstract

  59. ALMABRUK BA, Bajafar AA, Mohamed AN, Al-Zahrani SA, et al
    Efficacy of Probiotics in the Management of Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Cureus. 2024;16:e75954.
    Abstract

  60. BALKRISHNA A, Sinha S, Shukla S, Bhattacharya K, et al
    Anti-ulcerogenic activity of the marine-pearl derived medicine mukta Pishti in Rat model of pylorus ligation-induced peptic ulcer.
    J Ethnopharmacol. 2025;342:119378.
    Abstract

  61. G B, M B, P P, V S, et al
    Bile acid diarrhea in patients with chronic diarrhea. Current appraisal and recommendations for clinical practice.
    Dig Liver Dis. 2025 Jan 17:S1590-8658(24)01144-7. doi: 10.1016/j.dld.2024.
    Abstract

  62. YOSHIDA N, Yasuda T, Inagaki Y, Hasegawa D, et al
    The Impact of Hangeshashinto on Symptoms and Gut Microbiota in Diarrhea-type Irritable Bowel Syndrome: A Retrospective Analysis.
    J Anus Rectum Colon. 2025;9:105-116.
    Abstract

  63. RODINO-JANEIRO BK, Khannous-Lleiffe O, Pigrau M, Willis JR, et al
    Acute stress triggers sex-dependent rapid alterations in the human small intestine microbiota composition.
    Front Microbiol. 2025;15:1441126.
    Abstract

  64. PLOCIENNIK-KORYCKA PK, Pani SM, Bruc B, Contu P, et al
    Exploring Manual Therapy in the Management of Irritable Bowel Syndrome in Adults: A Scoping Review.
    Complement Ther Med. 2025 Jan 27:103136. doi: 10.1016/j.ctim.2025.103136.
    Abstract

  65. FLANAGAN K, Gassner K, Lang M, Ozelyte J, et al
    Human-derived microRNA 21 regulates indole and L-tryptophan biosynthesis transcripts in the gut commensal Bacteroides thetaiotaomicron.
    mBio. 2025 Jan 29:e0392824. doi: 10.1128/mbio.03928.
    Abstract

  66. ASAL MGR, El-Sayed AAI, Alsenany SA, Ramzy ZH, et al
    Self-administered active versus sham acupressure for diarrhea predominant irritable bowel syndrome: a nurse-led randomized clinical trial.
    BMC Nurs. 2025;24:106.
    Abstract

  67. TRIEU TH, Vieujean S, Delhougne N, Seidel L, et al
    Confocal Endomicroscopy Intestinal Epithelial Barrier Abnormalities in Individuals Without Documented Gastro-Intestinal Disease.
    United European Gastroenterol J. 2025 Jan 28. doi: 10.1002/ueg2.12756.
    Abstract

  68. GANZEVOORT IN, van der Veen AL, Alma MA, Berger MY, et al
    Children's and Their Parents' Experiences With Home-Based Guided Hypnotherapy: Qualitative Study.
    JMIR Pediatr Parent. 2025;8:e58301.
    Abstract

  69. JING C, Liu T, Li Q, Zhang C, et al
    Study of dynamic brain function in irritable bowel syndrome via Hidden Markov Modeling.
    Front Neurosci. 2025;18:1515540.
    Abstract

  70. FANG X, Wang X, Zheng W, Yin Y, et al
    Effect of Acupuncture on Anxiety, Depression, and Quality of Life in Patients with Irritable Bowel Syndrome: A Meta-Analysis.
    Int J Behav Med. 2025 Jan 27. doi: 10.1007/s12529-025-10348.
    Abstract

  71. DOENYAS C, Clarke G, Cserjesi R
    Gut-brain axis and neuropsychiatric health: recent advances.
    Sci Rep. 2025;15:3415.
    Abstract

  72. LIANG SB, Cheng HJ, Zhang QY, Han M, et al
    Chinese herbal formula Tongxie Yaofang granules for diarrhoea-predominant irritable bowel syndrome: a randomised, double-blind, placebo-controlled, phase II trial.
    BMJ Open. 2025;15:e088410.
    Abstract

  73. LAKEMEYER M, Latorre R, Blazkova K, Jensen D, et al
    Identification of a secreted protease from Bacteroides fragilis that induces intestinal pain and inflammation by cleavage of PAR2.
    bioRxiv [Preprint]. 2025 Jan 15:2025.01.15.633241.
    Abstract

  74. VELDMAN F, Hawinkels K, Keszthelyi D
    Efficacy of vagus nerve stimulation in gastrointestinal disorders: a systematic review.
    Gastroenterol Rep (Oxf). 2025;13:goaf009.
    Abstract

  75. CATASSI G, Catassi C
    An overview of progress in establishing a diagnostic tool for non-celiac gluten sensitivity.
    Expert Rev Mol Diagn. 2025 Jan 29:1-8. doi: 10.1080/14737159.2025.2458469.
    Abstract

  76. LEI Y, Sun X, Ruan T, Lu W, et al
    Effects of Probiotics and Diet Management in Patients With Irritable Bowel Syndrome: A Systematic Review and Network Meta-analysis.
    Nutr Rev. 2025 Jan 25:nuae217. doi: 10.1093.
    Abstract

  77. RICCI C, Saracino IM, Valerii MC, Spigarelli R, et al
    Very-Low-Absorbable Geraniol for the Treatment of Irritable Bowel Syndrome: A "Real-World" Open-Label Study on 1585 Patients.
    Nutrients. 2025;17:328.
    Abstract

  78. XU Y, Cai Q, Zhao C, Zhang W, et al
    Gegen Qinlian Decoction Attenuates Colitis-Associated Colorectal Cancer via Suppressing TLR4 Signaling Pathway Based on Network Pharmacology and In Vivo/In Vitro Experimental Validation.
    Pharmaceuticals (Basel). 2024;18:12.
    Abstract

  79. ONISOR D, Avram C, Ruta F, Brusnic O, et al
    Burden of Common Mental Disorders in Ulcerative Colitis and Irritable Bowel Syndrome Patients: An Analysis of Risk Factors.
    J Clin Med. 2025;14:499.
    Abstract

  80. ALMONAJJED MB, Wardeh M, Atlagh A, Ismaiel A, et al
    Impact of Microbiota on Irritable Bowel Syndrome Pathogenesis and Management: A Narrative Review.
    Medicina (Kaunas). 2025;61:109.
    Abstract

  81. KASTI A, Katsas K, Nikolaki MD, Triantafyllou K, et al
    The Role and the Regulation of NLRP3 Inflammasome in Irritable Bowel Syndrome: A Narrative Review.
    Microorganisms. 2025;13:171.
    Abstract

  82. NISTICO V, Conte F, Rossetti I, Ilia N, et al
    Exploring specific alterations at the explicit and perceptual levels in sense of ownership, agency, and body schema in Functional Motor Disorder: A pilot comparative study with Irritable Bowel Syndrome.
    Cortex. 2025;184:106-119.
    Abstract

  83. QI S, Zhao M, Sun Y, Boro S, et al
    Impact of vitamin D supplementation on symptom severity and quality of life in patients with irritable bowel syndrome: A meta-analysis.
    Adv Clin Exp Med. 2025 Jan 24. doi: 10.17219/acem/191463.
    Abstract

  84. DARWISH B, Aboualchamat G, Al Nahhas S
    Blastocystis ST1: Protein Profile and Specific Serum Immunoglobulin in Irritable Bowel Syndrome (IBS) Patients.
    Acta Parasitol. 2025;70:27.
    Abstract

  85. SINGH P, Chey SW, Nee J, Eswaran S, et al
    Is a Simplified, Less Restrictive Low FODMAP Diet Possible? Results From a Double-Blind, Pilot Randomized Controlled Trial.
    Clin Gastroenterol Hepatol. 2025;23:362-364.
    Abstract

  86. XIAO Y, Meng X, Luo Q, Hou X, et al
    Real-world safety of linaclotide in Chinese patients with irritable bowel syndrome with constipation: a multicenter, single-arm, prospective observational study.
    Therap Adv Gastroenterol. 2025;18:17562848251314819.
    Abstract

  87. KHAN Z, Muhammad SA, Amin MS, Gul A, et al
    The Efficacy of the Low-FODMAP (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols) Diet in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Cureus. 2025;17:e77053.
    Abstract


  88. Comparison chart: Some drugs for irritable bowel syndrome with diarrhea (IBS-D).
    Med Lett Drugs Ther. 2025;67:e1-e3.
    Abstract


  89. Comparison chart: Some drugs for irritable bowel syndrome with constipation (IBS-C).
    Med Lett Drugs Ther. 2025;67:e1-e3.
    Abstract


  90. Comparison chart: Some drugs for abdominal pain in irritable bowel syndrome (IBS).
    Med Lett Drugs Ther. 2025;67:e1-e2.
    Abstract


  91. Comparison chart: Safety of drugs for IBS in pregnancy and lactation.
    Med Lett Drugs Ther. 2025;67:e1-e2.
    Abstract


  92. Drugs for irritable bowel syndrome.
    Med Lett Drugs Ther. 2025;67:17-24.
    Abstract

  93. PEREYRA F, Schlottmann F, Casas MA, Steinberg L, et al
    Exploring the gut-brain axis in a large cohort of patients with irritable bowel syndrome: Is there a link between depression and intestinal and extra-intestinal symptoms?
    Gastroenterol Hepatol. 2025 Feb 3:502370. doi: 10.1016/j.gastrohep.2025.502370.
    Abstract

  94. PURI S, Nath DK, Lee Y
    Regulation of Feeding and Defecation in Drosophila by Trpgamma, Piezo, and DH44R2.
    Insect Biochem Mol Biol. 2025 Feb 3:104267. doi: 10.1016/j.ibmb.2025.104267.
    Abstract

  95. SUN Q, Weng RX, Li YC, Jia SM, et al
    Potentiation of visualized exosomal miR-1306-3p from primary sensory neurons contributes to chronic visceral pain via spinal P2X3 receptors.
    Pain. 2025 Feb 3. doi: 10.1097/j.pain.0000000000003537.
    Abstract

  96. DOGHISH AS, Elazazy O, Mohamed HH, Mansour RM, et al
    A Review on miRNAs in Enteric Bacteria-mediated Host Pathophysiology: Mechanisms and Implications.
    J Biochem Mol Toxicol. 2025;39:e70160.
    Abstract

  97. URIOT O, Deschamps C, Scanzi J, Brun M, et al
    Gut microbial dysbiosis associated to diarrheic irritable bowel syndrome can be efficiently simulated in the Mucosal ARtificial COLon (M-ARCOL).
    Bioengineered. 2025;16:2458362.
    Abstract

  98. SMIRNOFF L, Moskatel LS
    Dyspareunia and pelvic pain in women with chronic migraine: A retrospective, observational analysis.
    Headache. 2025 Feb 4. doi: 10.1111/head.14905.
    Abstract

  99. CHEN X, Tang R, Jin Y, Wu L, et al
    Similarities and Differences in Resting-State Brain Activity Changes of Distinct Chronic Pain Types.
    Oral Dis. 2025 Feb 4. doi: 10.1111/odi.15271.
    Abstract

  100. HAMAL A, Shin A, van Tilburg MAL
    Yoga, Meditation, Mindfulness, or Hypnotherapy for GI Disorders: Similar Mechanisms of Action?
    Neurogastroenterol Motil. 2025 Feb 3:e15014. doi: 10.1111/nmo.15014.
    Abstract

  101. BERENTSEN B, Thuen C, Hillestad EMR, Steinsvik EK, et al
    The Effects of Digital eHealth Versus Onsite 2-Day Group-Based Education in 255 Patients With Irritable Bowel Syndrome: Cohort Study.
    JMIR Hum Factors. 2025;12:e43618.
    Abstract

  102. TUNCEL ET, Ozcan SS, Korkmaz M, Borekci E, et al
    Serum salusin levels in diarrhea- and constipation-predominant irritable bowel syndrome.
    PeerJ. 2025;13:e18859.
    Abstract


  103. Reasons for Treatment Discontinuation in Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation.
    Gastroenterol Hepatol (N Y). 2024;20.
    Abstract


  104. Impact of Weight on the Efficacy, Time to Response, and Safety of Linaclotide in Adults With Chronic Idiopathic Constipation or Irritable Bowel Syndrome With Constipation: Post Hoc Descriptive Analysis by Body Mass Index.
    Gastroenterol Hepatol (N Y). 2024;20.
    Abstract


  105. Efficacy and Safety of Plecanatide in Treatment of Irritable Bowel Syndrome With Constipation and Chronic Idiopathic Constipation.
    Gastroenterol Hepatol (N Y). 2024;20.
    Abstract


  106. Patients With Irritable Bowel Syndrome With Constipation From the IBS in America 2024 Real-World Survey Experience Burdensome Symptoms Beyond Constipation.
    Gastroenterol Hepatol (N Y). 2024;20.
    Abstract


  107. Plecanatide Is Efficacious in Patients With Irritable Bowel Syndrome With Constipation and Bloating: Evaluation Using Trisymptom Composite Endpoints.
    Gastroenterol Hepatol (N Y). 2024;20.
    Abstract


  108. Irritable Bowel Syndrome With Constipation Poses a Substantial Burden to Patient Overall Health Status and Quality of Life: Results From the IBS in America 2024 Real-World Survey.
    Gastroenterol Hepatol (N Y). 2024;20.
    Abstract

  109. LI Y, Mai Y, Jiao Y, Yuan Y, et al
    Alterations in the Tongue Coating Microbiome in Patients With Diarrhea-Predominant Irritable Bowel Syndrome: A Cross-Sectional Study.
    APMIS. 2025;133:e70001.
    Abstract

  110. KHALIL J, Hill H, Einstadter D, Fass R, et al
    Combined oral contraceptives are associated with increased risk of developing gastroparesis in pre-menopausal women.
    Dig Liver Dis. 2025 Feb 1:S1590-8658(25)00202-6. doi: 10.1016/j.dld.2025.
    Abstract

  111. PROSPERO L, Riezzo G, D'Attoma B, Ignazzi A, et al
    The impact of locus of control on somatic and psychological profiles of patients with irritable bowel syndrome engaging in aerobic exercise.
    Sci Rep. 2025;15:3966.
    Abstract

  112. DENT E, Davinson N, Wilkie S, Stevens D, et al
    A qualitative exploration into the lived experiences of females with a gastrointestinal condition.
    J Health Psychol. 2025 Jan 31:13591053251315685. doi: 10.1177/13591053251315685.
    Abstract

  113. POGREBA BROWN K, Austhof E, McFadden CM, Scranton C, et al
    Determining the incidence, risk factors and biological drivers of irritable bowel syndrome (IBS) as part of the constellation of postacute sequelae of SARS-CoV-2 infection (PASC) outcomes in the Arizona CoVHORT-GI: a longitudinal cohort study.
    BMJ Open. 2025;15:e095093.
    Abstract

  114. TSAI K, Xu P, Guo J, Dean N, et al
    Do Bowel Disorders Affect Holmium Laser Enucleation of Prostate Outcomes? A Retrospective Cohort Study.
    Ther Adv Urol. 2025;17:17562872251317918.
    Abstract

  115. MINJOZ S, Jeanne R, Vercueil L, Sabourdy C, et al
    Heart Rate Variability Biofeedback to Manage the Mental Health of Adults With Irritable Bowel Syndrome: A Pilot Study.
    Stress Health. 2025;41:e70015.
    Abstract

  116. LIU D, Cao M, Wu S, Jiang Y, et al
    Modifiable factors for irritable bowel syndrome: evidence from Mendelian randomisation approach.
    eGastroenterology. 2025;3:e100126.
    Abstract

  117. LUCARINI E, Aguilera-Lizarraga J, Tejada MA
    Editorial: Advances in the pharmacotherapy of chronic pelvic pain conditions.
    Front Pharmacol. 2025;16:1546059.
    Abstract

  118. HAO Y, Qi J, Huang X, Liu C, et al
    Euodiae Fructus: a review of botany, application, processing, phytochemistry, quality control, pharmacology, and toxicology.
    Front Pharmacol. 2025;16:1509032.
    Abstract

  119. HACKER KS, Bedell A
    Reproductive and sexual health concerns in gastrointestinal illness: a narrative review.
    Transl Gastroenterol Hepatol. 2024;10:15.
    Abstract

  120. KRYNICKA P, Koulaouzidis G, Skonieczna-Zydecka K, Marlicz W, et al
    Application of Raman Spectroscopy in Non-Invasive Analysis of the Gut Microbiota and Its Impact on Gastrointestinal Health.
    Diagnostics (Basel). 2025;15:292.
    Abstract

  121. YOUSSOUFI N, Jaafari A, Mansour S, El Hamdi M, et al
    A Two-for-One Diagnosis: A Rare Case of Chronic Abdominal Pain Caused by Gastroptosis and Wilkie's Syndrome in a Young Woman.
    Diagnostics (Basel). 2025;15:270.
    Abstract

  122. ALOISIO CARUSO E, De Nunzio V, Tutino V, Notarnicola M, et al
    The Endocannabinoid System: Implications in Gastrointestinal Physiology and Pathology.
    Int J Mol Sci. 2025;26:1306.
    Abstract

  123. MOLINO S, De Lellis LF, Morone MV, Cordara M, et al
    Improving Irritable Bowel Syndrome (IBS) Symptoms and Quality of Life with Quebracho and Chestnut Tannin-Based Supplementation: A Single-Centre, Randomised, Double-Blind, Placebo-Controlled Clinical Trial.
    Nutrients. 2025;17:552.
    Abstract

  124. ZHANG H, Su Q
    Low-FODMAP Diet for Irritable Bowel Syndrome: Insights from Microbiome.
    Nutrients. 2025;17:544.
    Abstract

  125. ANTONELLI A, Bianchi M, Fear EJ, Giorgi L, et al
    Management of Fibromyalgia: Novel Nutraceutical Therapies Beyond Traditional Pharmaceuticals.
    Nutrients. 2025;17:530.
    Abstract

  126. TOVO PA, Ribaldone DG, Caviglia GP, Calvi C, et al
    Patients with Irritable Bowel Syndrome Exhibit Aberrant Expression of Endogenous Retroviruses and SETDB1.
    Cells. 2025;14:196.
    Abstract

  127. LIU H, Shao S, Chen B, Yang S, et al
    Mendelian randomization analysis reveals causal relationship between tonsillectomy and irritable bowel syndrome.
    Front Surg. 2025;12:1436227.
    Abstract

  128. REXWINKEL R, Vermeijden NK, Zeevenhooven J, Kelder J, et al
    The low FODMAP diet in adolescents functional abdominal in a non-guided setting: a prospective multicenter cohort study.
    Eur J Pediatr. 2025;184:189.
    Abstract

  129. CHEN Y, Fang JY
    The role of colonic microbiota amino acid metabolism in gut health regulation.
    Cell Insight. 2025;4:100227.
    Abstract

  130. GAO Y, Chen C, Huang X, Liu Y, et al
    Omentin-1, a Protective Adipokine for Irritable Bowel Syndrome.
    J Inflamm Res. 2025;18:1689-1701.
    Abstract

  131. THOMAS NS, Gillespie NA, Neale MC, Rosmalen JGM, et al
    Clinical heterogeneity in major depressive disorder underlies comorbidity with functional disorders.
    J Psychiatr Res. 2025;183:16-24.
    Abstract

  132. GROSEN AK, Boldsen JK, Mikkelsen S, Mark Dahl Baunwall S, et al
    Gastrointestinal symptoms and bowel habits in 53 046 healthy Danish blood donors: a nationwide cross-sectional study.
    BMJ Open Gastroenterol. 2025;12:e001518.
    Abstract

  133. HEYMANN JB, White KS, Bruce SE
    The Relationship Between Trauma Exposure, PTSD Symptoms, and Gastrointestinal Symptoms.
    Int J Behav Med. 2025 Feb 21. doi: 10.1007/s12529-025-10355.
    Abstract

  134. KORETZ RL
    JPEN Journal Club 91. Choosing the population to study.
    JPEN J Parenter Enteral Nutr. 2025 Feb 19. doi: 10.1002/jpen.2737.
    Abstract

  135. SILVA BCD, Ramos GP, Barros LL, Ramos AFP, et al
    DIAGNOSIS AND TREATMENT OF SMALL INTESTINAL BACTERIAL OVERGROWTH: AN OFFICIAL POSITION PAPER FROM THE BRAZILIAN FEDERATION OF GASTROENTEROLOGY.
    Arq Gastroenterol. 2025;62:e24107.
    Abstract

  136. YU RL, Weber HC
    Irritable bowel syndrome, the gut microbiome, and diet.
    Curr Opin Endocrinol Diabetes Obes. 2025.
    Abstract

  137. WANG L, Cao W, Zheng QH, Li D, et al
    Relationship Between FODMAP Diet and Irritable Bowel Syndrome: A Mendelian Randomization Study.
    Food Sci Nutr. 2025;13:e70037.
    Abstract

  138. DURSA EK, Cypel YS, Culpepper WJ, Bernhard PA, et al
    The Physical and Mental Health of Post-9/11 Female and Male Veterans: Findings from the Comparative Health Assessment Interview Research Study.
    J Womens Health (Larchmt). 2025 Feb 18. doi: 10.1089/jwh.2024.0605.
    Abstract

  139. ALEXANDERSSON BT, Jones MP, Forsberg A, Hedin CRH, et al
    Uncomplicated Diverticulosis Is Not Associated With Abdominal Pain or Abnormal Bowel Habit-A Population-Based Swedish Cohort Study.
    Neurogastroenterol Motil. 2025 Feb 17:e70000. doi: 10.1111/nmo.70000.
    Abstract

  140. LU JN, Dou JH, Yi ZL, Lian L, et al
    EXPRESS: Upregulation of LRRC8A in the anterior cingulate cortex mediates chronic visceral pain in adult male mice with neonatal maternal deprivation.
    Mol Pain. 2025 Feb 17:17448069251324645. doi: 10.1177/17448069251324645.
    Abstract

  141. PHAN TN, Tran QK, Truong XL, Nguyen THT, et al
    Anxiety and Depression Disorders in Vietnamese Patients With Irritable Bowel Syndrome: A Cross-Sectional Clinic-Based Study.
    JGH Open. 2025;9:e70116.
    Abstract

  142. PALMIERI B, Vadala M
    Clinoptilolite in the drug refractory chronic diarrhoea.
    Clin Ter. 2025;176:6-12.
    Abstract

  143. JIANAN Y, Kunming C, Chao LI, Xiang Z, et al
    Atractylenolide I ameliorates post-infectious irritable bowel syndrome by inhibiting the polymerase I and transcript release factor and c-Jun N-terminal kinase/inducible nitric oxide synthase pathway.
    J Tradit Chin Med. 2025;45:57-65.
    Abstract

  144. SITING LI, Shaojun W, Yehui Y, Gejing DE, et al
    Electroacupuncture alleviates zymosan-induced colorectal hypersensitivity.
    J Tradit Chin Med. 2025;45:32-38.
    Abstract

  145. KERN D, Ljotsson B, Lonndahl L, Hedman-Lagerlof E, et al
    Self-Guided vs Clinician-Guided Online Cognitive Behavioral Therapy for Atopic Dermatitis: A Randomized Clinical Trial.
    JAMA Dermatol. 2025;161:183-190.
    Abstract

  146. KHOSRAVANY Z, Khodavaisy S, Olyaiee A, Sadeghi A, et al
    A preliminary study of the association between Blastocystis and quantification of selected yeasts in IBD and IBS patients.
    Front Med (Lausanne). 2025;12:1514587.
    Abstract

  147. BUTT MF, Cefalo F, Sbarigia C, Dhali A, et al
    Impact of Opioid and Cannabis Use on Low-Dose Amitriptyline Efficacy in Cyclical Vomiting Syndrome: A Real-World Study in the United Kingdom.
    Neurogastroenterol Motil. 2025 Feb 27:e70007. doi: 10.1111/nmo.70007.
    Abstract

  148. FARRIS SG, Derby L, Kibbey MM
    Getting comfortable with physical discomfort: A scoping review of interoceptive exposure in physical and mental health conditions.
    Psychol Bull. 2025;151:131-191.
    Abstract

  149. FLUYAU D, Kailasam VK, Kim P, Revadigar N, et al
    Selective serotonin reuptake inhibitors and quality of life: a meta-analysis of randomized placebo-controlled trials.
    Int Clin Psychopharmacol. 2025 Feb 28. doi: 10.1097/YIC.0000000000000585.
    Abstract

  150. HOU S, Yu J, Li Y, Zhao D, et al
    Advances in Fecal Microbiota Transplantation for Gut Dysbiosis-Related Diseases.
    Adv Sci (Weinh). 2025 Feb 27:e2413197. doi: 10.1002/advs.202413197.
    Abstract

  151. GUADANO-PROCESI I, Berrilli F, Di Cave D
    Spatial and Genetic Diversity of Clinical Isolates of Blastocystis in Italy: A Network Analysis.
    Pathogens. 2025;14:139.
    Abstract

  152. GIACOSA A, Barrile GC, Gasparri C, Perna S, et al
    Positive Effect of Lecithin-Based Delivery Form of Curcuma and Boswellia Extracts on Irritable Bowel Syndrome After COVID-19 Infection.
    Nutrients. 2025;17:723.
    Abstract

  153. SANCHEZ-PELLICER P, Alamo-Marzo JM, Martinez-Villaescusa M, Nunez-Delegido E, et al
    Comparative Analysis of Gut Microbiota in Patients with Irritable Bowel Syndrome and Healthy Controls.
    J Clin Med. 2025;14:1198.
    Abstract

  154. MARANO G, Traversi G, Pola R, Gasbarrini A, et al
    Irritable Bowel Syndrome: A Hallmark of Psychological Distress in Women?
    Life (Basel). 2025;15:277.
    Abstract

  155. MOLFETTA R, Carnevale A, Marangio C, Putro E, et al
    Beyond the "Master" Role in Allergy: Insights into Intestinal Mast Cell Plasticity and Gastrointestinal Diseases.
    Biomedicines. 2025;13:320.
    Abstract

  156. LUNDERVOLD A, Bjorsvik BR, Billing J, Berentsen B, et al
    Brain Morphometry and Cognitive Features in the Prediction of Irritable Bowel Syndrome.
    Diagnostics (Basel). 2025;15:470.
    Abstract

  157. POP D, Man SC, Farcau D
    Anxiety and Depression in Children with Irritable Bowel Syndrome-A Narrative Review.
    Diagnostics (Basel). 2025;15:433.
    Abstract

  158. TORBICA AM, Miljic M, Radosavljevic M
    FODMAP Profile of Wholegrain Pasta.
    Foods. 2025;14:667.
    Abstract

  159. TORBICA AM, Filipcev B, Vujasinovic V, Miljic U, et al
    Biotechnological Tools for the Production of Low-FODMAP Wholegrain Wheat and Rye Cookies and Crackers.
    Foods. 2025;14:582.
    Abstract

  160. VAN GILS T, Simren M
    The role of gluten and wheat in irritable bowel syndrome and noncoeliac gluten or wheat sensitivity.
    Curr Opin Gastroenterol. 2025 Feb 18. doi: 10.1097/MOG.0000000000001090.
    Abstract

  161. WANG Z, Chen Y, Li X, Lin L, et al
    Placebo response variability on health-related quality of life outcomes in irritable bowel syndrome: an arm-based network meta-analysis.
    Qual Life Res. 2025 Feb 25. doi: 10.1007/s11136-025-03927.
    Abstract

  162. KIRK D, Louca P, Attaye I, Zhang X, et al
    Multifluid Metabolomics Identifies Novel Biomarkers for Irritable Bowel Syndrome.
    Metabolites. 2025;15:121.
    Abstract

  163. SPECKMANN B, Jordan PM, Werz O, Hofstetter RK, et al
    Bacillusmegaterium DSM 32963 Enhances Specialized Pro-Resolving Mediator Production from an n-3 PUFA Salt in a Dynamic Model of the Human Intestine.
    Metabolites. 2025;15:105.
    Abstract

  164. LU D, Ma X, Tao K, Lei H, et al
    Advancements in the Pathogenesis, Diagnosis, and Therapeutic Implications of Intestinal Bacteria.
    Curr Issues Mol Biol. 2025;47:106.
    Abstract

  165. JENT S, Kristin Luthi JJ, Meichtry A, Bez NS, et al
    Developing a core outcome set for nutrition care in adult outpatients with irritable bowel syndrome (COS-RD-IBS Study).
    Clin Nutr ESPEN. 2025 Feb 22:S2405-4577(25)00080.
    Abstract

  166. BARANGUAN CASTRO ML, Ros Arnal I, Garcia Romero R, Lorenzo Garrido H, et al
    Low FODMAP diet in children with functional abdominal pain disorders. Is it always worth trying?: Low FODMAP diet in children with functional abdominal pain disorders.
    Arch Pediatr. 2025 Feb 22:S0929-693X(25)00047.
    Abstract

  167. YU X, Chen X, Ouyang J, Xi B, et al
    Exploring the mechanisms of Shugan-Jieyu-Jianpi formula against irritable bowel syndrome combined with non-alcoholic fatty liver disease by network pharmacology and experimental validation.
    Growth Factors. 2025 Feb 22:1-19. doi: 10.1080/08977194.2025.2467135.
    Abstract

  168. GOMES P, Laroute V, Beaufrand C, Bezirard V, et al
    Postbiotic potential of Lactococcus lactis CNCM I-5388 in alleviating visceral pain in female rat through GABA production: The innovative concept of the "active-GAD bag".
    FASEB J. 2025;39:e70383.
    Abstract

  169. SULAIMI F, Ong TSK, Tang ASP, Quek J, et al
    Risk factors for developing irritable bowel syndrome: systematic umbrella review of reviews.
    BMC Med. 2025;23:103.
    Abstract

  170. SOMEILI A, Mutaen AA, Alqahtani AM, Mobaraki RA, et al
    Aspects on Self-Reported Symptoms in Irritable Bowel Syndrome: A Cross-Sectional Study.
    Gastroenterology Res. 2025;18:31-37.
    Abstract

  171. DENG N, Xie S, Liu Q, Peng H, et al
    The intestinal microbiota modulates the visceral sensitivity involved in IBS induced by restraint combined with tail clustering.
    Front Cell Infect Microbiol. 2025;15:1549617.
    Abstract

  172. EL-SALHY M, Johansson M, Klevstul M, Hatlebakk JG, et al
    Quality of life, functional impairment and healthcare experiences of patients with irritable bowel syndrome in Norway: an online survey.
    BMC Gastroenterol. 2025;25:143.
    Abstract

  173. SEATON N, Wileman V, Norton C, Hudson J, et al
    The relationships between depression, inflammation and self-reported disease activity in IBD and their impact on healthcare usage.
    BMC Gastroenterol. 2025;25:140.
    Abstract

  174. LI P, Tang Y, Liu L, Yang L, et al
    The diagnostic criteria for psychosomatic research-revised (DCPR-R) in a National China multicenter cohort of patients with irritable bowel syndrome and overlapping gastroesophageal reflux disease.
    BMC Gastroenterol. 2025;25:136.
    Abstract

  175. STILES E, Robinson A, Fitzgerald E, Fleury M, et al
    Duodenal Peptic Ulcer Perforation in the Puerperium Case Report Series.
    AJP Rep. 2025;15:e32-e35.
    Abstract

  176. CHU P, He Y, Hu F, Wang X, et al
    The effects of low FODMAP diet on gut microbiota regulation: A systematic review and meta-analysis.
    J Food Sci. 2025;90:e70072.
    Abstract

  177. MOTELOW JE, Malakar A, Krishna Murthy SB, Verbitsky M, et al
    Interstitial Cystitis: a phenotype and rare variant exome sequencing study.
    medRxiv [Preprint]. 2025 Feb 18:2025.02.16.25322147.
    Abstract

  178. BARNETT BS, Mauney EE, King F 4th
    Psychedelic-assisted therapy: An overview for the internist.
    Cleve Clin J Med. 2025;92:171-180.
    Abstract

  179. CHAN Y, Chang BW, Kaboj AK, Raphael Y, et al
    Radiographic identification of visceroptosis in hypermobile Ehlers-Danlos syndrome patients with functional gastrointestinal symptoms compared to healthy subjects.
    Clin Transl Gastroenterol. 2025 Mar 3. doi: 10.14309/ctg.0000000000000834.
    Abstract

  180. ZHANG X, Liu H, Li Y, Wen Y, et al
    Linking dietary fiber to human malady through cumulative profiling of microbiota disturbance.
    Imeta. 2025;4:e70004.
    Abstract

  181. LINDSELL HB, Williams NC, Magistro D, Corsetti M, et al
    Could the Therapeutic Effect of Physical Activity on Irritable Bowel Syndrome Be Mediated Through Changes to the Gut Microbiome? A Narrative and Hypothesis Generating Review.
    Neurogastroenterol Motil. 2025 Mar 3:e70004. doi: 10.1111/nmo.70004.
    Abstract

  182. CHEN X, Carvalho B, Sinha A, Pittman N, et al
    Irritable Bowel Syndrome with Diarrhea in Pediatric Patients is Associated with Type 2 and Type 9 T Cells in the Intestinal Mucosa.
    Cell Mol Gastroenterol Hepatol. 2025 Feb 28:101488.
    Abstract

  183. SENGUPTA JN, Terashvili M, Medda BK
    Visceral analgesic effect of eluxadoline (Viberzi): A central action.
    J Pharmacol Exp Ther. 2025;392:100056.
    Abstract

  184. MOREAU LA, Ford AC, Brookes MJ, Graca S, et al
    Management of diarrhoea in patients with stable ulcerative colitis with low FODMAP diet, amitriptyline, ondansetron or loperamide: the MODULATE RCT.
    Health Technol Assess. 2025 Mar 12:1-30. doi: 10.3310/GHFE4871.
    Abstract

  185. ULLAH H, Arbab S, Chang C, Bibi S, et al
    Gut microbiota therapy in gastrointestinal diseases.
    Front Cell Dev Biol. 2025;13:1514636.
    Abstract

  186. RONDINELLA D, Raoul PC, Valeriani E, Venturini I, et al
    The Detrimental Impact of Ultra-Processed Foods on the Human Gut Microbiome and Gut Barrier.
    Nutrients. 2025;17:859.
    Abstract

  187. GAO Y, Borjihan Q, Zhang W, Li L, et al
    Complex Probiotics Ameliorate Fecal Microbiota Transplantation-Induced IBS in Mice via Gut Microbiota and Metabolite Modulation.
    Nutrients. 2025;17:801.
    Abstract

  188. OH CK, Chung HH, Kim YJ, Kim JB, et al
    Comparison of Rifaximin Monotherapy and Rifaximin Combined with Probiotics in Patients with Irritable Bowel Syndrome: A Randomized Controlled Trial.
    Nutrients. 2025;17:763.
    Abstract

  189. JEONG ES, Jung HK, Choi E, Yun K, et al
    Characterization of post-inflammatory irritable bowel syndrome animal model following acute colitis recovery.
    Sci Rep. 2025;15:8512.
    Abstract

  190. OU H, Lai Z, Ye X, Wang X, et al
    Irritable bowel syndrome and structural brain changes - A two-sample Mendelian randomization study of cortical thickness and surface area.
    Rev Esp Enferm Dig. 2025 Mar 11. doi: 10.17235/reed.2025.10983/2024.
    Abstract

  191. WINDER C, Lodhia A, Basso M, Cohen Kadosh K, et al
    Gut microbiome differences in individuals with PTSD compared to trauma-exposed controls: a systematic review.
    Front Neurosci. 2025;19:1540180.
    Abstract

  192. BAI Y, Zhang M, Chen L, Zhou P, et al
    Gastrointestinal traits, common inflammatory disorders, gallstones, and biliary tract cancer: A network Mendelian randomization study.
    J Adv Res. 2025 Mar 8:S2090-1232(25)00151-1. doi: 10.1016/j.jare.2025.
    Abstract

  193. ZEROUGA I, Valeur J, Sommer C, Carlsen MH, et al
    Habitual Intake of Macronutrients and Fermentable Oligo-, Di-, Monosaccharides and Polyols is not associated with Irritable Bowel Syndrome-like Symptoms in Inflammatory Bowel Disease.
    Clin Nutr ESPEN. 2025 Mar 8:S2405-4577(25)00095.
    Abstract

  194. OLSEN BC, Opheim R, Kristensen VA, Hoivik ML, et al
    Prevalence of Irritable Bowel Syndrome Based on Rome IV Criteria in Patients in Biochemical and Endoscopic Remission From Newly Diagnosed Inflammatory Bowel Disease: One- and Three-Year Results (the IBSEN III Cohort).
    Inflamm Bowel Dis. 2025 Mar 10:izaf047. doi: 10.1093.
    Abstract

  195. PELLEGRINO R, Gravina AG
    Irritable bowel syndrome remains a complex disorder of gut-brain interaction: Too many actors on stage.
    World J Gastroenterol. 2025;31:101357.
    Abstract

  196. LARAUCHE M, Mahurkar-Joshi S, Biraud M, Ju T, et al
    Sex-dependent alterations of colonic epithelial permeability: relevance to irritable bowel syndrome.
    Front Physiol. 2025;16:1509935.
    Abstract

  197. PETERSON MD, O'Leary M, Ashbaugh K, Haapala H, et al
    Medication and Therapy Profiles for Pain and Symptom Management Among Adults With Cerebral Palsy.
    Mayo Clin Proc Innov Qual Outcomes. 2025;9:100597.
    Abstract

  198. CINAR E, Turkoglu Aytar MB, Baklaci M, Hepguler S, et al
    Fecal calprotectin levels in patients with fibromyalgia: A cross-sectional study.
    Arch Rheumatol. 2024;39:522-528.
    Abstract

  199. GIORGIO V, Venezia I, Pensabene L, Blasi E, et al
    Psycho-gastroenterological profile of an Italian population of children with disorders of gut-brain interaction: A case-control study.
    World J Clin Pediatr. 2025;14:97543.
    Abstract

  200. ALMARIO CV, Choi SY, Chey WD, Spiegel BMR, et al
    Trends in Prevalence of Rome IV Disorders of Gut-Brain Interaction During the COVID-19 Pandemic: Results From a Nationally Representative Sample of Over 160,000 People in the US.
    Neurogastroenterol Motil. 2025 Mar 10:e70020. doi: 10.1111/nmo.70020.
    Abstract

  201. ZHOU Q, Yang L, Verne ZT, Zhang BB, et al
    Human colonic EVs induce murine enteric neuroplasticity via the lncRNA GAS5/miR-23/NMDA NR2B axis.
    JCI Insight. 2025;10:e178631.
    Abstract

  202. COLOMIER E, Halminen J, Bjorck M, Hoskuldsdottir G, et al
    Prevalence and Factors Associated With Symptom Profiles of Disorders of Gut-Brain Interaction in Obesity Before and After Treatment.
    Neurogastroenterol Motil. 2025 Mar 10:e70017. doi: 10.1111/nmo.70017.
    Abstract

  203. FAN H, Zhan Y, Cheng X, Tan M, et al
    Lacidophilin tablets relieve irritable bowel syndrome in rats by regulating gut microbiota dysbiosis and intestinal inflammation.
    Sci Rep. 2025;15:8151.
    Abstract

  204. YU S, Zhou Y, Liu S, Zhang Q, et al
    Both general and central obesity are associated with increased risk of irritable bowel syndrome: a large-scale prospective cohort study.
    Am J Clin Nutr. 2025 Mar 5:S0002-9165(25)00127.
    Abstract

  205. BAST E, Jester DJ, Palacio A, Krengel M, et al
    Gulf War Illness: A Historical Review and Considerations of a Post-Viral Syndrome.
    Mil Med. 2025 Mar 21:usaf092. doi: 10.1093.
    Abstract

  206. WU S, Yang Z, Liu S, Zhang Q, et al
    Sugar-Sweetened Beverages, Artificially Sweetened Beverages and Sugar Forms With Long-Term Risk of Irritable Bowel Syndrome: A Large-Scale Prospective Cohort Study.
    Food Sci Nutr. 2025;13:e70094.
    Abstract

  207. ABDELNAIM MA, Hebel T, Lang-Hambauer V, Schlaier J, et al
    Deep brain stimulation for obsessive compulsive disorder leads to symptom changes of comorbid irritable bowel syndrome.
    Front Psychiatry. 2025;16:1545318.
    Abstract

  208. TUMAS V, Aureliano MJ, Rieder CRM, Schuh AFS, et al
    Modifiable risk factors associated with the risk of developing Parkinson's disease: a critical review.
    Arq Neuropsiquiatr. 2025;83:1-10.
    Abstract

  209. RUZMAN E, Zaja O, Karuza J, Banjari I, et al
    THE PREVALENCE OF ORTHOREXIA NERVOSA AMONG GYM PARTICIPANTS FROM CROATIA: AN OBSERVATIONAL STUDY.
    Acta Clin Croat. 2024;63:306-315.
    Abstract

  210. YANG L, Fang Z, Zhu J, Li X, et al
    The potential of Sijunzi decoction in the fight against gastrointestinal disorders: a review.
    Front Pharmacol. 2025;16:1464498.
    Abstract

  211. FORSTER PM, Jakob MO, Yusuf D, Bubeck M, et al
    A transcriptional atlas of gut-innervating neurons reveals activation of interferon signaling and ferroptosis during intestinal inflammation.
    Neuron. 2025 Mar 12:S0896-6273(25)00136-9. doi: 10.1016/j.neuron.2025.
    Abstract

  212. FRIESEN HJ, Singh N, Schurman JV, Deacy AD, et al
    A Scoping Review of Sleep Disturbances in Children and Adolescents with Abdominal Pain Disorders.
    Pediatric Health Med Ther. 2025;16:67-73.
    Abstract

  213. MANDA O, Hadjivassiliou M, Varrassi G, Zavridis P, et al
    Exploring the Role of the Cerebellum in Pain Perception: A Narrative Review.
    Pain Ther. 2025 Mar 17. doi: 10.1007/s40122-025-00724.
    Abstract

  214. SEVERO JS, Silva ACAD, Santos BLBD, Reinaldo TS, et al
    Physical Exercise as a Therapeutic Approach in Gastrointestinal Diseases.
    J Clin Med. 2025;14:1708.
    Abstract

  215. LUO J, Xu Q, Xu S, Zhai L, et al
    Decoding Abdominal Pain in Constipation-predominant Irritable Bowel Syndrome and Functional Constipation: Mechanisms and Managements.
    Curr Gastroenterol Rep. 2025;27:22.
    Abstract

  216. XING Y, Martin L
    Is there a sex difference in response to FODMAP diet group education for IBS? A clinical practice service evaluation.
    Nutr Health. 2025 Mar 17:2601060251324235. doi: 10.1177/02601060251324235.
    Abstract

  217. JULIAN-FLORES A, Aguilar-Zarate P, Michel MR, Sepulveda-Torre L, et al
    Exploring the Therapeutic Potential of Medicinal Plants in the Context of Gastrointestinal Health: A Review.
    Plants (Basel). 2025;14:642.
    Abstract

  218. ASARE-WEREHENE M, Bohn MK, Ming-Freckleton A, Selvaratnam R, et al
    The case of a bloody mess - Bictegravir/emtricitabine/tenofovir alafenamide induced colitis.
    Clin Biochem. 2025 Mar 13:110910. doi: 10.1016/j.clinbiochem.2025.110910.
    Abstract

  219. HAJJEH O, Rajab I, Bdair M, Saife S, et al
    Enteric nervous system dysfunction as a driver of central nervous system disorders: The Forgotten brain in neurological disease.
    Neuroscience. 2025;572:232-247.
    Abstract

  220. SANTIBANEZ M, Lounsbury N, Moreno M, Singh-Franco D, et al
    Thrombosis Secondary to Intravenous Dicyclomine Administration: A Case Report and Literature Review.
    J Pharm Pract. 2025 Mar 14:8971900251326808. doi: 10.1177/08971900251326808.
    Abstract

  221. BANKER H, Goel A, Kumawat S, Anamika F, et al
    Cognitive Impairment in IBS: A Narrative Overview.
    J Gastrointestin Liver Dis. 2025;34:122-127.
    Abstract

  222. SHAH E, Lee TY, Baldwin Z, Kort J, et al
    Healthcare Utilization and Costs of Care in Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation After Initiating Oral Therapies: Real-World Analysis in the US Medicare Population.
    Adv Ther. 2025 Mar 28. doi: 10.1007/s12325-025-03163.
    Abstract

  223. LIECHTY Z, Baldwin A, Isidean S, Suvarnapunya A, et al
    Dynamics of the gut microbiome in subjects challenged with Shigella sonnei 53G in a controlled human infection model.
    mSphere. 2025 Mar 28:e0090624. doi: 10.1128/msphere.00906.
    Abstract

  224. ABBOUD M, Haidar S, Mahboub N, Mamo T, et al
    Association between the metabolic syndrome and the irritable bowel syndrome: A cross-sectional study among a sample of Lebanese adults.
    Br J Nutr. 2025 Mar 28:1-37. doi: 10.1017/S0007114525000650.
    Abstract

  225. KACZKA A, Blonska A, Chojnacki C, Gasiorowska A, et al
    Periodic Changes in the Gut Microbiome in Women with the Mixed Type of Irritable Bowel Syndrome.
    Biomedicines. 2025;13:652.
    Abstract

  226. KRYNICKA P, Kaczmarczyk M, Skonieczna-Zydecka K, Styburski D, et al
    Untargeted Metabolomic Profiling of Colonic Mucosa in Individuals with Irritable Bowel Syndrome.
    Biomedicines. 2025;13:629.
    Abstract

  227. SEETHARAMAN J
    Recurrent Abdominal Pain in a Child - Evaluation and Management.
    Indian J Pediatr. 2025 Mar 28. doi: 10.1007/s12098-025-05469.
    Abstract

  228. BALSIGER LM, van Gils T, Hatem Y, Blomsten A, et al
    Intra- and Interobserver Variability of Acute Food-Induced Reactions During Confocal Laser Endomicroscopy: An International Multicenter Validation Study.
    Neurogastroenterol Motil. 2025 Mar 27:e70031. doi: 10.1111/nmo.70031.
    Abstract

  229. BAGHDADI G, Feyzpour M, Shahrokhi SA, Amiri R, et al
    The association between the Mediterranean Diet and the prime diet quality score and new-diagnosed irritable bowel syndrome: a matched case-control study.
    Front Med (Lausanne). 2025;12:1529374.
    Abstract

  230. STOYANOVA M, Milusheva M, Georgieva M, Ivanov P, et al
    Synthesis, Cytotoxic and Genotoxic Evaluation of Drug-Loaded Silver Nanoparticles with Mebeverine and Its Analog.
    Pharmaceuticals (Basel). 2025;18:397.
    Abstract

  231. MARASCO G, Cremon C, Salvi D, Meacci D, et al
    Functional Foods and Nutraceuticals in Irritable Bowel Syndrome.
    J Clin Med. 2025;14:1830.
    Abstract

  232. GIORGIO V, Quatrale G, Mennini M, Piccirillo M, et al
    Bifidobacterium adolescentis PRL2019 in Pediatric Irritable Bowel Syndrome: A Multicentric, Randomized, Double-Blind, Placebo-Controlled Trial.
    Microorganisms. 2025;13:627.
    Abstract

  233. BARBARO MR, Bianco F, Cremon C, Marasco G, et al
    A Probiotic Mixture of Lactobacillus rhamnosus LR 32, Bifidobacterium lactis BL 04, and Bifidobacterium longum BB 536 Counteracts the Increase in Permeability Induced by the Mucosal Mediators of Irritable Bowel Syndrome by Acting on Zonula Occludens 1
    Int J Mol Sci. 2025;26:2656.
    Abstract

  234. DENG FS, Lin MH, Huang CL, Wu CC, et al
    Effects of Lactococcus cremoris PS133 in 5-Hydroxytryptophan-Induced Irritable Bowel Syndrome Model Rats.
    Int J Mol Sci. 2025;26:2464.
    Abstract

  235. MOSTAFA MEA, Alrasheed T
    Improvement of irritable bowel syndrome with glucagon like peptide-1 receptor agonists: a systematic review and meta-analysis.
    Front Endocrinol (Lausanne). 2025;16:1548346.
    Abstract

  236. KHAN A, Mushtaq M, Movva G, Sohal A, et al
    Gastrointestinal disease in end-stage renal disease.
    World J Nephrol. 2025;14:101917.
    Abstract

  237. PARSI AO, Verne GN, Jiang Y, Theus SA, et al
    SARS-CoV-2 Infection, Vaccination, and Irritable Bowel Syndrome in Veterans: A Cross-Sectional Study.
    Int J Gasteroenterol (N Y). 2024;8:76-84.
    Abstract

  238. ZHU J, Zou Y, Wu Y, Deng X, et al
    Exploring the Mechanism of Action of Honeybran-Fried Cimicifuga Rhizoma in the Treatment of IBS-D Based on Metabolomics and Network Pharmacology.
    Biomed Chromatogr. 2025;39:e70026.
    Abstract

  239. JIN Y, Lei X, Zhang Y, Gao R, et al
    Guchang Zhixie Pill: A Comprehensive Review of the Clinical Applications, Toxicological Profile, and Quality Markers.
    Curr Top Med Chem. 2025 Mar 21. doi: 10.2174/0115680266328765250217050926.
    Abstract

  240. DEAN YE, Loayza Pintado JJ, Rouzan SS, Nale LL, et al
    The Relationship Between Irritable Bowel Syndrome and Metabolic Syndrome: A Systematic Review and Meta-Analysis of 49,662 Individuals.
    Endocrinol Diabetes Metab. 2025;8:e70041.
    Abstract

  241. PRIEGO-PARRA BA, Reyes-Diaz SA, Ordaz-Alvarez HR, Martinez-Perez GP, et al
    Gastrointestinal Cognition: Pain Catastrophizing in Irritable Bowel Syndrome, a Cross-Sectional Study in Mexico.
    Neurogastroenterol Motil. 2025 Mar 24:e70022. doi: 10.1111/nmo.70022.
    Abstract

  242. TIAN HL, Wang L, Ma CL, Yang B, et al
    [Fecal microbiota transplantation for the treatment of intestinal disorders: An analysis of treatment of 15 000 patients].
    Zhonghua Wei Chang Wai Ke Za Zhi. 2025;28:296-303.
    Abstract

  243. XU Y, Ye C, Li N, Chen QY, et al
    [Challenges and progress in in the clinical application of fecal microbiota transplantation].
    Zhonghua Wei Chang Wai Ke Za Zhi. 2025;28:266-273.
    Abstract

  244. YING X, Tao Y, Yuan Y, Ni D, et al
    Microwave irradiation benefits fructan degradation in sourdough steamed cake by tunning the beta-fructosidase FosE-substrate interaction.
    Food Chem. 2025;480:143960.
    Abstract

  245. MARASCO G, Hod K, Colecchia L, Cremon C, et al
    Long-Term Impact of COVID-19 on Disorders of Gut-Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities.
    United European Gastroenterol J. 2025 Mar 21. doi: 10.1002/ueg2.70005.
    Abstract

  246. ARRAS W, Breugelmans T, Oosterlinck B, De Man JG, et al
    The intestinal mucin isoform landscape reveals region-specific biomarker panels for inflammatory bowel disease patient stratification.
    J Crohns Colitis. 2024 Sep 27:jjae155. doi: 10.1093.
    Abstract

  247. RUBERTO S, Santovito A, Caviglia GP, Noli M, et al
    Mycobacterium avium Subsp. paratuberculosis and Human Endogenous Retrovirus in Italian Patients With Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS).
    Immunology. 2025 Apr 4. doi: 10.1111/imm.13923.
    Abstract

  248. ALMADI MK, Sabr MS, Kofi M, Alaboodi T, et al
    Epidemiology and Risk Factors of Irritable Bowel Syndrome in the Saudi Population: A Systematic Review.
    Cureus. 2025;17:e79974.
    Abstract

  249. YU J, Li X, Sun Y, Wang L, et al
    Transcriptomic analysis and experiment to verify the mechanism of Xiaoyao San in the treatment of irritable bowel syndrome with depression.
    J Ethnopharmacol. 2025 Apr 1:119732. doi: 10.1016/j.jep.2025.119732.
    Abstract

  250. ADLER EC, Levine EH, Ibarra AN, Boparai ES, et al
    Gut-Directed Hypnotherapy for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Neurogastroenterol Motil. 2025 Apr 3:e70037. doi: 10.1111/nmo.70037.
    Abstract

  251. JOHNSSON A, Ljotsson B, Liliequist BE, Skuladottir H, et al
    Cognitive behavioural therapy targeting cardiac anxiety post-myocardial infarction: results from two sequential pilot studies.
    Eur Heart J Open. 2025;5:oeaf020.
    Abstract

  252. MCNABOE RQ, Kong Y, Henderson WA, Cong X, et al
    Optimizing Sensor Locations for Electrodermal Activity Monitoring Using a Wearable Belt System.
    J Sens Actuator Netw. 2025;14:31.
    Abstract

  253. GERSON J
    Case Study: An Integrative Modification of Gut-Directed Hypnotherapy for a Patient with Intermittent Flares of Long-Standing Irritable Bowel Syndrome.
    Int J Clin Exp Hypn. 2025 Apr 1:1-6. doi: 10.1080/00207144.2025.2478858.
    Abstract

  254. KIM B, Wang Z, Meng X, Xie Z, et al
    An interorgan neuroimmune circuit promotes visceral hypersensitivity.
    Res Sq [Preprint]. 2025 Mar 17:rs.3.rs-6221928. doi: 10.21203/rs.3.rs-6221928.
    Abstract

  255. GERHOLD P, Lowe B, Huber S, Weigel A, et al
    [Podcasts for psychoeducation in irritable bowel syndrome: A mixed-methods analysis].
    Z Gastroenterol. 2025 Mar 31. doi: 10.1055/a-2550-9549.
    Abstract

  256. FAKHRI BAFGHI MS, Khoshnam Rad N, Roostaei G, Nikfar S, et al
    The reality of modeling irritable bowel syndrome: progress and challenges.
    Expert Opin Drug Discov. 2025;20:433-445.
    Abstract

  257. ISLAM JMA, Alam MJ, Karim MR, Ahmed F, et al
    Total and Segmental Colonic Transit Time in Patients with Constipation Attending in Dhaka Medical College Hospital: A Case Control Study.
    Mymensingh Med J. 2025;34:491-501.
    Abstract

  258. AL-MOHAISSEN MA, Al Zohaifi MA, Lee T, Almalki NA, et al
    Clinical Characterization of Blood Pressure Phenotypes: The BP Phenotype Score.
    Blood Press. 2025 Mar 30:1-22. doi: 10.1080/08037051.2025.2486284.
    Abstract

  259. PETTERSSON R, Strandh M, Lucas S
    Violence in adulthood amplifies the health correlates of childhood maltreatment.
    BMC Public Health. 2025;25:1193.
    Abstract

  260. GROEN SR, Keszthelyi D, Wilms E, Huig J, et al
    Colonic mucosal TRPA1 expression profiles in irritable bowel syndrome and its correlation to symptom severity: An exploratory study.
    Auton Neurosci. 2025;259:103273.
    Abstract

  261. HASEGAWA R, Nakaya K, Kanazawa M, Fukudo S, et al
    Corticotropin-releasing hormone receptor-1 antagonist attenuates visceral hypersensitivity induced by trinitrobenzene sulfonic acid colitis and maternal separation in rats.
    Biopsychosoc Med. 2025;19:5.
    Abstract

  262. NOZU T, Miyagishi S, Ishioh M, Takakusaki K, et al
    Irisin prevents visceral hypersensitivity and colonic hyperpermeability in a rat model of irritable bowel syndrome.
    Peptides. 2025;188:171394.
    Abstract

  263. CHU H, Zhong Y, Zhao J, Shan Y, et al
    Unravelling behavioural contributions to IBS risk: evidence from univariate and multivariate Mendelian randomisation.
    J Glob Health. 2025;15:04112.
    Abstract

  264. XUE F, Xue J, Zhao B, Zhu S, et al
    The Associations of Tobacco, Alcohol, and Coffee Consumption with Upper and Lower Gastrointestinal Disease Risk: A Mendelian Randomization Study.
    Gut Liver. 2025 Apr 11. doi: 10.5009/gnl240440.
    Abstract

  265. SANTUCCI NR, Waheed U, Li J, Mansi S, et al
    Auricular Allodynia is Associated With Worse Outcomes in Children With Functional Abdominal Pain Disorders Using Neurostimulation.
    Neuromodulation. 2025 Apr 10:S1094-7159(25)00129.
    Abstract

  266. JAFARI NASAB S, Feizi A, Hajihashemi P, Ani A, et al
    Dietary Quality Index-International and the odds of irritable bowel syndrome: a case-control study.
    Br J Nutr. 2025 Apr 10:1-26. doi: 10.1017/S0007114525000753.
    Abstract

  267. BOCCHIO F, Mancabelli L, Milani C, Lugli GA, et al
    Compendium of Bifidobacterium-based probiotics: characteristics and therapeutic impact on human diseases.
    Microbiome Res Rep. 2024;4:2.
    Abstract

  268. ZHONG Y, Bai H, Zhang Y, Yang X, et al
    Association of rotating shift work with incident irritable bowel syndrome: a large population-based prospective cohort study.
    Front Public Health. 2025;13:1541122.
    Abstract

  269. CHOI Y, Youn YH, Kang SJ, Shin JE, et al
    2025 Seoul Consensus on Clinical Practice Guidelines for Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2025;31:133-169.
    Abstract

  270. LUO J, To WLW, Xu Q, Zhang J, et al
    Clinical practice guidelines for the diagnosis of constipation-predominant irritable bowel syndrome and functional constipation in adults: a scoping review.
    BMC Gastroenterol. 2025;25:234.
    Abstract

  271. MUJAGIC Z
    Gut Feelings Matter: The Unresolved Questions of Irritable Bowel Syndrome-Like Symptoms in Inflammatory Bowel Disease in Remission.
    Inflamm Bowel Dis. 2025 Apr 9:izaf066. doi: 10.1093.
    Abstract

  272. ANDREWS MB, Adler DG
    Diarrhea-predominant irritable bowel syndrome treatment options eluxadoline, rifaximin, and alosetron: analysis of the FDA adverse event reporting system (FAERS) database.
    Expert Opin Drug Saf. 2025 Apr 9:1-7. doi: 10.1080/14740338.2025.2490841.
    Abstract

  273. MELCHIOR C, Hreinsson JP, Tack J, Keller J, et al
    Disorders of the gut-brain interaction among European people with obesity: Prevalence and burden of compatible symptoms.
    United European Gastroenterol J. 2025 Apr 7. doi: 10.1002/ueg2.12700.
    Abstract

  274. WANG Q, Zhao L, Liu J, Chen L, et al
    Meta analysis of clinical efficacy of acupoint application in the treatment of irritable bowel syndrome.
    Afr Health Sci. 2024;24:351-361.
    Abstract

  275. GAO Z, Mei Z, Zhang Y, Lv S, et al
    Exploring the Genetic Link between Irritable Bowel Syndrome and Polycystic Ovary Syndrome: Bidirectional Mendelian Randomization and Machine Learning Approaches.
    Endocr Metab Immune Disord Drug Targets. 2025.
    Abstract

  276. SINOPOULOU V, Groen J, Gordon M, Mougey E, et al
    Efficacy of interventions for the treatment of irritable bowel syndrome, functional abdominal pain-not otherwise specified, and abdominal migraine in children: a systematic review and network meta-analysis.
    Lancet Child Adolesc Health. 2025;9:315-324.
    Abstract

  277. GUILMINEAU C, Tremblay-Franco M, Vialaneix N, Servien R, et al
    Phoenics: a novel statistical approach for longitudinal metabolomic pathway analysis.
    BMC Bioinformatics. 2025;26:105.
    Abstract

  278. VON MUHLENBROCK C, Landskron G, Madrid AM
    Treatment of small intestinal bacterial overgrowth in Chilean patients with irritable bowel syndrome: A prospective and comparative study.
    Rev Gastroenterol Mex (Engl Ed). 2025 Apr 15:S2255-534X(25)00002.
    Abstract

  279. GONCHARENKO AI, Gorbovskoi FV, Kargina EA, Kondrat'eva NM, et al
    [Therapy for irritable bowel syndrome: focus on butylbromide hyoscine. A review].
    Ter Arkh. 2025;97:176-184.
    Abstract

  280. SEETHARAMAN J, Poddar U, Srivastava A, Sarma MS, et al
    Spectrum of Functional Abdominal Pain Disorders in Children and Their Clinical, Social Characteristics: A Cross-Sectional Study.
    JGH Open. 2025;9:e70162.
    Abstract

  281. GOELEN N, Scheepers J, Carbone F, Holvoet L, et al
    The Waiting Room Questionnaire, a Patient-Reported Outcome Instrument Including Pictograms for Facilitating the Diagnosis of Functional Gastrointestinal Disorders.
    Neurogastroenterol Motil. 2025 Apr 14:e70019. doi: 10.1111/nmo.70019.
    Abstract

  282. FANG Y, Zhu J, Wang Z, Li K, et al
    [Mechanism research progress on acupuncture-moxibustion therapy for functional gastrointestinal disorders: review and prospects].
    Zhongguo Zhen Jiu. 2025;45:551-558.
    Abstract

  283. TIAN Y, Zi J, Hu Y, Zeng Y, et al
    Shared and Unique Genetic Links between Neuroticism and Gastrointestinal Tract Diseases.
    Depress Anxiety. 2024;2024:5515448.
    Abstract

  284. WANG J, Meng N, Chen K, Huang X, et al
    The Relationship Between Depressive Symptoms and Functional Gastrointestinal Disorders (FGIDs): The Chain Mediating Effect of Sleep Disorders and Somatic Symptom.
    Depress Anxiety. 2024;2024:5586123.
    Abstract

  285. WANG L, Zhang Y, Ran Y, Li L, et al
    Association between AHR in EGCs and IBS-D patients: the indole pathway of tryptophan metabolism.
    Front Nutr. 2025;12:1566595.
    Abstract

  286. HYDER N, Raza ML
    Stress and the gut microbiota-brain axis.
    Prog Brain Res. 2025;291:175-203.
    Abstract

  287. THAKUR R, Kaur S
    Use of postbiotics and parabiotics from lactobacilli in the treatment of infectious diarrhea.
    Microb Pathog. 2025;204:107580.
    Abstract

  288. CHEN W, Li T, Lin Y, Chen Z, et al
    Patchouli alcohol restores gut homeostasis in irritable bowel syndrome with diarrhea through myosin Va-mediated neurotransmitter regulation.
    Phytomedicine. 2025;141:156681.
    Abstract

  289. KEUKENS A, Veth VB, van de Kar MMA, Bongers MY, et al
    Effects of a low-FODMAP diet on patients with endometriosis, a prospective cohort study.
    BMC Womens Health. 2025;25:174.
    Abstract

  290. LIEBANA-CASTILLO AR, Redondo-Cuevas L, Nicolas A, Martin-Carbonell V, et al
    Should We Treat SIBO Patients? Impact on Quality of Life and Response to Comprehensive Treatment: A Real-World Clinical Practice Study.
    Nutrients. 2025;17:1251.
    Abstract

  291. NASS BYS, Dibbets P, Markus CR
    Mediating Role of Negative Affectivity in the Association Between Lifetime Trauma and Gastrointestinal Symptoms.
    Healthcare (Basel). 2025;13:755.
    Abstract

  292. LINSALATA M, Prospero L, Ignazzi A, Riezzo G, et al
    Depression in Diarrhea-Predominant IBS Patients: Exploring the Link Between Gut Barrier Dysfunction and Erythrocyte Polyunsaturated Fatty Acid Levels.
    J Clin Med. 2025;14:2483.
    Abstract

  293. TILL SR, Whitmore G, As-Sanie S, Matallana L, et al
    Cannabidiol use and perceptions of effectiveness in women with chronic pelvic pain.
    J Obstet Gynaecol Can. 2025 Apr 9:102839. doi: 10.1016/j.jogc.2025.102839.
    Abstract

  294. KIM DH, Song HY, Nam K
    [Pharmacologic Treatment of Irritable Bowel Syndrome with Predominant Constipation].
    Korean J Gastroenterol. 2025;85:110-116.
    Abstract

  295. KIM MC, Park Y, Lee HS
    [Treatment of Irritable Bowel Syndrome with Predominant Diarrhea].
    Korean J Gastroenterol. 2025;85:105-109.
    Abstract

  296. KANG SJ
    [Dietary Therapy in Irritable Bowel Syndrome].
    Korean J Gastroenterol. 2025;85:97-104.
    Abstract

  297. HELM ED, Nguyen C, Rotholz S, Guntupalli SR, et al
    Feasibility of assessing symptoms associated with ovarian cancer using an electronic medical intake questionnaire.
    Gynecol Oncol Rep. 2025;59:101739.
    Abstract

  298. SANDBERG-JANZON A, Karling P
    Drug Survival of Drugs Recommended for Irritable Bowel Syndrome: A Retrospective Observational Study.
    Neurogastroenterol Motil. 2025 Apr 24:e70063. doi: 10.1111/nmo.70063.
    Abstract

  299. ANNAHAZI A, Bauer R, Efferth T, Khayyal MT, et al
    A Review of the Mechanisms of Action of the Herbal Medicine, STW 5-II, Underlying Its Efficacy in Disorders of Gut-Brain Interaction.
    Neurogastroenterol Motil. 2025 Apr 24:e70047. doi: 10.1111/nmo.70047.
    Abstract

  300. TSUBOTA M, Sasaki K, Shin E, Okamura Y, et al
    HMGB1 derived from macrophages and enteric glial cells contributes to the butyrate-induced colonic hypersensitivity in mice.
    Eur J Pharmacol. 2025 Apr 22:177660. doi: 10.1016/j.ejphar.2025.177660.
    Abstract

  301. SINGH P, Dean G, Iram S, Peng W, et al
    Efficacy of Mediterranean Diet vs. Low-FODMAP Diet in Patients With Nonconstipated Irritable Bowel Syndrome: A Pilot Randomized Controlled Trial.
    Neurogastroenterol Motil. 2025 Apr 24:e70060. doi: 10.1111/nmo.70060.
    Abstract

  302. KINSINGER S, Palsson O
    Survey of Current Practices and Experiences of Clinicians Treating Irritable Bowel Syndrome (IBS) With Cognitive Behavioral Therapy and/or Gut-Directed Hypnosis.
    Neurogastroenterol Motil. 2025 Apr 24:e70058. doi: 10.1111/nmo.70058.
    Abstract

  303. FARZANEGAN M, Azizi A, Fard SS, Sadeghi A, et al
    Effectiveness of a bioenergy economy program versus mindfulness-based cognitive therapy on the severity and psychological symptoms of irritable bowel syndrome.
    J Educ Health Promot. 2025;14:107.
    Abstract

  304. ROMETSCH C, Martin A, Cosci F
    Predictors of Treatment Success of Psychotherapy in Functional Disorders: A Systematic Review of the Literature.
    Clin Psychol Psychother. 2025;32:e70075.
    Abstract

  305. LU YL, Huang C, Huang SY, Li T, et al
    The mechanism of patchouli alcohol in treating IBS-D based on BMP-Smad pathway.
    Biomed Pharmacother. 2025;187:118050.
    Abstract

  306. BAKHSHAIE J, Smit T, Bradford A, Lackner JM, et al
    Gastrointestinal-specific anxiety as a transdiagnostic mechanism involved in persons with irritable bowel syndrome who smoke.
    J Health Psychol. 2025 Apr 23:13591053251333950. doi: 10.1177/13591053251333950.
    Abstract

  307. JAFARI NASAB S, Hajihashemi P, Feizi A, Shahoon H, et al
    Effects of Spirulina platensis supplementation on quality of life, severity of disease and serum total antioxidant capacity, malondialdehyde and zonulin in constipation-predominant irritable bowel syndrome: protocol for a randomised, double-blinded, p
    BMJ Open. 2025;15:e086521.
    Abstract

  308. NASAB SJ, Feizi A, Hajihashemi P, Entezari MH, et al
    Effects of Spirulina (Arthrospira) platensis supplementation on intestinal permeability, antioxidant and inflammatory markers, quality of life and disease severity in patients with constipated-predominant irritable bowel syndrome: a randomized double?
    Nutr J. 2025;24:64.
    Abstract

  309. SHIN A
    Expanding the menu of dietary therapies in irritable bowel syndrome.
    Lancet Gastroenterol Hepatol. 2025 Apr 18:S2468-1253(25)00070.
    Abstract

  310. KHASAWNEH M, Mokhtare M, Moayyedi P, Black CJ, et al
    Efficacy of gut-brain neuromodulators in irritable bowel syndrome: an updated systematic review and meta-analysis.
    Lancet Gastroenterol Hepatol. 2025 Apr 18:S2468-1253(25)00051.
    Abstract

  311. CUFFE MS, Staudacher HM, Aziz I, Adame EC, et al
    Efficacy of dietary interventions in irritable bowel syndrome: a systematic review and network meta-analysis.
    Lancet Gastroenterol Hepatol. 2025 Apr 18:S2468-1253(25)00054.
    Abstract

  312. BENARD MV, de Bruijn CMA, Matamoros S, Wentink-Bonnema EMS, et al
    Transient colonization with Blastocystis spp. after transmission via fecal microbiota transplantation.
    Eur J Clin Microbiol Infect Dis. 2025 Apr 21. doi: 10.1007/s10096-025-05124.
    Abstract

  313. MEI C, Han L, Xue H
    Exploring the Comorbidity Mechanism among Functional Diarrhea, Irritable Bowel Syndrome with Predominant Diarrhea, and Functional Dyspepsia through the Gut-brain Axis and the Pharmacological Mechanisms of Shen-Ling-Bai-Zhu-San Therapy.
    Comb Chem High Throughput Screen. 2025.
    Abstract

  314. DU Z, Zhao C, Li J, Shen Y, et al
    Ginsenosides and gut microbiota: differential effects on healthy individuals and irritable bowel syndrome subtypes.
    PeerJ. 2025;13:e19223.
    Abstract

  315. SOUFAN F, Ghosson A, Jaber R, Ghandour A, et al
    The Gut-Brain Axis in Irritable Bowel Syndrome: Implementing the Role of Microbiota and Neuroimmune Interaction in Personalized Prevention-A Narrative Review.
    Health Sci Rep. 2025;8:e70660.
    Abstract

  316. WEI X, Jia X, Su X
    Evidence-Based Bibliometric Analysis of Acupuncture in Functional Dyspepsia: Clinical Efficacy and Research Trends.
    J Multidiscip Healthc. 2025;18:2141-2153.
    Abstract

  317. KIM TH, Son Y, Park J, Kim S, et al
    Post-Acute Sequelae of COVID-19 on Irritable Bowel Syndrome in Individuals With Mental Illness in South Korea: A Population-Based Cohort Study.
    J Med Virol. 2025;97:e70345.
    Abstract

  318. WANG XJ, Philpot L, Ebbert J, Dilmaghani S, et al
    Digital Therapeutic Combining Hypnosis and Diaphragmatic Breathing Intervention for Functional Abdominal Bloating: A Feasibility Study.
    Clin Transl Gastroenterol. 2025;16:e00811.
    Abstract

  319. BOS M, Monden R, Wray NR, Zhou Y, et al
    Familial coaggregation and shared familiality of functional and internalizing disorders in the Lifelines cohort.
    Psychol Med. 2025;55:e126.
    Abstract

  320. BONTEMPO AC, Bontempo JM, Duberstein PR
    Ignored, dismissed, and minimized: Understanding the harmful consequences of invalidation in health care-A systematic meta-synthesis of qualitative research.
    Psychol Bull. 2025;151:399-427.
    Abstract

  321. WHORWELL PJ
    Anticholinergic agents and impaired cognitive function: is there a risk for patients with irritable bowel syndrome?
    Therap Adv Gastroenterol. 2025;18:17562848251338479.
    Abstract

  322. DONG Z, Wang X, Xuan L, Wang J, et al
    The interaction effect between childhood trauma and negative events during adulthood on development and severity of irritable bowel syndrome.
    BMC Gastroenterol. 2025;25:321.
    Abstract

  323. REMES-TROCHE JM, Coss-Adame E, Schmulson M, Garcia-Zermeno KR, et al
    Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociacion Mexicana de Gastroenterologia, 2024.
    Rev Gastroenterol Mex (Engl Ed). 2025 Apr 29:S2255-534X(25)00015.
    Abstract

  324. FU Z, Liu CZ, Zheng Q, Chi LL, et al
    Efficacy of acupuncture at pain-sensitive acupoints for diarrhoea-predominant irritable bowel syndrome (IBS-D): protocol of a multicentre, randomised, sham-controlled trial.
    BMJ Open. 2025;15:e091082.
    Abstract

  325. RICHTER V, Broide E, Shalem T, Cohen DL, et al
    Association Between Ethnicity and Treatment Preferences in Patients with Irritable Bowel Syndrome.
    Rambam Maimonides Med J. 2025;16.
    Abstract

  326. AUDIBERT A, Mas-Orea X, Rey L, Belloy M, et al
    Toxoplasma gondii chronic infection decreases visceral nociception through peripheral opioid receptor signaling.
    PLoS Pathog. 2025;21:e1013106.
    Abstract

  327. ALIYU AI, Katsumata R, Tornblom H, Simren M, et al
    Gastrointestinal transit abnormalities in irritable bowel syndrome and their relation to symptoms.
    Expert Rev Gastroenterol Hepatol. 2025.
    Abstract

  328. SANZ MORALES P, Wijeyesekera A, Robertson MD, Major G, et al
    An in vitro batch culture study to assess the fermentation of human milk oligosaccharides by faecal microbiota from healthy and irritable bowel syndrome stool donors.
    Gut Microbiome (Camb). 2025;6:e4.
    Abstract

  329. MUSTAFA F, Noor R, Murtaza A, Kanwal W, et al
    Small Intestinal Bacterial Overgrowth (SIBO) - Prevention and Therapeutic Role of Nutrition, Prebiotics, Probiotics, and Prokinetics.
    Curr Pharm Des. 2025 Apr 28. doi: 10.2174/0113816128373584250407134451.
    Abstract

  330. ZHENG H, Chen Y, Lu S, Liu Z, et al
    Mechanosensory Piezo2 regulated by gut microbiota participates in the development of visceral hypersensitivity and intestinal dysmotility.
    Gut Microbes. 2025;17:2497399.
    Abstract

  331. LI MG, Qu ST, Yu Y, Xu Z, et al
    Upregulation of NR2A in Glutamatergic VTA Neurons Contributes to Chronic Visceral Pain in Male Mice.
    Neurosci Bull. 2025 Apr 28. doi: 10.1007/s12264-025-01402.
    Abstract

  332. MALLARDI D, Maqoud F, Guido D, Aloisio M, et al
    Mapping Research Trends on Intestinal Permeability in Irritable Bowel Syndrome with a Focus on Nutrition: A Bibliometric Analysis.
    Nutrients. 2025;17:1064.
    Abstract

  333. SHOKRANI A, Seck A, Feng B, Pierce DM, et al
    Methods for Quantitative Analyses of Nerve Fiber Deformation in the Myenteric Plexus Under Loading of Mouse Distal Colon and Rectum.
    bioRxiv [Preprint]. 2025 Apr 8:2025.04.02.646858. doi: 10.1101/2025.04.02.646858
    Abstract

  334. TANG Y, Tang X, Wen Q
    Analysis of Electroacupuncture Parameters for Irritable Bowel Syndrome: A Data Mining Approach.
    J Pain Res. 2025;18:2175-2189.
    Abstract

  335. AGGELETOPOULOU I, Geramoutsos G, Pastras P, Triantos C, et al
    Vitamin D in Irritable Bowel Syndrome: Exploring Its Role in Symptom Relief and Pathophysiology.
    Nutrients. 2025;17:1028.
    Abstract

  336. SAHU S, Varshney A, Chaudhary M, Ghoshal U, et al
    Irritable Bowel Syndrome-like Symptoms in Patients With Ulcerative Colitis in Remission as Compared to Irritable Bowel Syndrome: Symptom Severity and Inflammatory Markers.
    J Neurogastroenterol Motil. 2025 Apr 28. doi: 10.5056/jnm24010.
    Abstract

  337. KENDLER KS, Ohlsson H, Neale M, van Loo H, et al
    A multivariate Swedish national twin-sibling study in women of major depression, anxiety disorder, fibromyalgia, and irritable bowel syndrome.
    Psychol Med. 2025;55:e125.
    Abstract

  338. KROUCH D, Vreeke GJC, America AHP, Mes JJ, et al
    Amylase trypsin inhibitors activation of toll-like receptor 4 revisited: The dominance of lipopolysaccharides contamination.
    Int J Biol Macromol. 2025 Apr 25:143378. doi: 10.1016/j.ijbiomac.2025.143378.
    Abstract

  339. HASLER R, Miks MH, Bajic D, Soyyilmaz B, et al
    Human milk oligosaccharides modulating inflammation in infants, adults and older individuals - from concepts to applications.
    Adv Nutr. 2025 Apr 24:100433. doi: 10.1016/j.advnut.2025.100433.
    Abstract

  340. WOJAS O, Krzych-Falta E, Zybul P, Zalikowska-Gardocka M, et al
    The Overlap of Allergic Disorders and Upper Gastrointestinal Symptoms: Beyond Eosinophilic Esophagitis.
    Nutrients. 2025;17:1355.
    Abstract

  341. BLACK CJ, Olano C, Quigley EMM, Ford AC, et al
    Common misconceptions and controversies in the management of irritable bowel syndrome.
    Nat Rev Gastroenterol Hepatol. 2025 Apr 25. doi: 10.1038/s41575-025-01065.
    Abstract

  342. WU Y, Jiang Y, Gong Y, Yao T, et al
    A "Janus" structured nanoclay microgel system for targeted probiotic therapy in diarrhea-predominant irritable bowel syndrome.
    J Control Release. 2025;383:113769.
    Abstract

  343. IZQUIERDO SANTERVAS S, Maroto Martin C, Fiz-Lopez A, Garrote Adrados JA, et al
    Small intestine bacterial overgrowth (SIBO) breath test does not predict symptom severity in gut-brain interaction disorders: role of anxiety, depression, and inflammatory biomarkers.
    Rev Esp Enferm Dig. 2025 Apr 25. doi: 10.17235/reed.2025.11157/2025.
    Abstract

  344. LITVAK A, Geiger J, Ford B, Byrne MM, et al
    An 8-Year Experience of Robot-Assisted Laparoscopic Surgical Management of Median Arcuate Ligament Syndrome.
    Ann Vasc Surg. 2025;114:212-218.
    Abstract

  345. SCARLATA K, Zickgraf HF, Satherley RM, Shapiro JM, et al
    A Call to Action: Unraveling the Nuance of Adapted Eating Behaviors in Individuals With Gastrointestinal Conditions.
    Clin Gastroenterol Hepatol. 2025;23:893-901.
    Abstract

  346. LIU J, Liu L, Yang J, Zhao X, et al
    Gastrointestinal Symptoms and Psychological Conditions: A Literature Review with Emphasis on the Evidence in Military Personnel from China.
    Adv Ther. 2025 May 8. doi: 10.1007/s12325-025-03190.
    Abstract

  347. SOLEIMANI E, Chitsaz M
    Structural modeling of IBS severity: the mediating role of negative meta-emotions in stress, hostile attribution, and cognitive bias - a cross-sectional study.
    Ann Med Surg (Lond). 2025;87:2633-2637.
    Abstract

  348. BALLMER-WEBER B, Krieger-Grubel C
    [Food intolerances: more often suspected than confirmed].
    Praxis (Bern 1994). 2025;114:144-148.
    Abstract

  349. PAWELEC-PECIAK O, Lanocha-Arendarczyk N, Grzeszczak K, Kosik-Bogacka D, et al
    The Role of Blastocystis spp. in the Etiology of Gastrointestinal and Autoimmune Diseases.
    Pathogens. 2025;14:313.
    Abstract

  350. YAN B, Wang S, Chen J, Zhong X, et al
    Evaluation of cinitapride's efficacy and safety in treating functional dyspepsia with overlapping symptoms: a real-world study in Chinese healthcare settings.
    Rev Assoc Med Bras (1992). 2025;71:e20241628.
    Abstract

  351. GUO Y, Wang L, Huang JQ, Lu MW, et al
    Valorization of Pomegranate Peel: Mechanisms and Clinical Applications in Irritable Bowel Syndrome Management.
    Int J Mol Sci. 2025;26:3530.
    Abstract

  352. HONG G, Zhao Y, Zhou J, Hu L, et al
    Circadian rhythm perturbation causes IBS-like characteristics and altered fecal metabolome in mice.
    BMC Microbiol. 2025;25:274.
    Abstract

  353. ZIPP CR, Semlitsch T, Togel G, Krenn C, et al
    An overview of systematic reviews on the efficacy and safety of osteopathic techniques.
    J Bodyw Mov Ther. 2025;42:1186-1197.
    Abstract

  354. SOKMEN O, Dundar AN, Bagci U, Togay SO, et al
    The FODMAP-Reducing Potential of Sourdough-Derived Lactobacillus Strains From the Marmara Region of Turkey.
    Food Sci Nutr. 2025;13:e70241.
    Abstract

  355. DENG Z, Wang K, Hou T
    Causality Between Irritable Bowel Syndrome and Suicide Attempt: A Mendelian Randomization Study.
    Brain Behav. 2025;15:e70513.
    Abstract

  356. WANG C, Wang T, Chen Y, Lie W, et al
    Ebastine in combination with low-dose antidepressants for refractory irritable bowel syndrome: A randomized controlled trial.
    Technol Health Care. 2025 May 2:9287329251334289. doi: 10.1177/09287329251334289
    Abstract

  357. HOD K, Marasco G, Colecchia L, Cremon C, et al
    Psychological and Clinical Factors Mediate Post-COVID-19 Irritable Bowel Syndrome.
    Neurogastroenterol Motil. 2025 May 15:e70079. doi: 10.1111/nmo.70079.
    Abstract

  358. GOMEZ-ESCUDERO O, Remes-Troche JM, Coss-Adame E, Garcia-Zermeno KR, et al
    Clinical practice recommendations on the use of neuromodulators in gastroenterology: AMG (Asociacion Mexicana de Gastroenterologia) - AMNM (Asociacion Mexicana de Neurogastroenterologia y Motilidad) expert joint review.
    Rev Gastroenterol Mex (Engl Ed). 2025 May 14:S2255-534X(25)00007.
    Abstract

  359. LEHNER MD, Ulsemer P, Christochowitz S
    Menthacarin, a proprietary combination of peppermint and caraway oil, alters cultured human fecal microbiota composition, resulting in increased SCFA production.
    Front Pharmacol. 2025;16:1569052.
    Abstract

  360. TEMIDO MJ, Cristiano M, Gouveia C, Mesquita B, et al
    Antidepressants in irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Ann Gastroenterol. 2025;38:284-293.
    Abstract

  361. JUBAERE A, Chowdhury FK, Newaz AAS, Islam S, et al
    Diagnostic Value of Fecal Lactoferrin in Differentiating Inflammatory Bowel Disease From Irritable Bowel Syndrome: A Comparative Study in a Bangladeshi Cohort.
    Cureus. 2025;17:e82187.
    Abstract

  362. LI N, Ren J, Guan L, Xu Y, et al
    [Study on activation mechanism of SGCs in representation along the distribution of stomach meridian in IBS-D mice].
    Zhongguo Zhen Jiu. 2025;45:593-600.
    Abstract

  363. MCGRATH IM, Rukins V, Laisk T, Mortlock S, et al
    Interaction between genetic risk and comorbid conditions in endometriosis.
    HGG Adv. 2025 May 13:100456. doi: 10.1016/j.xhgg.2025.100456.
    Abstract

  364. DEVI D, Bhattacharya S, Tiwari S, Tripathi A, et al
    Exploring the Impact of Yoga Intervention on Psychological Symptoms in Irritable Bowel Syndrome Patients: A Randomized Controlled Study.
    Int J Yoga. 2025;18:58-66.
    Abstract

  365. KASTI AN, Katsas K, Pavlidis DE, Stylianakis E, et al
    Clinical Trial: A Mediterranean Low-FODMAP Diet Alleviates Symptoms of Non-Constipation IBS-Randomized Controlled Study and Volatomics Analysis.
    Nutrients. 2025;17:1545.
    Abstract

  366. VELASCO-ABURTO S, Llama-Palacios A, Sanchez MC, Ciudad MJ, et al
    Nutritional Approach to Small Intestinal Bacterial Overgrowth: A Narrative Review.
    Nutrients. 2025;17:1410.
    Abstract

  367. LIN X, Xia L, Zhou Y, Xie J, et al
    Crosstalk Between Bile Acids and Intestinal Epithelium: Multidimensional Roles of Farnesoid X Receptor and Takeda G Protein Receptor 5.
    Int J Mol Sci. 2025;26:4240.
    Abstract

  368. YU J, Wang Z, Chen Y, Dong Y, et al
    Restraint Stress Disrupted Intestinal Homeostasis via 5-HT/HTR7/Wnt/beta-Catenin/NF-kB Signaling.
    Int J Mol Sci. 2025;26:4021.
    Abstract

  369. GILL SK, Kumari S, Biswal BK, Acharya BN, et al
    From pharmacophore predictions to pharmaceutical possibilities: an integrated approach to screen M(3) selective muscarinic receptor antagonist.
    Mol Divers. 2025 May 13. doi: 10.1007/s11030-025-11208.
    Abstract

  370. XU J, Zhao X, Yang S, Tang M, et al
    Chlorogenic acid and intestinal health: mechanistic insights and therapeutic applications.
    Food Funct. 2025 May 13. doi: 10.1039/d5fo00853.
    Abstract

  371. MOHAMED SIRAJ H, Usaid M, Shaikh S, Dalain M, et al
    Bacterial Histamine as a Therapeutic Target for Abdominal Pain in Irritable Bowel Syndrome: A Literature Review.
    Cureus. 2025;17:e82132.
    Abstract

  372. HE T, Song LQ, Weng XY, Pan P, et al
    Clinical relevance of inflammatory markers in the evaluation of severity of ulcerative colitis: A retrospective study.
    Open Life Sci. 2025;20:20251088.
    Abstract

  373. ZHANG Y, Lin Z, Yao Q, He J, et al
    Milk peptides alleviate irritable bowel syndrome by suppressing colonic mast cell activation and prostaglandin E2 production in mice.
    Food Res Int. 2025;211:116470.
    Abstract

  374. KUMARI N, Pal Y, Tailor CS, Negi D, et al
    Unraveling the Nutritional Perspectives of Probiotics and Prebiotics in Female Healthcare.
    Recent Adv Food Nutr Agric. 2025.
    Abstract

  375. AGHAMOHAMMADI V, Rezakhani Moghadam H, Najafi E, Nasiri K, et al
    Mindfulness is associated with the weight status, severity of disease, and severity of extra-intestinal symptoms among individuals with irritable bowel syndrome.
    Front Psychol. 2025;16:1545033.
    Abstract

  376. ALRASHEEDI AA, Jahlan EA, Bakarman MA
    The effect of low-FODMAP diet on patients with irritable bowel syndrome.
    Sci Rep. 2025;15:16382.
    Abstract

  377. MEMEL ZN, Shah ND, Beck KR
    Diet, nutraceuticals, and lifestyle interventions for the treatment and management of irritable bowel syndrome.
    Nutr Clin Pract. 2025 May 10. doi: 10.1002/ncp.11307.
    Abstract

  378. HAGHIGHATDOOST F, Feizi A, Hajihashemi P, Ani A, et al
    The Association Between Ultra-Processed Foods Consumption and Disorders of Gut-Brain Interaction: The Isfahan Functional Disorders (ISFUN) Study.
    Neurogastroenterol Motil. 2025 May 7:e70071. doi: 10.1111/nmo.70071.
    Abstract

  379. ROSSI CM, Lenti MV, Merli S, Fiorita M, et al
    Effect of seasonal exposure in aeroallergen-sensitised patients with irritable bowel syndrome-diarrhoea.
    Front Allergy. 2025;6:1568595.
    Abstract

  380. CHOI NR, Choi WG, Park J, Kim YT, et al
    Scutellaria baicalensis extracts alleviate zymosan-induced irritable bowel syndrome symptoms by modulating inflammation and ion channel activity.
    Anim Cells Syst (Seoul). 2025;29:360-371.
    Abstract

  381. NASAB SJ, Feizi A, Hajihashemi P, Entezari MH, et al
    Correction: Effects of Spirulina (Arthrospira) platensis supplementation on intestinal permeability, oxidative stress markers, quality of life, and disease severity in patients with constipation-predominant irritable bowel syndrome: a randomized doubl
    Nutr J. 2025;24:83.
    Abstract

  382. LI Q, Zhang J, Yang C, Dong X, et al
    Evaluation of post-market adverse events of lubiprostone: a real-world adverse event analysis from the FAERS database.
    BMC Gastroenterol. 2025;25:395.
    Abstract

  383. AL SNIH GM, Bailey KR, Oblizajek NR, Bharucha AE, et al
    Symptoms of Constipation: Relationship between questionnaires and diaries and Impact on Quality of Life.
    Clin Gastroenterol Hepatol. 2025 May 20:S1542-3565(25)00426.
    Abstract

  384. HASAN ABMN, Asaduzzaman M, Mahfuj MN, Islam R, et al
    Prevalence of irritable bowel syndrome and its association to mental health among the private university students of Dhaka, Bangladesh.
    PLOS Glob Public Health. 2025;5:e0004670.
    Abstract

  385. MUGO CW, Church E, Horniblow RD, Mollan SP, et al
    Unravelling the gut-brain connection: a systematic review of migraine and the gut microbiome.
    J Headache Pain. 2025;26:125.
    Abstract

  386. BHATTACHARYA R, Pratima K, Preeti, Ambedkar SN, et al
    Prevalence of psychiatric disorders in patients of irritable bowel syndrome fulfilling Rome IV criteria: An observational study.
    J Family Med Prim Care. 2025;14:1478-1485.
    Abstract

  387. LIU H, Si S, Zhang H, Zhan S, et al
    Dissecting the bidirectional associations between the progression of gastrointestinal and endocrine diseases.
    Front Endocrinol (Lausanne). 2025;16:1538603.
    Abstract

  388. HAJIANI S, Tajabadi Ebrahimi M, Sadeghi A, Zarrabi Ahrabi N, et al
    The impact of a multi-species probiotic supplementation on clinical symptoms and biochemical factors in patients with irritable bowel syndrome: a randomised controlled trial.
    Arch Physiol Biochem. 2025 May 20:1-11. doi: 10.1080/13813455.2025.2507749.
    Abstract

  389. KRYNICKA P, Koulaouzidis G, Marlicz W, Koulaouzidis A, et al
    Innovations in the diagnosis, treatment, and management of disorders of gut-brain interaction (DGBI).
    Expert Rev Gastroenterol Hepatol. 2025.
    Abstract

  390. RUSKA P, Jerkovic A, Sila S, Mocic Pavic A, et al
    Autonomic nervous system abnormalities in children with inflammatory bowel disease and irritable bowel syndrome: a comparative study.
    Clin Auton Res. 2025 May 19. doi: 10.1007/s10286-025-01134.
    Abstract

  391. RAJA S, Teitelbaum JE, Pereira K, Guli K, et al
    Efficacy of low FODMAP diet in pediatric patients with disorders of gut-brain interaction.
    JPGN Rep. 2025;6:75-79.
    Abstract

  392. ZHANG B
    Expression of transient receptor potential vanilloid type 1 (TRPV1) in colonic mucosa of patients with irritable bowel syndrome.
    Am J Transl Res. 2025;17:2782-2789.
    Abstract

  393. MENDOZA-DOMINGUEZ G, Garrido-Santos ZM, Lau C, Balbuena R, et al
    Real-world experience with the diagnosis of bile acid malabsorption (BAM) using serum 7-alpha-C4 and 48-hour stool bile acids.
    Rev Gastroenterol Mex (Engl Ed). 2025 May 17:S2255-534X(25)00039.
    Abstract

  394. CHENG HS, Tey YH, Hu SY, Yeo AYN, et al
    Advancements and Challenges in Modeling Mechanobiology in Intestinal Host-Microbiota Interaction.
    ACS Appl Mater Interfaces. 2025 May 18. doi: 10.1021/acsami.4c20961.
    Abstract

  395. WILEMAN V, Chilcot J, Norton C, Hart A, et al
    Modifiable psychological factors are associated with clusters of pain, fatigue, faecal incontinence and IBS-type symptoms in inflammatory bowel disease: a latent profile analysis.
    J Crohns Colitis. 2024 Dec 5:jjae183. doi: 10.1093.
    Abstract

  396. SALEEM MM, Masood S, Rahmatullah MM, Ayesha Imdad I, et al
    Gut Microbiota Dysbiosis and Its Role in the Development of Irritable Bowel Syndrome.
    Cureus. 2025;17:e83084.
    Abstract

  397. WANG YW, Li QY, Liu LF, Tan X, et al
    Long-term exposure to constant light disrupts intestinal stem cells through sympathoexcitation-induced Wnt5a signaling inhibition.
    Gastroenterol Rep (Oxf). 2025;13:goaf031.
    Abstract

  398. LATERZA L, Cremon C, Coppola G, Settanni CR, et al
    Multistrain Probiotics Plus Vitamin D Improve Gut Barrier Function and Gut Microbiota Composition in Irritable Bowel Syndrome Without Constipation: Results from a Double-Blind, Randomized, Placebo-Controlled Trial.
    Nutrients. 2025;17:1708.
    Abstract

  399. YAO Q, Zhang W, Wang Y, Shi L, et al
    Lactobacillus plantarum and Galacto-Oligosaccharides Synbiotic Relieve Irritable Bowel Syndrome by Reshaping Gut Microbiota and Attenuating Mast Cell Hyperactivation.
    Nutrients. 2025;17:1670.
    Abstract

  400. RESTANI P, Di Lorenzo C, Antoce AO, Araujo M, et al
    Moderate Wine Consumption and Gastrointestinal Diseases.
    Nutrients. 2025;17:1608.
    Abstract

  401. DI PIERRO F, Ficuccilli F, Tessieri L, Menasci F, et al
    Irritable Bowel Syndrome with Diarrhea (IBS-D): Effects of Clostridium butyricum CBM588 Probiotic on Gastrointestinal Symptoms, Quality of Life, and Gut Microbiota in a Prospective Real-Life Interventional Study.
    Microorganisms. 2025;13:1139.
    Abstract

  402. HIRATA M, Fornari Laurindo L, Dogani Rodrigues V, Cristina Castilho Caracio F, et al
    Investigating the Health Potential of Mentha Species Against Gastrointestinal Disorders-A Systematic Review of Clinical Evidence.
    Pharmaceuticals (Basel). 2025;18:693.
    Abstract

  403. SZEKELY AB, Nseir M, Roth B, Ohlsson B, et al
    Leptin and PAI-1 Levels Are Decreased After a Dietary Intervention in Patients with Irritable Bowel Syndrome.
    Int J Mol Sci. 2025;26:4607.
    Abstract

  404. NIU J, Zhang G, Ning W, Liu H, et al
    The causal effects of primary biliary cholangitis on irritable bowel syndrome a mendelian randomization study.
    Int J Surg. 2025 May 26. doi: 10.1097/JS9.0000000000002457.
    Abstract

  405. LIU J, Cheng K, Lu Y, Cabral H, et al
    Effects of Sex and Race on Epidemiology and Comorbidities of Patients with Irritable Bowel Syndrome: A Rome III Era Retrospective Study.
    Diseases. 2025;13:161.
    Abstract

  406. KIM SH, Kang W, Kim M, Hong S, et al
    Temple stay diet and its impact on gut microbiome and irritable bowel syndrome: a prospective cohort study.
    Food Funct. 2025 May 27. doi: 10.1039/d4fo06143.
    Abstract

  407. RETTURA F, Lambiase C, Tedeschi R, Grosso A, et al
    Mucoprotectants and gut barrier: mechanisms of action and clinical applications in IBS. Is there a possible role?
    Front Pharmacol. 2025;16:1538791.
    Abstract

  408. MANNING LP, Tuck CJ, Biesiekierski JR
    Predicting response to the low FODMAP diet in irritable bowel syndrome: Current evidence and clinical considerations.
    Asia Pac J Clin Nutr. 2025;34:373-385.
    Abstract

  409. CHERNOGOROVA MV, Medvedeva EA, Yurenev GL, Maryin GG, et al
    [Small intestinal bacterial overgrowth in gastrointestinal diseases - a consequence or a cause of progression?].
    Vopr Pitan. 2025;94:5-17.
    Abstract

  410. PASCUAL-MATO M, Garate Vinas G, Munoz San Martin M, Gonzalez-Quintanilla V, et al
    Calcitonin gene-related peptide (CGRP) in the pathophysiology of gastrointestinal disorders - A key mediator in the gut-brain axis.
    Rev Esp Enferm Dig. 2025 May 26. doi: 10.17235/reed.2025.11310/2025.
    Abstract

  411. ALI A, Shah A, Amina A, Ruddock-Scott ZA, et al
    Prevalence of Irritable Bowel Syndrome Symptoms and Associated Risk Factors Among Medical Students.
    Cureus. 2025;17:e82900.
    Abstract

  412. ZVOLENSKY MJ, Smit T, Wein PY, Bakhshaie J, et al
    Gastrointestinal-specific anxiety and smoking abstinence expectancies among persons with irritable bowel syndrome.
    J Behav Med. 2025 May 26. doi: 10.1007/s10865-025-00576.
    Abstract

  413. SHUDT C, Smith S, Bortsov A, Parr K, et al
    Vestibulodynia Presentation is Differentiated by the Presence of Additional Chronic Primary Pain Conditions.
    J Pain. 2025 May 22:105450. doi: 10.1016/j.jpain.2025.105450.
    Abstract

  414. LIN H, Lv Y, Liu H, Lin Z, et al
    Baicalein alleviates chronic acute stress-induced irritable bowel syndrome-like symptoms in rats via modulating the ODC1/NF-kappaB pathway and oxidative stress.
    Biochem Biophys Res Commun. 2025;771:152058.
    Abstract

  415. LAKHAN SE
    Postmarket Safety Surveillance of FDA-Cleared Prescription Digital Therapeutics Using the Manufacturer and User Facility Device Experience (MAUDE) Database: A Pharmacovigilance Study.
    Cureus. 2025;17:e85343.
    Abstract

  416. AMIEVA-BALMORI M, Martinez-Perez GP, Francisco MR, Triana-Romero A, et al
    Dietary characteristics of Mexican patients with irritable bowel syndrome: Is there a distinction from the general population?
    Rev Gastroenterol Mex (Engl Ed). 2025 Jun 3:S2255-534X(25)00041.
    Abstract

  417. BERTUCCIOLI A, Sisti D, Lazzerini N, Palazzi CM, et al
    Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11.
    Front Med (Lausanne). 2025;12:1604319.
    Abstract

  418. JIANG S, Xu K, Chen X
    Identifying modifiable factors and their causal effects on osteoporosis risk.
    Sci Rep. 2025;15:19472.
    Abstract

  419. JO YW, Min JH, Kwon JW, Her Y, et al
    Rosacea and Its Potential Role in the Development of Irritable Bowel Syndrome: Insights From the Korean National Health Insurance Service-National Sample Cohort.
    J Korean Med Sci. 2025;40:e97.
    Abstract

  420. BAR-EL L, Veisman I, Simons M, Delpra C, et al
    Gut feeling: understanding the endometriosis-digestive link to enhance patient care and symptom control.
    Curr Opin Obstet Gynecol. 2025 May 8. doi: 10.1097/GCO.0000000000001041.
    Abstract

  421. NG RWY, Chen Z, Yang L, Wong OWH, et al
    Association between attention-deficit/hyperactivity disorders and intestinal disorders: A systematic review and Meta-analysis.
    Sci Rep. 2025;15:19278.
    Abstract

  422. XUE X, Hu J, Pei W, Mao T, et al
    Single-cell RNA-seq reveals the immune profile changes in patients with diarrhoeal-irritable bowel syndrome.
    Biochim Biophys Acta Mol Basis Dis. 2025 May 31:167945.
    Abstract

  423. EL DAIBANI A, Burgess G, Rysztak L, Jutkiewicz E, et al
    Delta opioid receptors: Overlooked outlier or the next big thing.
    Curr Opin Pharmacol. 2025;83:102528.
    Abstract

  424. WALZ KC, Suchodolski JS, Werner M, Grimm F, et al
    Long-Term Follow-Up After Acute Gastroenteritis Caused by Giardia Infection in Juvenile Dogs.
    J Vet Intern Med. 2025;39:e70123.
    Abstract

  425. WAN Y, Cao C, Zeng W
    The sympathetic neurons in the gut: Perspectives on metabolic and immune health and diseases.
    Curr Opin Neurobiol. 2025;93:103051.
    Abstract

  426. MORALES PS, Wijeyesekera A, Robertson MD, Kennedy J, et al
    A focus group study to assess perspectives of patients with irritable bowel syndrome on human milk oligosaccharides and lifestyle insights.
    Eur J Nutr. 2025;64:196.
    Abstract

  427. RUAN J, Zhu J, Li K, Wang Z, et al
    Effect of Electroacupuncture on Intestinal Mucosal Barrier in IBS-D Rats: Analysis Based on RNA-seq.
    Comb Chem High Throughput Screen. 2025.
    Abstract

  428. TULLY PJ, Cosh S, Wittert G, Martin S, et al
    Insight inTo Stress and POOping on Work TIME (ITS POO TIME): Protocol for a Web-Based, Cross-Sectional Study.
    JMIR Res Protoc. 2025;14:e58655.
    Abstract

  429. HUANG Y, Cai L, Liu J, Yang R, et al
    Is there a bidirectional relationship between allergic rhinitis and irritable bowel syndrome? A meta-analysis.
    J Glob Health. 2025;15:04155.
    Abstract

  430. SMOLINSKA S, Popescu FD, Zemelka-Wiacek M
    A Review of the Influence of Prebiotics, Probiotics, Synbiotics, and Postbiotics on the Human Gut Microbiome and Intestinal Integrity.
    J Clin Med. 2025;14:3673.
    Abstract

  431. HUANG G, Cai L, Guo J, Zhu R, et al
    Antibiotic-related dysbiosis of gut microbiota in healthy volunteers: a comparative study of ceftazidime-avibactam, piperacillin-tazobactam, and ceftriaxone.
    Eur J Clin Microbiol Infect Dis. 2025 Jun 12. doi: 10.1007/s10096-025-05184.
    Abstract

  432. ANDREWS MB, Adler DG
    Constipation-predominant irritable bowel syndrome treatment options Linaclotide, Lubiprostone, plecanatide, and Tenapanor: analysis of the FDA adverse event reporting system (FAERS) database.
    Expert Opin Drug Saf. 2025 Jun 12. doi: 10.1080/14740338.2025.2519833.
    Abstract

  433. LIU X, Lin R, Li X, He M, et al
    Association of maternal smoking, breastfeeding, and multiple birth with irritable bowel syndrome in older adults: a UK Biobank cohort study.
    Gastroenterol Rep (Oxf). 2025;13:goaf042.
    Abstract

  434. VENKATARAMAN A, Figueroa EE, Castro J, Navarro FMC, et al
    A Cellular Basis for Heightened Gut Sensitivity in Females.
    bioRxiv [Preprint]. 2025 May 28:2025.05.23.654927.
    Abstract

  435. SJOBLOM K, Frankenstein K, Klintwall L, Nilbrink J, et al
    Online Transdiagnostic Emotion Regulation Treatment for Adolescents With Mental Health Problems: A Randomized Clinical Trial.
    JAMA Netw Open. 2025;8:e2514871.
    Abstract

  436. GOTHLIN H, Hasseus B, Sjoberg K, Bankvall M, et al
    Manifestations of the oral mucosa and salivary glands in irritable bowel syndrome and microscopic colitis - A systematic review.
    Acta Odontol Scand. 2025;84:349-362.
    Abstract

  437. XIA Y, Liang C, Luo H, Zhang Y, et al
    Therapeutic Potential of Flavonoids and Flavonoid-Rich Compounds in Irritable Bowel Syndrome.
    Drug Des Devel Ther. 2025;19:4895-4910.
    Abstract

  438. VON MUHLENBROCK C, Nunez P, Herrera K, Pacheco N, et al
    Fecal microbiota transplantation through colonoscopy for the management of severe refractory irritable bowel syndrome: Preliminary results.
    Rev Gastroenterol Mex (Engl Ed). 2025 Jun 9:S2255-534X(25)00064.
    Abstract

  439. AL-BELTAGI M, Saeed NK, Bediwy AS, Elbeltagi R, et al
    Breaking the cycle: Psychological and social dimensions of pediatric functional gastrointestinal disorders.
    World J Clin Pediatr. 2025;14:103323.
    Abstract

  440. LOVDAHL J, Blomqvist-Storm M, Palsson OS, Ringstrom G, et al
    Nurse-Administered Gut-Directed Hypnotherapy for Irritable Bowel Syndrome: A Two-Year Follow-Up Study.
    United European Gastroenterol J. 2025 Jun 9. doi: 10.1002/ueg2.70060.
    Abstract

  441. MATIJASIC M, Baresic A, Cipcic Paljetak H, Peric M, et al
    Serum proteins and faecal microbiota as potential biomarkers in newly diagnosed, treatment-naive inflammatory bowel disease and irritable bowel syndrome patients.
    J Mol Med (Berl). 2025 Jun 7. doi: 10.1007/s00109-025-02558.
    Abstract

  442. YAN F, Huang H, Li Y
    Mood instability and 22 gastrointestinal disorders: investigating the causal relationships and the mediating factors by Mendelian randomization analysis.
    J Affect Disord. 2025;388:119591.
    Abstract

  443. NAVEED M, Choudary MAA, Aziz T, Makhdoom SI, et al
    Using novel approaches to conjugate peptides of Macrotermes bellicosus and Curcuma longa for targeted intervention of irritable bowl diseases caused by tumor necrosis factor superfamily member 15 (TNFSF15).
    Mol Immunol. 2025;183:286-295.
    Abstract

  444. AL-BELTAGI M, Saeed NK, Bediwy AS, El-Sawaf Y, et al
    Exploring the gut-exercise link: A systematic review of gastrointestinal disorders in physical activity.
    World J Gastroenterol. 2025;31:106835.
    Abstract

  445. GAO Y, Gong X, Qi J, Guo P, et al
    Evaluation of the combined use of linaclotide and probiotics on clinical treatment efficacy and quality of life in patients with constipation-predominant irritable bowel syndrome.
    Am J Transl Res. 2025;17:3333-3344.
    Abstract

  446. HAO L, Ge Y, Chen Z, Yuan D, et al
    Interaction Between Group 3 Innate Lymphoid Cells, Microbiota, and Intestinal Diseases: Mechanisms and Therapeutic Potential.
    J Innate Immun. 2025 Jun 18:1-17. doi: 10.1159/000546972.
    Abstract

  447. ROJAS DL, Torres-Soto NY, Martin-Estal I, de Ita JR, et al
    Impact of benevolent childhood experiences on mental and physical health in Mexican population.
    Child Abuse Negl. 2025;167:107559.
    Abstract

  448. FRIAS J, Martins M, Peixoto A, Macedo G, et al
    Rifaximin as a Therapeutic Ally in the Modulation of Dysbiosis: A Narrative Review of Its Applicability in Gastrointestinal Disorders.
    GE Port J Gastroenterol. 2025 Apr 21:1-15. doi: 10.1159/000545926.
    Abstract

  449. LIU Q, Shi Z, Jiang Y, Zhang T, et al
    Efficacy and safety of Chinese botanical drug Si Shen Wan in irritable bowel syndrome: a meta-analysis and trial sequential analysis of randomized controlled trials.
    Front Pharmacol. 2025;16:1534904.
    Abstract

  450. XU X, Huang Y, Ma Z, Liu Z, et al
    Exploration of TCM Comprehensive Treatment of Irritable Bowel Syndrome Based on Pathophysiological Mechanism.
    Int J Gen Med. 2025;18:3075-3091.
    Abstract

  451. RUSZKOWSKI J, Kachlik Z, Walaszek M, Storman D, et al
    Fecal microbiota transplantation from patients into animals to establish human microbiota-associated animal models: a scoping review.
    J Transl Med. 2025;23:662.
    Abstract

  452. MCKERCHAR S, Mire EL, Badcock N, Jones M, et al
    No Evidence for Unconscious Attentional Bias in People With Clinically Significant Symptoms of Functional Gastrointestinal Disorders: A Study Using the Emerging Electroencephalographic Paradigm of Fast Periodic Visual Stimulation.
    Neurogastroenterol Motil. 2025 Jun 16:e70099. doi: 10.1111/nmo.70099.
    Abstract

  453. YANG NN, Xie XX, Yan WL, Liu YD, et al
    The Autonomic Nervous System in Acupuncture for Gastrointestinal Dysmotility: From Anatomical Insights to Clinical Medicine.
    Int J Med Sci. 2025;22:2620-2636.
    Abstract

  454. BLANKENBERGER A, Lesmana E, Yang L, Comba IY, et al
    Longitudinal Changes in the Gut Microbiome of Patients With Irritable Bowel Syndrome After Campylobacter Infection are Associated With Proteolytic Activity.
    Gastro Hep Adv. 2025;4:100683.
    Abstract

  455. WANG YF, Yao ZY, Xiao Y, Wang XQ, et al
    [A cross-sectional questionnaire survey on the prevalence and risk factors of 4 major functional gastrointestinal disorders among children in Shanghai].
    Zhonghua Er Ke Za Zhi. 2025;63:747-753.
    Abstract

  456. ISHIOH M, Nozu T, Miyagishi S, Funayama T, et al
    Carnosine improves colonic hyperpermeability through the brain histamine H1 receptor, basal forebrain cholinergic neurons, adenosine A2B receptors and vagus nerve in rats.
    Eur J Pharmacol. 2025;1002:177844.
    Abstract

  457. BOSI A, Banfi D, Capo JD, Ponti A, et al
    Sex-dependent alteration of the enteric neuromuscular function after antibiotic-induced dysbiosis in juvenile mice and effect of Lactocaseibacillus rhamnosus GG.
    Biomed Pharmacother. 2025;189:118263.
    Abstract

  458. CUENDE-ESTEVEZ M, Hussein H, Pia F, Backaert W, et al
    Increased Allergic Rhinitis Prevalence and Symptom Severity in Patients With Irritable Bowel Syndrome.
    Neurogastroenterol Motil. 2025 Jun 14:e70108. doi: 10.1111/nmo.70108.
    Abstract

  459. ZHANG L, Song Z, Huang X, Jiang B, et al
    Research progress on the regulation of interstitial cell of Cajal autophagy and apoptosis crosstalk by traditional Chinese medicine in gastrointestinal motility disorders.
    J Ethnopharmacol. 2025 Jun 11:120128. doi: 10.1016/j.jep.2025.120128.
    Abstract

  460. DENDRINOS E, Kim H, Hubik D, Green J, et al
    Clinical outcomes of patients seen by psychiatrists in a multidisciplinary clinic for disorders of gut-brain interaction.
    Intern Med J. 2025 Jun 27. doi: 10.1111/imj.70134.
    Abstract

  461. ZHAO P, Han Q, Qiu X
    Comments to the Editor: opinions on "Causal effects of primary biliary cholangitis on irritable bowel syndrome: a Mendelian randomization study".
    Int J Surg. 2025 Jun 27. doi: 10.1097/JS9.0000000000002759.
    Abstract

  462. LI E, Wang J, Guo B, Zhang W, et al
    Effects of short-chain fatty acid-producing probiotic metabolites on symptom relief and intestinal barrier function in patients with irritable bowel syndrome: a double-blind, randomized controlled trial.
    Front Cell Infect Microbiol. 2025;15:1616066.
    Abstract

  463. FENNESSY A, Doyle M, Boland A, Bourke R, et al
    Four-strain probiotic exerts a positive effect on irritable bowel syndrome symptoms occurring in inflammatory bowel diseases in absence of inflammation (train-IBD trial).
    World J Gastrointest Pharmacol Ther. 2025;16:101268.
    Abstract

  464. BHAGAVATHULA AS, Al Qady AM, Aldhaleei WA
    Diagnostic accuracy and quality of artificial intelligence models in irritable bowel syndrome: A systematic review.
    World J Gastroenterol. 2025;31:106836.
    Abstract

  465. CHENG P, Jia R, Jin B, Zhou F, et al
    IBS May Have a Causal Effect on Increased Tryptophan Metabolites Levels: Insights from a Bidirectional Two-Sample Mendelian Randomization Study.
    Int J Tryptophan Res. 2025;18:11786469251327399.
    Abstract

  466. KUZMIN L, Kubiak K, Lange E
    Efficacy of a Low-FODMAP Diet on the Severity of Gastrointestinal Symptoms and Quality of Life in the Treatment of Gastrointestinal Disorders-A Systematic Review of Randomized Controlled Trials.
    Nutrients. 2025;17:2045.
    Abstract

  467. BUTT MF, Scotto D, Gilmartin CGS, Dhali A, et al
    A Medical Student Curriculum on Functional Medical Disorders.
    Clin Teach. 2025;22:e70117.
    Abstract

  468. JANEV A, Zupancic D, Veranic P, Kuret T, et al
    Oxidative stress and chronic inflammation as partners in crime in interstitial cystitis/bladder pain syndrome.
    J Innate Immun. 2025 Jun 26:1-39. doi: 10.1159/000546901.
    Abstract

  469. CLARK DA, Moayyedi P
    Fecal CD200 as a Measure of Immunosuppressive CD200L and Proinflammatory CD200S at the Feto-Maternal Interface.
    Am J Reprod Immunol. 2025;94:e70120.
    Abstract

  470. ALIPOUR-VAEZI M, McNamara RS, Rukstalis MR, Gentry EC, et al
    Comparative Risk of Developing Interstitial Cystitis With Childhood Gastrointestinal, Urological, Autoimmune, or Psychiatric Disorders.
    Neurourol Urodyn. 2025 Jun 25. doi: 10.1002/nau.70104.
    Abstract

  471. WANG X, Sun Z, Xue H, An R, et al
    Artificial Intelligence Applications to Personalized Dietary Recommendations: A Systematic Review.
    Healthcare (Basel). 2025;13:1417.
    Abstract

  472. LEVINE J, Islam RK, Mo L, Kim BS, et al
    Dupilumab in Atopic Dermatitis Linked to Reduced Irritable Bowel Syndrome Risk: A Real-World Cohort Study.
    Allergy. 2025 Jun 25. doi: 10.1111/all.16637.
    Abstract

  473. LIN DK, Chang HC
    Association of Atopic Dermatitis or Allergic Rhinitis With Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Allergy. 2025 Jun 25. doi: 10.1111/all.16630.
    Abstract

  474. STASI C, Bellini M
    Digestive Manifestations of Post-COVID-19: A Focus on Therapeutic Strategies.
    Pathogens. 2025;14:555.
    Abstract

  475. SANTONICOLA A, Moscato P, Soldaini C, Loi G, et al
    The effect of medical cannabis on gastrointestinal symptoms in fibromyalgia and disorders of gut-brain interaction: a patient?centred real?world observational study.
    Clin Exp Rheumatol. 2025;43:1074-1081.
    Abstract

  476. MUKHOPADHYAY S, Ulaganathan N, Dumpuri P, Aich P, et al
    Integrative AI-Based Approaches to Connect the Multiome to Use Microbiome-Metabolome Interactive Outcome as Precision Medicine.
    Methods Mol Biol. 2025;2952:15-37.
    Abstract

  477. SUN Z, Jiang L, Xing Y, Luo F, et al
    Efficacy of a single low dose of esketamine for patients with irritable bowel syndrome: study protocol for a randomised controlled trial.
    BMJ Open. 2025;15:e099793.
    Abstract

  478. JAAFARI H, Houghton LA, West RM, Shuweihdi F, et al
    Dietary patterns are associated with variations in the global prevalence and severity of Rome IV Irritable Bowel Syndrome.
    Clin Gastroenterol Hepatol. 2025 Jun 21:S1542-3565(25)00523.
    Abstract

  479. ZHANG C, Liu L, Wang Z, Jiang J, et al
    Commentary on "The causal effects of primary biliary cholangitis on irritable bowel syndrome: a Mendelian randomization study".
    Int J Surg. 2025 Jun 20. doi: 10.1097/JS9.0000000000002793.
    Abstract

  480. WU X, Chen G, Yang L, Lv Z, et al
    Comprehensive antibiotic resistome comparison of Escherichia coli from irritable bowel syndrome and ulcerative colitis.
    Curr Res Microb Sci. 2025;8:100398.
    Abstract

  481. SABATE JM
    [Irritable bowel syndrome].
    Rev Prat. 2025;75:408-413.
    Abstract

  482. FENG Y, Zhou C, He Y, Wu Y, et al
    Shugan Decoction Ameliorated WAS-Induced Abnormal Colonic Motility in Rats by Inhibiting Colonic TRPV4-PGE(2) Signaling.
    Neurogastroenterol Motil. 2025 Jun 22:e70104. doi: 10.1111/nmo.70104.
    Abstract

  483. MORALES-GUZMAN AS, Alarcon-Aguilar A, Luna-Lopez A, Santana-Vargas AD, et al
    Abnormal Homeostasis in the Redox State and Related Signaling Pathways, in Irritable Bowel Syndrome.
    Neurogastroenterol Motil. 2025 Jun 22:e70097. doi: 10.1111/nmo.70097.
    Abstract

  484. PALANIVELU L, Chen YY, Liang YW, Li SJ, et al
    Diffusion kurtosis imaging biomarkers associated with amelioration of neuroinflammation, gray matter microstructural abnormalities, and gut dysbiosis by central thalamic deep brain stimulation in autistic -like young rats.
    Neuroimage. 2025;317:121344.
    Abstract

  485. AIHARA Y, Ito Y, Takeshita E, Oba M, et al
    Prevalence and management of gastrointestinal complications in Duchenne muscular dystrophy: A retrospective cohort study.
    Brain Dev. 2025;47:104379.
    Abstract

  486. ZENG X, He W, Chen X, Luo H, et al
    Letter to the editor: a commentary on "The causal effects of primary biliary cholangitis on irritable bowel syndrome a mendelian randomization study".
    Int J Surg. 2025 Jun 20. doi: 10.1097/JS9.0000000000002690.
    Abstract

  487. BASMISIRLI E, Kip M, Altun H, Inanc N, et al
    Evaluating the Quality and Reliability of YouTube Videos Providing Nutritional Recommendations for Irritable Bowel Syndrome.
    J Hum Nutr Diet. 2025;38:e70088.
    Abstract

  488. TANG Y, Liu Z, Wu X, He Z, et al
    EXPRESS: The Involvement of Spinal lncRNA RT1-CE10 in Chronic Functional Visceral Pain.
    Mol Pain. 2025 Jul 3:17448069251358692. doi: 10.1177/17448069251358692.
    Abstract

  489. YUAN S, Bai M, Sun H
    Letter to the editor: the causal effects of primary biliary cholangitis on irritable bowel syndrome a mendelian randomization study.
    Int J Surg. 2025 Jul 2. doi: 10.1097/JS9.0000000000002802.
    Abstract

  490. ROSSI CM, Merli S, Lenti MV, De Amici M, et al
    Clinical and atopic features of patients with wheat allergy dependent on augmentation factors (WALDA) presenting with urticaria: a monocentric study.
    Eur Ann Allergy Clin Immunol. 2025 Jul 3. doi: 10.23822/EurAnnACI.1764-1489.
    Abstract

  491. SUN N, Cao LS, Xia WY, Wang JM, et al
    Gut sensory neurons as regulators of neuro-immune-microbial interactions: from molecular mechanisms to precision therapy for IBD/IBS.
    J Neuroinflammation. 2025;22:172.
    Abstract

  492. YAO G, Zhou Y, Jin J, Zhou P, et al
    Adding a C-terminal amino acid prevents the conformational interconversion of plecanatide analogues.
    Chembiochem. 2025 Jul 2:e202500237. doi: 10.1002/cbic.202500237.
    Abstract

  493. DING X, Li T, Zhao J, Fan M, et al
    Legume seed coat polysaccharides: Extraction, physicochemical properties, and anti-inflammatory potential against intestinal inflammation-A review.
    Int J Biol Macromol. 2025 Jun 30:145662. doi: 10.1016/j.ijbiomac.2025.145662.
    Abstract

  494. SUN Y, Wu D, Lu L, Wang J, et al
    Mesenchymal stem cell-derived apoptotic vesicles regulate irritable bowel syndrome in mice via the 5-HT brain-gut axis.
    Stem Cell Res Ther. 2025;16:326.
    Abstract

  495. BERTALAN E, Horvath Z, Gajdos P, Magyarodi T, et al
    Psychometric properties of the Hungarian Visceral Sensitivity Index (VSI-H): insights from two cross-sectional studies on self-reported IBS and gluten-related conditions.
    BMC Psychol. 2025;13:679.
    Abstract

  496. SHANKAR R, Yip AW
    Sentiment analysis and topic modeling of social media data to explore public discourse on irritable bowel syndrome.
    Sci Rep. 2025;15:21550.
    Abstract

  497. SILVA H, Porter J, Barrett J, Gibson PR, et al
    Dietary Intake, Symptom Control and Quality of Life After Dietitian-Delivered Education on a FODMAP Diet for Irritable Bowel Syndrome: A 7-Year Follow Up.
    Neurogastroenterol Motil. 2025 Jul 1:e70116. doi: 10.1111/nmo.70116.
    Abstract

  498. NEWTON JM, Edwards WJS, Thompson GS, Gentekaki E, et al
    Effect of antibiotic administration on Blastocystis persistence and gut microbiome-metabolome dynamics in an irritable bowel syndrome longitudinal case study.
    Access Microbiol. 2025;7:000926.
    Abstract

  499. DESAI BJ, Person H
    A Practical Approach to Functional Abdominal Pain and Irritable Bowel Syndrome in Children and Adolescents.
    Adv Pediatr. 2025;72:219-234.
    Abstract

  500. FUKUSHIMA T, Okamoto T, Hamaya T, Kodama H, et al
    Serum Serotonin Levels as a Potential Risk Factor for Overactive Bladder in a Community-Dwelling Population: A Four-Year Longitudinal Study.
    Low Urin Tract Symptoms. 2025;17:e70019.
    Abstract

  501. YANG Y, Sui J, Liao W, Wang S, et al
    Clinical Evidence on the Health Benefits and Safety of Probiotic Lacticaseibacillus rhamnosus: A Systematic Review.
    Probiotics Antimicrob Proteins. 2025 Jul 11. doi: 10.1007/s12602-025-10646.
    Abstract

  502. FLAHERTY A, Tomlinson E, Weaver B, Akhbari B, et al
    Factors Associated with Non-Unions of Fifth Metatarsal Fractures.
    Arch Bone Jt Surg. 2025;13:367-377.
    Abstract

  503. WANG M, Tan Y, Guo H, Peng H, et al
    Sex hormone-binding globulin and sex-specific association between irritable bowel syndrome and type 2 diabetes: a prospective cohort study.
    Nutr J. 2025;24:108.
    Abstract

  504. ZHAI L, Zheng Y, Lo CW, Xu S, et al
    Butyrate-producing commensal bacteria mediates the efficacy of herbal medicine JCM-16021 on abdominal pain in diarrhea-predominant irritable bowel syndrome: a randomized clinical trial.
    Phytomedicine. 2025;145:157040.
    Abstract

  505. ROSSI CM, Lenti MV, Di Sabatino A
    Mechanistic Gaps in Linking Aero- and Food Allergens to Irritable Bowel Syndrome.
    Neurogastroenterol Motil. 2025 Jul 10:e70122. doi: 10.1111/nmo.70122.
    Abstract

  506. MORANO D, Scarlata GGM, Spagnuolo R, Suraci E, et al
    [Functional disorders of the upper digestive tract: epidemiological, clinical and therapeutic aspects.].
    Recenti Prog Med. 2025;116.
    Abstract

  507. HADI HS, Ali Hadi M, Aljuranii LA, Al-Fahham AA, et al
    Respiratory dysfunction in patients with irritable bowel syndrome.
    Pol Merkur Lekarski. 2025;53:347-351.
    Abstract

  508. ARIF TB, Damianos JA, Rahman AU, Hasnain N, et al
    Fecal Microbiota Transplantation for Disorders of Gut-Brain Interaction: Current Insights, Effectiveness, and Future Perspectives.
    Curr Gastroenterol Rep. 2025;27:50.
    Abstract

  509. BURKADZE A, Burkadze E, Kandashvili T, Silagadze T, et al
    Factor Analysis of the BDI-II and HAMD-21 in Patients With Irritable Bowel Syndrome.
    Alpha Psychiatry. 2025;26:44020.
    Abstract

  510. MINE K, Murata Y, Fujino M, Fujino T, et al
    A Refractory, Gas-Predominant Subgroup of Irritable Bowel Syndrome Markedly Improved With Relatively Long-Term Paroxetine Treatment: A Preliminary Study.
    Cureus. 2025;17:e85494.
    Abstract

  511. SALMELA E, Kalle K, Lindfors K, Saavalainen P, et al
    Long-term health outcomes of people without celiac disease avoiding gluten consumption: a 25-year prospective cohort study.
    Eur J Clin Nutr. 2025 Jul 8. doi: 10.1038/s41430-025-01641.
    Abstract

  512. GWEE KA
    "Ulcerative Colitis and Irritable Bowel Syndrome Are Diagonally Opposite." Missing the Trees for the Woods.
    J Neurogastroenterol Motil. 2025;31:289-290.
    Abstract

  513. KESHAVARZI A, Talebi SS, Ahmadpanah M, Soltanian A, et al
    Sexual function, depression, and quality of life in patients with irritable bowel syndrome.
    BMC Gastroenterol. 2025;25:504.
    Abstract

  514. REYES-DIAZ SA, Priego-Parra BA, Ordaz-Alvarez HR, Nunez-Jimenez EL, et al
    Unequal burdens: Irritable bowel syndrome in sexual and gender minority communities vs cisgender heterosexual individuals.
    Clin Transl Gastroenterol. 2025 Jul 7. doi: 10.14309/ctg.0000000000000883.
    Abstract

  515. PONIEWIERKA E, Szura E, Valach P
    Effects of physical activity on symptoms of irritable bowel syndrome.
    Prz Gastroenterol. 2025;20:173-177.
    Abstract

  516. BAI X, Ihara E, Tanaka Y, Minoda Y, et al
    The interplay of gut microbiota and intestinal motility in gastrointestinal function.
    J Smooth Muscle Res. 2025;61:51-58.
    Abstract

  517. SUMBIZI C, Hassan O, Ng'wanasayi M, Ngimba C, et al
    Rectosigmoid endometriosis, a rare cause of lower GI bleeding in a premenopausal woman: Case report.
    Int J Surg Case Rep. 2025;133:111608.
    Abstract

  518. LIU Q, Fang W, Zheng P, Xie S, et al
    Multi-kingdom microbiota analysis reveals bacteria-viral interplay in IBS with depression and anxiety.
    NPJ Biofilms Microbiomes. 2025;11:129.
    Abstract

  519. MINA S, Daher S, Jamal Elddin S, Mina N, et al
    Post-infectious irritable bowel syndrome in a paediatric population: first data in a Middle Eastern country.
    BMC Pediatr. 2025;25:531.
    Abstract

  520. LI J, Zhang K, Yan F, Wang Y, et al
    Aptamer-chitosan modified chlorogenic acid derived nanoparticles for enhancing target treatment in diarrhea-predominant irritable bowel syndrome.
    Int J Biol Macromol. 2025;320.
    Abstract

  521. MANNILA E, Hokkanen L, Ahonen E, Turpeinen AM, et al
    Tolerance of protein hydrolyzed lactose-free A1 milk and A2 milk in lactose-tolerant and lactose-intolerant volunteers - a randomized cross-over trial with two parallel groups.
    J Dairy Sci. 2025 Jul 2:S0022-0302(25)00476-X. doi: 10.3168/jds.2025-26712.
    Abstract

  522. PECYNA P, Bykowska-Derda A, Gabryel M, Mankowska-Wierzbicka D, et al
    Blautia spp. in the gut microbiome: Its relation to dietary choices and to the nutritional status of patients with irritable bowel syndrome.
    Nutrition. 2025;138:112836.
    Abstract

  523. DELI F, Whelan K, Bear DE
    Nutritional adequacy in critically ill adults receiving noninvasive ventilation: A descriptive cohort study.
    JPEN J Parenter Enteral Nutr. 2025 Apr 23. doi: 10.1002/jpen.2764.
    Abstract

  524. ROBERTSON K, Hahn O, Tantry A, Robinson BG, et al
    Gpr37 modulates the severity of inflammation-induced GI dysmotility by regulating enteric reactive gliosis.
    iScience. 2025;28:112885.
    Abstract

  525. GANZEVOORT IN, Berger MY, Benninga MA, Vlieger AM, et al
    Using media to enhance paediatric patient recruitment for research in primary care.
    Prim Health Care Res Dev. 2025;26:e62.
    Abstract


  526. Unraveling the genetic susceptibility of irritable bowel syndrome: integrative genome-wide analyses in 845,492 individuals: a diagnostic study: Erratum.
    Int J Surg. 2025;111:4971.
    Abstract

  527. CHEN D, Ni D, Yang H
    Combination therapy with otilonium bromide and trimebutine maleate demonstrates significant clinical advantages in irritable bowel syndrome patients.
    Am J Transl Res. 2025;17:4859-4866.
    Abstract

  528. SKELTON M, Mitchell BL, Assary E, Li D, et al
    Genome-wide insights into generalised anxiety using a dimensional symptom severity approach.
    medRxiv [Preprint]. 2025 Jul 11:2025.07.10.25331321.
    Abstract

  529. ATAYA J, Swileh N, Alchawa Z, Kabboul H, et al
    Exploring the relationship between irritable bowel syndrome and psychosocial, demographic, and health factors in Syrian hospital settings.
    BMC Psychiatry. 2025;25:708.
    Abstract

  530. LI K, Chu H, Zou L, Ruan J, et al
    [Effect of moxibustion on small intestinal mucosal immune barrier in rats with diarrhea-predominant irritable bowel syndrome].
    Zhongguo Zhen Jiu. 2025;45:935-944.
    Abstract

  531. RIDGE A, Cooling N, Seidel B
    A mixed immediate and delayed allergy to oral vitamin D supplementation: a case report.
    J Med Case Rep. 2025;19:344.
    Abstract

  532. KIM HJ, Jeon HJ, Kang WS, Choi JW, et al
    Awareness of Psychosomatic Medicine in Korea: Results From an Online Survey Conducted With Doctors and the General Public.
    J Korean Med Sci. 2025;40:e138.
    Abstract

  533. PIVA SR, Smith C, Anderst W, Bell KM, et al
    Demographic and Biomedical Characteristics of an Observational Cohort With Chronic Low Back Pain: A Descriptive Analysis.
    JOR Spine. 2025;8:e70094.
    Abstract

  534. QI T, Wang Y, Liu Y, Li W, et al
    Bacteria into bloodstream caused by oral probiotics based on whole genome sequencing: A case report.
    Medicine (Baltimore). 2025;104:e43337.
    Abstract

  535. CRENN P
    The sick gut with diarrhea: FODMAPS for treatment?
    Curr Opin Clin Nutr Metab Care. 2025 Jul 8. doi: 10.1097/MCO.0000000000001141.
    Abstract

  536. BJORKEVOLL SMG, Randulff Hillestad EM, Lied GA, Teige ES, et al
    A 12-Week Strict Low FODMAP Diet Reduces the Severity Levels of Fatigue, Depression, Anxiety, and Inattention in Patients with Irritable Bowel Syndrome.
    Curr Dev Nutr. 2025;9:107483.
    Abstract

  537. GALVEZ A, Kuhlmann P, Barker M, Chen A, et al
    Association of HRQOL with Symptom Patterns in an Online Cohort of Patients with Interstitial Cystitis/Bladder Pain Syndrome.
    Urology. 2025 Jul 10:S0090-4295(25)00629-6. doi: 10.1016/j.urology.2025.
    Abstract

  538. CHOJNACKI M, Blonska A, Kaczka A, Chojnacki J, et al
    Assessment of the Gut Microbiome in Patients with Coexisting Irritable Bowel Syndrome and Chronic Fatigue Syndrome.
    Nutrients. 2025;17:2232.
    Abstract

  539. ROHNER S, Schnepper R, Meinlschmidt G, Schaefert R, et al
    Basel Long COVID Cohort Study (BALCoS): protocol of a prospective cohort study.
    BMJ Open. 2025;15:e093981.
    Abstract

  540. GOYAL O, Goyal MK, Gupta A, Batta S, et al
    Self-Reported Food Triggers and Food Fears Impact Nutrient Intake and Quality of Life in Patients with Irritable Bowel Syndrome and Functional Dyspepsia.
    Korean J Gastroenterol. 2025;85:345-356.
    Abstract

  541. SHAHROKH S, Namazi N, Abbasinazari M, Abazarikia A, et al
    Assessment of the Efficacy and Safety of Sublingual Melatonin on Symptom Severity, Quality of Life, and Sleep Disorders in Patients with Irritable Bowel Syndrome.
    Iran J Pharm Res. 2025;24:e156425.
    Abstract

  542. SEILER CL, Rueda GH, Miranda PM, Nardelli A, et al
    Effect of gluten and wheat on symptoms and behaviours in adults with irritable bowel syndrome: a single-centre, randomised, double-blind, sham-controlled crossover trial.
    Lancet Gastroenterol Hepatol. 2025 Jul 18:S2468-1253(25)00090.
    Abstract

  543. ELSENBRUCH S
    Unravelling the power of nocebo in symptom response to food challenge in irritable bowel syndrome.
    Lancet Gastroenterol Hepatol. 2025 Jul 18:S2468-1253(25)00126.
    Abstract

  544. BAIDOO N, Sanger GJ
    The Ageing of the Human Lower Bowel.
    Br J Hosp Med (Lond). 2025;86:1-16.
    Abstract

  545. XIONG J, Xu T, Wang Z, Huang Y, et al
    The hidden genetic and microbial networks connecting neuropsychiatric and digestive disorders.
    Comput Struct Biotechnol J. 2025;27:3114-3126.
    Abstract

  546. SAMUELS THA, Warrell CE
    Travellers' diarrhoea - solidifying our knowledgebase.
    Curr Opin Infect Dis. 2025 Jul 24. doi: 10.1097/QCO.0000000000001131.
    Abstract

  547. GAUTAM M, Goel U, Bader A, Azim S, et al
    Patterns of prescription and discontinuation of glucagon-like peptide-1 receptor agonists among patients with irritable bowel syndrome.
    Ann Gastroenterol. 2025;38:420-427.
    Abstract

  548. TEPERIKIDIS L, Mademlis C, Hatzinakos G, Lazaridis N, et al
    Replication and extension of a meta-analysis of antidepressants for irritable bowel syndrome: a comparison of odds ratios and risk ratios using artificial intelligence-powered tools.
    Ann Gastroenterol. 2025;38:462-463.
    Abstract

  549. SMITH JS, Coffey MJ, Jaffe A, Chuang S, et al
    Disorders of Gut-Brain Interaction in a Pediatric Cystic Fibrosis Cohort.
    Pediatr Pulmonol. 2025;60:e71214.
    Abstract

  550. WIERZBICKA A, Khaidakov B, Zakerska-Banaszak O, Andrzejewska P, et al
    Effects of a polyphenol-rich extract blend, probiotics, and hydrolyzed fiber on quality of life and gut health markers in patients with irritable bowel syndrome-A randomized, double-blind, placebo-controlled trial.
    Front Nutr. 2025;12:1603011.
    Abstract

  551. VAN DEN BELT M, Liu Z, Janssen Duijghuijsen L, Zoetendal EG, et al
    Randomised controlled trial: nutritional supplements to relieve irritable bowel syndrome symptoms by targeting the gut microbiota.
    J Nutr Sci. 2025;14:e46.
    Abstract

  552. FIESS A, Hartmann A, Ernst M, Schuster AK, et al
    Sequelae of preterm birth over the lifespan: an exploratory analysis of behavioral problems in childhood and increased risk of major depression and anxiety in adulthood from a cohort study.
    EClinicalMedicine. 2025;85:103316.
    Abstract

  553. SOGAME M, Ito M
    Advanced multidimensional quality evaluation of encapsulated peppermint oil products in various formulas.
    J Nat Med. 2025 Jul 18. doi: 10.1007/s11418-025-01934.
    Abstract

  554. ZHOU Y, Zhou B, Ke X, Ma Y, et al
    Glucokinase activators contribute to gastrointestinal disease risks through metabolic-immune interplay in the gut-liver axis: insights from a multi-omics study.
    Acta Diabetol. 2025 Aug 1. doi: 10.1007/s00592-025-02571.
    Abstract

  555. WU H, Zhao F, Jia W, Li P, et al
    [L'axe cerveau-intestin : l'aube des troubles neurologiques ?].
    Ann Biol Clin (Paris). 2025;83:0.
    Abstract

  556. LENOVER MOYER MB, Shenk MK
    Physical Activity and Irritable Bowel Syndrome: The Role of Evolutionary Mismatch in Chronic Disease Risk.
    Am J Biol Anthropol. 2025;187:e70104.
    Abstract

  557. KUHNELOVA S, Roznovsky L, Dolezilkova J, Madar R, et al
    Blastocystis in the human gastrointestinal tract - commensal or "silent" pathogen?
    Epidemiol Mikrobiol Imunol. 2025;74:118-125.
    Abstract

  558. JACOBS JP, Labus JS, Dong TS, Shin AS, et al
    Extraintestinal symptoms in irritable bowel syndrome are associated with stress reactivity and the gut microbiome in a sex-dependent manner.
    Clin Gastroenterol Hepatol. 2025 Jul 29:S1542-3565(25)00640.
    Abstract

  559. WU Y, Guo F, Xu X, Liu Y, et al
    Based on Proteomics Data Revealing the Potential of Traditional Chinese Medicine in Treating Irritable Bowel Syndrome.
    Mediators Inflamm. 2025;2025:7748351.
    Abstract

  560. POULADI A, Arabpour E, Bahrami O, Sadeghi A, et al
    Impacts of the Long-Term Low-FODMAP Diet in Patients With Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    J Hum Nutr Diet. 2025;38:e70105.
    Abstract

  561. SHABBIR P, Malik S, Naveed M, Anwar MF, et al
    Remission of irritable bowel syndrome with lifestyle medicine.
    Pak J Med Sci. 2025;41:2156-2159.
    Abstract

  562. SAEEDINIA E, Poursharifi H, Momeni F, Vahedi M, et al
    Psychological determinants of irritable bowel syndrome and its impact on quality of life: a machine learning approaches.
    Gastroenterol Hepatol Bed Bench. 2025;18:100-114.
    Abstract

  563. AYDEMIR S, Arvas YE, Aydemir ME, Barlik F, et al
    Antiprotozoal Effects of Pediococcus acidilactici-Derived Postbiotic on Blastocystis Subtypes ST1/ST3.
    Pathogens. 2025;14:664.
    Abstract

  564. DUZEN OFLAS N, Yilmaz Urun Y
    Vitamin D Deficiency and Supplementation in Irritable Bowel Syndrome: Retrospective Evaluation of Subtype and Sex-Based Differences.
    Medicina (Kaunas). 2025;61:1229.
    Abstract

  565. SAVULESCU-FIEDLER I, Benea SN, Caruntu C, Nancoff AS, et al
    Rewiring the Brain Through the Gut: Insights into Microbiota-Nervous System Interactions.
    Curr Issues Mol Biol. 2025;47:489.
    Abstract

  566. CHIMINACIO I, Petry JF, Campos NNLRV, Obrzut C, et al
    Multiple lesions of endometriosis in the small intestine treated by the shaving technique: A case report.
    Case Rep Womens Health. 2025;47:e00731.
    Abstract

  567. CHEN A, Shi J, Wu H, Shi W, et al
    Chronic back pain: recognising twelfth rib syndrome.
    BMJ Case Rep. 2025;18:e266106.
    Abstract

  568. NAIZR S, Abbas Z, Gazder DP, Shahid A, et al
    Incidence and Characterization of SIBO in NAFLD Patients.
    Euroasian J Hepatogastroenterol. 2025;15:38-43.
    Abstract

  569. ALHOSANI N, Al Rifai A
    Pancreatic Heterotopia Presenting as Ileal Intussusception in an Adult: A Case Report and Literature Review.
    Cureus. 2025;17:e86745.
    Abstract

  570. HANNING N, Verboven R, Smet A, Timmermans JP, et al
    In-depth study of gastrointestinal motility, intestinal barrier function and secretory function in an irritable bowel syndrome post-inflammatory rat model.
    Eur J Pharmacol. 2025;1004:177990.
    Abstract

  571. MONIRUZZAMAN M, Shah A, Morrison M, Koloski N, et al
    Mechanisms of action and clinical effectiveness of herbal treatments for disorders of gut-brain interaction.
    Dig Liver Dis. 2025 Jul 25:S1590-8658(25)00905-3. doi: 10.1016/j.dld.2025.
    Abstract

  572. FLEMING C, Hardacre CJ, Memon A
    Pneumatosis intestinalis presenting with acute abdomen.
    BMJ Case Rep. 2025;18:e264888.
    Abstract

  573. KUZMINSKA O, Vitkovska B, Kuvaiskov Y, Hatton CG, et al
    Efficacy and Safety of the Enterosorbent Silicolgel in Irritable Bowel Syndrome, IBS-D and IBS-M: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial.
    Neurogastroenterol Motil. 2025 Jul 25:e70118. doi: 10.1111/nmo.70118.
    Abstract

  574. ZHOU Y, Zhang L, Xia T, Zhang X, et al
    Effects of manual acupuncture on fatty acid metabolism in a rat model of diarrhea-predominant irritable bowel syndrome: a multi-tissue metabolomic and plasma lipidomic investigation.
    Acupunct Med. 2025;43:218-232.
    Abstract

  575. DEKIMECHE I, Grasland M, Jolu A, Essid D, et al
    Iconographic validation of the Bristol scale in patient with neurological diseases.
    Fr J Urol. 2025 Aug 5:102949. doi: 10.1016/j.fjurol.2025.102949.
    Abstract

  576. VALITUTTI F, Cavalli E, Leter B, Leonard M, et al
    Coeliac disease and microbiota: is it time for personalised biotics intervention? A scoping review.
    BMJ Nutr Prev Health. 2025;8:e001100.
    Abstract

  577. CHIN SW, Low ZY, Tan WQ, Azman AS, et al
    Microbiota-Host Interactions: Exploring Their Dynamics and Contributions to Human Diseases.
    Microbiologyopen. 2025;14:e70043.
    Abstract

  578. SILVA MT, Amado DM, Rocha PRS, Barreto JOM, et al
    Integrative and Complementary Health Practices for Chronic Pain: summary of clinical guideline recommendations.
    Epidemiol Serv Saude. 2025;34:e20240771.
    Abstract

  579. FOWLER S, Paech GM, Hoedt EC, Pryor JC, et al
    Altered peripheral CRY1 gene expression may contribute to both organic and functional gastrointestinal disease.
    Exp Physiol. 2025 Aug 6. doi: 10.1113/EP092725.
    Abstract

  580. HAN LL, Mei CF, Xue H
    Exploring the relationship between co-abundance of gut microbiota and novel metabolic pathways in different subtypes of irritable bowel syndrome: insights from the American Gut Project.
    Front Med (Lausanne). 2025;12:1615717.
    Abstract

  581. CHEN SJ, Chang HC, Gau SY
    Psoriasis Patients are Associated with Increased Risk of New-Onset Irritable Bowel Syndrome: A Multicenter, Retrospective Cohort Study.
    Int J Med Sci. 2025;22:3422-3428.
    Abstract

  582. VILLE A, McRae R, Nomchong J, Reidlinger DP, et al
    Effects of a Low FODMAP Diet in Inflammatory Bowel Disease and Patient Experiences: A Mixed Methods Systematic Literature Review and Meta-Analysis.
    J Hum Nutr Diet. 2025;38:e70106.
    Abstract

  583. WEI Z, Zhang Y, Xu S, Tong M, et al
    Paternal separation as an independent risk factor for irritable bowel syndrome in rural Chinese left-behind children: a multicenter cross-sectional study.
    Front Public Health. 2025;13:1592358.
    Abstract

  584. AGUILERA-LIZARRAGA J, Hussein H, Cuende-Estevez M, Boeckxstaens G, et al
    Response to Rossi et al.
    Neurogastroenterol Motil. 2025 Aug 4:e70134. doi: 10.1111/nmo.70134.
    Abstract

  585. KOLOSKI NA, Jones MP, Shah A, Holtmann G, et al
    Evidence for Brain-To-Gut and Gut-To-Brain Pathways in Primary Care Patients With Disorders of Gut-Brain Interaction, Inflammatory Bowel Disease and Gastroesophageal Reflux Disease.
    Neurogastroenterol Motil. 2025 Aug 4:e70117. doi: 10.1111/nmo.70117.
    Abstract

  586. LEE TY, Lin YH, Chang WY, Lin LY, et al
    5-HT(7) antagonists confer analgesia via suppression of neurotrophin overproduction in submucosal nerves of mouse models with visceral hypersensitivity.
    J Physiol. 2025 Aug 4. doi: 10.1113/JP286444.
    Abstract

  587. ZHAO D, Zhou G, Shen Z, Hong Y, et al
    Capsaicin ameliorates irritable bowel syndrome in a mouse model by restoring intestinal barrier function and promoting gut microbial homeostasis.
    Chin Med J (Engl). 2025 Aug 4. doi: 10.1097/CM9.0000000000003750.
    Abstract

  588. OZOJIDE KO, Ozigbo AA, Ghartey KK, Okobi OE, et al
    Demographic and Clinical Epidemiology of Irritable Bowel Syndrome in U.S. Community Health Centers: A Cross-Sectional Analysis of the 2022-2023 National Ambulatory Medical Care Survey.
    Cureus. 2025;17:e87124.
    Abstract

  589. YUAN R, Zhou Y, Ren Y, Hou X, et al
    Mendelian Randomization Analysis Reveals Causal Associations Between Beverages and Irritable Bowel Syndrome: Alcohol, but Not Others.
    Food Sci Nutr. 2025;13:e70761.
    Abstract

  590. ISHIHARA N, Kimura S, Hase K
    [An Intestinal Metabolite Exacerbates Stress-induced Diarrhea].
    Yakugaku Zasshi. 2025;145:667-672.
    Abstract

  591. EL-SALHY M, Valeur J, Bronstad I, Gilja OH, et al
    Possible Role of Butyric Acid in Long-Term Symptom Relief in Irritable Bowel Syndrome Patients Following Fecal Microbiota Transplantation.
    Neurogastroenterol Motil. 2025 Aug 1:e70115. doi: 10.1111/nmo.70115.
    Abstract

  592. PALSSON O, Simren M, Sperber AD, Bangdiwala S, et al
    The Prevalence and Burden of Disorders of Gut-Brain Interaction (DGBI) before versus after the COVID-19 Pandemic.
    Clin Gastroenterol Hepatol. 2025 Jul 23:S1542-3565(25)00623.
    Abstract

  593. HUGHES M, Ruaro B, McMahan ZH, Alam U, et al
    Raynaud's phenomenon is associated with an increased risk of cardiovascular disease and venous thromboembolism.
    Semin Arthritis Rheum. 2025;74:152799.
    Abstract

  594. SCHARF MW, Forsgard RA, Prado SBR, Ganda Mall JP, et al
    Acute effects of butyrate on intestinal permeability in patients with irritable bowel syndrome assessed by a novel colonoscopy research model.
    Gut Microbes. 2025;17:2545414.
    Abstract

  595. MAYINDZA EKAGHBA EL, Perruchon O, Lerouge P, Mengome LE, et al
    Effects of Polysaccharides Extracted from Stem Barks on the Spontaneous Contractile Activity of the Ileal Smooth Muscle.
    Molecules. 2025;30:3156.
    Abstract

  596. MCCLAIN J, Capo G, Terris M, Santamaria P, et al
    Prevalence and Phenotype of Lower Urinary Tract Symptoms in Fibromyalgia: A Retrospective Observational Study at a Single Tertiary Medical Center.
    J Clin Med. 2025;14:5584.
    Abstract

  597. SIRAGUSA N, Baldassari G, Ferrario L, Passera L, et al
    The Ten Dietary Commandments for Patients with Irritable Bowel Syndrome: A Narrative Review with Pragmatic Indications.
    Nutrients. 2025;17:2496.
    Abstract

  598. ZHOU Q, Verne GN
    Molecular Mechanisms and Pathways in Visceral Pain.
    Cells. 2025;14:1146.
    Abstract

  599. STONE J, Coebergh J, Khoja L, Butler M, et al
    Migraine and functional neurological disorder (FND)-a review of comorbidity and potential overlap.
    Brain Commun. 2025;7:fcaf288.
    Abstract

  600. JUNG EH, Zheng W, Weiss RJ, Mathew NE, et al
    Colopathy associated with pentosan polysulfate use.
    Front Pharmacol. 2025;16:1494467.
    Abstract

  601. ZHOU Y, Yang Z, Liu S, Xie S, et al
    Long-term risk of irritable bowel syndrome associated with MASLD, MASLD type and different cardiometabolic risk factors: a large-scale prospective cohort study.
    BMC Gastroenterol. 2025;25:576.
    Abstract

  602. KILPATRICK LA, Chang L, Labus JS, Shin AS, et al
    Sex-based associations between neighborhood disadvantage and brain-gut alterations in individuals with irritable bowel syndrome.
    Biol Sex Differ. 2025;16:61.
    Abstract

  603. ZHENG B, Huang Z, Wang Z, Du J, et al
    Association of dietary creatine intake from meat protein sources with different types of intestinal problems: insights from NHANES 2005-2010.
    Front Nutr. 2025;12:1586569.
    Abstract

  604. SABOUR S, Sadeghi Koupaei H, Ghasemi H, Amin M, et al
    Anaerobic gut bacteria and their potential role in the initiation, exacerbation, and development of human colorectal cancer: a narrative review.
    Front Cell Infect Microbiol. 2025;15:1559001.
    Abstract

  605. GONZALEZ LUNA AJ, Covarrubias Robles U, Castrejon Cardona CD, Cuevas Calla CV, et al
    Contained Perforation of a Jejunal Diverticulum in an Elderly Patient: A Case Report.
    Cureus. 2025;17:e87719.
    Abstract

  606. IACOB T, Scarlata GGM, Abenavoli L, Leucuta DC, et al
    Irritable bowel syndrome after Clostridioides difficile infection.
    Med Pharm Rep. 2025;98:320-324.
    Abstract

  607. HOLTMANN G, Talley NJ, Nandurkar S, Gibson PR, et al
    Randomized, Placebo-Controlled, Double-Blind 8-Week Trial on the Efficacy of A Proprietary Kiwifruit Extract on Constipation-Predominant Irritable Bowel Syndrome.
    JGH Open. 2025;9:e70250.
    Abstract

  608. ARONIADIS OC, Guthmueller B, Dehlin K, Srivastava S, et al
    Safety and Efficacy of Fecal Microbiota, Live-jslm to Prevent Recurrent Clostridioides difficile Infection in Participants With Irritable Bowel Syndrome.
    Infect Dis Ther. 2025 Aug 10. doi: 10.1007/s40121-025-01208.
    Abstract

  609. STEEN OD, Bos M, van Ockenburg SL, Zhou Y, et al
    Functional and internalizing disorders co-aggregate with cardiometabolic and immune-related diseases within families: a population-based cohort study.
    BMC Med. 2025;23:469.
    Abstract

  610. THUEN C, Hinderaker HK, Steinsvik EK, Vikoren LAS, et al
    Implementing a digital treatment program for patients with irritable bowel syndrome into routine care: a qualitative evaluation of barriers and facilitators perceived by key stakeholders.
    BMC Health Serv Res. 2025;25:1049.
    Abstract

  611. LILIEQUIST BE, Ljotsson B, Olafsdottir E, Braunschweig F, et al
    Symptom Preoccupation in Atrial Fibrillation and its Association With Quality of Life: A Cross-Sectional Study.
    JACC Adv. 2025;4:102058.
    Abstract

  612. YIN J
    Transcutaneous Vagal Nerve Stimulation for Gastrointestinal Disorders.
    J Transl Gastroenterol. 2025;3:93-99.
    Abstract

  613. WANG T, Song XG, Ruan JR, Han XY, et al
    [Study on the mechanism of moxibustion in improving autophagy of intestinal epithelial cells in rats with diarrhea-predominant irritable bowel syndrome based on PI3K/AKT/mTOR signaling pathway].
    Zhen Ci Yan Jiu. 2025;50:936-945.
    Abstract

  614. ALZAMORA-SCHMATZ MC, Gubbels A
    More than the Lesion: Unraveling the Complexities of Endometriosis-Associated Pain.
    Semin Reprod Med. 2025 Aug 25. doi: 10.1055/s-0045-1811206.
    Abstract

  615. JEONG YD, Kim S, Son Y, Kim TH, et al
    Global Prevalence of Functional Abdominal Pain Disorder among Children and Adolescents According to the Rome III and IV Criteria: A Systematic Review and Meta-Analysis.
    Gut Liver. 2025 Aug 25. doi: 10.5009/gnl250225.
    Abstract

  616. GHOSH D, Mittal A, Arora MK
    Effect of Source and Degree of Esterification of High Methoxyl Pectin on Oral Colon-Targeted Multiparticulated Delivery of Otilonium Bromide.
    ACS Omega. 2025;10:36481-36495.
    Abstract

  617. BUREYCHAK T, Sjodahl J, Barazanji N, Orell G, et al
    Exploring Associations of Different Types of Childhood Trauma With Symptomatology in Irritable Bowel Syndrome.
    Neurogastroenterol Motil. 2025 Aug 24:e70148. doi: 10.1111/nmo.70148.
    Abstract

  618. MADVA EN, Huffman JC, Castillo C, Harnedy LE, et al
    A Randomized Waitlist-Controlled Trial of a Positive Psychology Intervention for Irritable Bowel Syndrome: The WISH Proof-of-Concept Trial.
    Neurogastroenterol Motil. 2025 Aug 24:e70146. doi: 10.1111/nmo.70146.
    Abstract

  619. ZHANG Q, He M, Wang X, Gao J, et al
    Integrating gene expression, neurochemical signatures, and neurocognitive profiles to decode cortical reorganization in IBS-D.
    Prog Neuropsychopharmacol Biol Psychiatry. 2025 Aug 22:111474.
    Abstract

  620. MEHRA A, Sachdeva V, Khanna J, Singh G, et al
    Mirtazapine revisited: new therapeutic perspectives and formulation advances.
    Naunyn Schmiedebergs Arch Pharmacol. 2025.
    Abstract

  621. MELCHIOR C, Hammer H, Bor S, Orozco EB, et al
    European Consensus on Functional Bloating and Abdominal Distension-An ESNM/UEG Recommendations for Clinical Management.
    United European Gastroenterol J. 2025 Aug 22. doi: 10.1002/ueg2.70098.
    Abstract

  622. FAN X, Li Y, Lin X
    A pharmacovigilance study of the association between linaclotide/plecanatide and muscle spasms based on food and drug administration adverse event reporting system.
    Front Pharmacol. 2025;16:1635792.
    Abstract

  623. FAZELI MOGHADAM E, Samadi M, Mohammadi S, Yarizadeh H, et al
    The Relationship of Dietary Nutrient Patterns and Irritable Bowel Syndrome: A Multicenter Case-Control Study.
    Food Sci Nutr. 2025;13:e70742.
    Abstract

  624. TSENG S, Pathria M
    Mastocytic enterocolitis in a patient with chronic diarrhoea.
    BMJ Case Rep. 2025;18:e266244.
    Abstract

  625. HASENBRING M, Levenig C, Titze C
    [Comorbidity of chronic pain and fatigue : Common mechanisms, common treatment steps?].
    Schmerz. 2025 Aug 21. doi: 10.1007/s00482-025-00898.
    Abstract

  626. XU JG, Yuan Y, Ma HK, Huang S, et al
    Electroacupuncture ameliorates visceral hypersensitivity and negative emotions by regulating paraventricular hypothalamic nucleus and colonic corticotropin-releasing factor signaling.
    World J Psychiatry. 2025;15:107342.
    Abstract

  627. CHEN X, Liu X, Li F, He H, et al
    Depression and health outcomes: An umbrella review of systematic reviews and meta-analyses of observational studies.
    Transl Psychiatry. 2025;15:298.
    Abstract

  628. CAMPOS VMS, Prudente TP, Leao LL, da Costa MS, et al
    Analyses of different prescriptions for health using artificial intelligence: a critical approach based on the international guidelines of health institutions.
    Health Inf Sci Syst. 2025;13:52.
    Abstract

  629. WANG SR, Zhou J, Zhang JY, Li SF, et al
    A bibliometric analysis of global research status and trends in irritable bowel syndrome and gut microbiota metabolites.
    Front Microbiol. 2025;16:1559926.
    Abstract

  630. DOWAIS R, Muhanna SIJ, Ghafar RJ, Alzaqh M, et al
    Expectations of the adult population of the Hashemite Kingdom of Jordan about irritable bowel syndrome.
    Medicine (Baltimore). 2025;104:e43964.
    Abstract

  631. SAIDARA E, Barlow GM, Pimentel M
    The evolution of irritable bowel syndrome as a group of organic diseases: a narrative review.
    Expert Rev Gastroenterol Hepatol. 2025.
    Abstract

  632. ZHAO M, Luo R, Shen Y, Zhang Y, et al
    Factors associated with symptom relief in patients with irritable bowel syndrome: a retrospective cohort study.
    Front Med (Lausanne). 2025;12:1643177.
    Abstract

  633. ALSHEHRI WM, Elhady HM, Alharbi AA, Alshehri WA, et al
    Prevalence of Irritable Bowel Syndrome and Its Association With Anxiety Among Family Physicians in Primary Healthcare in Tabuk, Saudi Arabia.
    Cureus. 2025;17:e88138.
    Abstract

  634. KHALID A, Mohajer-Bastami A, Khamise A, Pouwels S, et al
    Evaluating Psychological Interventions for Pain, Recovery, and Outcomes in Surgical and Medical Care.
    Cureus. 2025;17:e88097.
    Abstract

  635. SHAH ND, Staudacher HM
    Cultural competence in the delivery of nutrition and symptom care in irritable bowel syndrome.
    Lancet Gastroenterol Hepatol. 2025 Aug 13:S2468-1253(25)00236.
    Abstract

  636. YE J, Sun H, Zhang Q, He J, et al
    Microalgae-based Intestinal villi-targeting multistage biosystem for irritable bowel syndrome treatment.
    Nat Commun. 2025;16:7614.
    Abstract

  637. KARUNANAYAKE A, Rajindrajith S, Kumari MV, Devanarayana NM, et al
    Effects of body mass index on gastric motility: Comparing children with functional abdominal pain disorders and healthy controls.
    World J Clin Pediatr. 2025;14:100306.
    Abstract

  638. KHAN U, Bronstad I, Hillestad EMR, Steinsvik EK, et al
    Increase in circulating GLP-1 following low FODMAP diet in irritable bowel syndrome patients.
    Front Nutr. 2025;12:1615671.
    Abstract

  639. ALYAMI SH, Lomer MCE, Gibson R
    Gastrointestinal Symptoms and the Assessment of Diet in Shift Workers: A Systematic Scoping Review.
    J Hum Nutr Diet. 2025;38:e70114.
    Abstract

  640. ALDERSON SL, Black CJ, Ford AC, Everitt HA, et al
    Management of irritable bowel syndrome in primary care.
    Br J Gen Pract. 2025;75:429-431.
    Abstract

  641. LIU AY, Vera AO, Enos CW
    Irritable Bowel Syndrome Risk in Acne Patients: Implications for Dermatologic Care.
    Cutis. 2025;116:32-35.
    Abstract

  642. MOHAMMED HA, Sulaiman GM, Al-Saffar AZ, Mohsin MH, et al
    Aromatic Volatile Compounds of Essential Oils: Distribution, Chemical Perspective, Biological Activity, and Clinical Applications.
    Food Sci Nutr. 2025;13:e70825.
    Abstract

  643. LONG Q, Li L, Deng N, Tan Z, et al
    One mechanism of spleen-kidney yang deficiency IBS-D: intestinal microbiota affect ATPase.
    Front Microbiol. 2025;16:1595418.
    Abstract

  644. CHOI WG, Ko SJ, Shim JH, Bae CH, et al
    Integrative In Silico and In Vivo Analysis of Banhasasim-Tang for Irritable Bowel Syndrome: Mechanistic Insights into Inflammation-Related Pathways.
    Pharmaceuticals (Basel). 2025;18:1123.
    Abstract

  645. KOVACS E, Szabo K, Varvara RA, Uifalean A, et al
    Resistant Starch and Microbiota-Derived Secondary Metabolites: A Focus on Postbiotic Pathways in Gut Health and Irritable Bowel Syndrome.
    Int J Mol Sci. 2025;26:7753.
    Abstract

  646. MAVROUDIS I, Franekova K, Petridis F, Ciobica A, et al
    Comorbidities Across Functional Neurological Disorder Subtypes: A Comprehensive Narrative Synthesis.
    Life (Basel). 2025;15:1322.
    Abstract

  647. ALAEDDIN S, Ko Y, Steiner-Lim GZ, Jensen SO, et al
    The Effect of Faecal Microbiota Transplantation on Cognitive Function in Cognitively Healthy Adults with Irritable Bowel Syndrome: Protocol for a Randomised, Placebo-Controlled, Double-Blinded Pilot Study.
    Methods Protoc. 2025;8:83.
    Abstract

  648. LANE RM, Egan LJ, McGuire BE, McKernan DP, et al
    Endocannabinoid system modulation for visceral abdominal pain in inflammatory bowel disease and irritable bowel syndrome: A protocol for systematic review and meta-analysis.
    HRB Open Res. 2025;8:40.
    Abstract

  649. FANG L, Zhu F, Xie X, Shi Y, et al
    Efficacy and safety analysis of ultrasound endoscopy-guided sclerotherapy of esophagogastric varices: A retrospective study.
    Medicine (Baltimore). 2025;104:e43499.
    Abstract

  650. BAYDOUN H, Hussain N, Wu KO, Kelly CR, et al
    What's New and What's Next in Fecal Microbiota Transplantation?
    Biologics. 2025;19:481-496.
    Abstract

  651. SAPS M, Arrizabalo S
    Abdominal pain in children: guidelines at last.
    Expert Rev Gastroenterol Hepatol. 2025.
    Abstract

  652. MCCLELLAN N, Ahlawat R, Kambanis PE, Graver H, et al
    Patterns of Symptom Change in Behaviors and Cognitions During 10-Session Cognitive Behavioral Therapy (CBT-T) for Non-Underweight Eating Disorders.
    Int J Eat Disord. 2025;58:1392-1398.
    Abstract

  653. YOUSEF A, Ahmed ST, H Nguyen Wenker T, Nono-Djotsa ABS, et al
    Upper gastrointestinal symptoms and Gulf War Illness in a clinical cohort of US veterans: a retrospective, cross-sectional study.
    BMJ Open Gastroenterol. 2025;12:e001859.
    Abstract

  654. LUPE SE, Olson JM, Kamp K, Heitkemper M, et al
    First Real-World Evidence of an AI-Enhanced Digital Collaborative Care Model to Improve IBS Symptoms.
    Neurogastroenterol Motil. 2025 Sep 4:e70144. doi: 10.1111/nmo.70144.
    Abstract

  655. FAISAL, Sekhar SRM, Anurag DS, Kumar V, et al
    Deciphering Gut Microbiome Dynamics in Irritable Bowel Syndrome Using Deep Learning.
    Neurogastroenterol Motil. 2025 Sep 4:e70153. doi: 10.1111/nmo.70153.
    Abstract

  656. MOSTAMAND S
    Median arcuate ligament syndrome: challenges, comorbidities, and controversies.
    Curr Opin Pediatr. 2025;37:447-451.
    Abstract

  657. CHMELIR T, Jarkovska D, Pandey S, Chottova Dvorakova M, et al
    Neurogastroenterology: Current insights into gastrointestinal innervation in health and disease.
    Auton Neurosci. 2025;261:103339.
    Abstract

  658. MASSIRONI S, Gallo C, Franchina M, Sbarigia C, et al
    Carcinoid syndrome mimicking irritable bowel syndrome: don't fall into the trap.
    Expert Rev Gastroenterol Hepatol. 2025 Sep 3. doi: 10.1080/17474124.2025.2557245
    Abstract

  659. MIRGHANI HO
    Imaging findings of irritable bowel syndrome patients, and the diagnostic value of irritable bowel syndrome: A systematic review.
    World J Methodol. 2025;15:99785.
    Abstract

  660. TIAN Q, Yu D, Shen J, Fang L, et al
    Wuling powder ameliorates diarrhea-predominant irritable bowel syndrome in mice by modulating gut mucosal microbiota and alleviating intestinal inflammation.
    Front Cell Infect Microbiol. 2025;15:1652186.
    Abstract

  661. WANG D, Guo Y, Wu Z, Zhang H, et al
    Electroacupuncture at ST36 Alleviates Visceral Hypersensitivity and Anxiety via ACC-AIC Circuit Modulation in IBS Rats.
    Neuropsychiatr Dis Treat. 2025;21:1761-1781.
    Abstract

  662. PANDIT SS, Meganathan P, Vedagiri H
    Harmonizing gut microbiota dysbiosis: Unveiling the influence of diet and lifestyle interventions.
    Metabol Open. 2025;27:100384.
    Abstract

  663. LICHTENSTEIN GR
    Exploring Irritable Bowel Syndrome Symptoms in Patients With Inflammatory Bowel Disease.
    Gastroenterol Hepatol (N Y). 2025;21:407.
    Abstract

  664. GRACIE DJ, Ford AC
    Irritable Bowel Syndrome in Inflammatory Bowel Disease Patients: Prevalence, Etiology, and Treatment.
    Gastroenterol Hepatol (N Y). 2025;21:415-423.
    Abstract

  665. YANG J, Li X, Wang C, Yang X, et al
    A Novel CHRM3-Driven Preclinical Model of Irritable Bowel Syndrome.
    FASEB J. 2025;39:e71015.
    Abstract

  666. MAJURI M, Vuokko A, Korhonen M, Karvala K, et al
    Environmental exposure-related health worries, work ability and health, surveyed by occupational health services.
    Int J Occup Med Environ Health. 2025 Aug 29:208604.
    Abstract

  667. MILLER VE, Barnhill J, Greco CM, Castro G, et al
    Prevalence of Chronic Overlapping Pain Conditions in Participants With Chronic Low Back Pain Enrolled in a Pragmatic Trial of Mindfulness-Based Stress Reduction.
    Eur J Pain. 2025;29:e70119.
    Abstract

  668. VITA AA, Teo S, Murphy C, Khandaker AM, et al
    Safety, tolerability, and preliminary effects of cricket chitin for adults with IBS: a double-blind randomized crossover pilot trial.
    Food Funct. 2025 Sep 2. doi: 10.1039/d5fo01540.
    Abstract

  669. LU YH, Lei SY, Yang T, Xu YS, et al
    PDE4 inhibitor apremilast ameliorates TNBS-induced irritable bowel syndrome in mice by activating the Nrf-2 signaling pathway in enteric glial cells.
    Acta Pharmacol Sin. 2025 Sep 1. doi: 10.1038/s41401-025-01649.
    Abstract

  670. SUN MY, Xing HH, Lin X, Hong-haoWu, et al
    Electroacupuncture at Baliao Points Attenuates Visceral Hypersensitivity in Irritable Bowel Syndrome via Gut-Microbiota-Mast Cell-TPRV1 Axis Modulation.
    Neurogastroenterol Motil. 2025 Aug 31:e70137. doi: 10.1111/nmo.70137.
    Abstract

  671. FOWLER S, Dowling LRC, Simm N, Talley NJ, et al
    Sleep Disturbances, Fatigue and Immune Markers in the Irritable Bowel Syndrome and Inflammatory Bowel Disease, a Systematic Review.
    Neurogastroenterol Motil. 2025 Aug 31:e70133. doi: 10.1111/nmo.70133.
    Abstract

  672. SALARI-MOGHADDAM A, Feizi A, Hajihashemi P, Ani A, et al
    Adherence to EAT-Lancet diet and odds of irritable bowel syndrome and functional dyspepsia: the Isfahan functional disorders (ISFUN) study.
    Nutr J. 2025;24:134.
    Abstract

  673. SALAGA M, Binienda A, Canale V, Grychowska K, et al
    Serotonin type 6 receptor inverse agonists and neutral antagonists inhibit defecation: relevance to intestinal motility disorders.
    Eur J Pharmacol. 2025;1005:178099.
    Abstract

  674. MOROZOV SV, Pilipenko VI, Isakov VA, Sasunova AN, et al
    [The use of plant protein-based foods for the correction of dietary patterns in alimentary-dependent diseases: opportunities and prospects. A review].
    Ter Arkh. 2025;97:727-734.
    Abstract

  675. YE J, Wu X, Liu J, Guo Y, et al
    An Effective Oral Drug Delivery Route for Pharmacokinetic Complications: Spirulina Lipid Nanotechnology System.
    Adv Sci (Weinh). 2025 Sep 12:e09731. doi: 10.1002/advs.202509731.
    Abstract

  676. GORDON M, Groen J, Sinopoulou V, Chogle A, et al
    European and North American guidelines for treating irritable bowel syndrome and functional abdominal pain in childhood: a guide for health-care professionals.
    Lancet Child Adolesc Health. 2025 Sep 9:S2352-4642(25)00209.
    Abstract

  677. MARASCO G, Barbara G, Bellini M, Portincasa P, et al
    Management of bile acid diarrhea in Italy: a survey.
    Intern Emerg Med. 2025 Sep 12. doi: 10.1007/s11739-025-04060.
    Abstract

  678. KHAN U, Lied GA
    Wheat-Related Gastrointestinal Diseases: Narrative Review.
    Turk J Gastroenterol. 2025;36:540-546.
    Abstract

  679. YAKLAI K, Kunasol C, Suparan K, Apaijai N, et al
    Electroacupuncture alleviates symptoms and identifies a potential microbial biomarker in patients with constipation-predominant irritable bowel syndrome.
    World J Gastrointest Pharmacol Ther. 2025;16:109046.
    Abstract

  680. GARG A, Aldaoud N, Khan W, Kulairi ZI, et al
    Intraparenchymal Anaplastic Meningioma With Isolated Motor Deficits.
    Cureus. 2025;17:e89822.
    Abstract

  681. GHUSN W, Gala K, Mrad R, Salame M, et al
    Disparities in the burden of gastrointestinal diseases: a comprehensive analysis of data from randomized clinical trials from 2000-2023.
    Ann Gastroenterol. 2025;38:488-496.
    Abstract

  682. BENAMOUZIG R, El Arja W, Bejou B, Airinei G, et al
    Panenteric Capsule Endoscopy in Young Patients with Suspected Irritable Bowel Syndrome: A Self-Controlled Feasibility Study.
    Clin Exp Gastroenterol. 2025;18:205-213.
    Abstract

  683. KIM YJ
    Therapeutic Potential of Melatonin in Functional Dyspepsia.
    Korean J Helicobacter Up Gastrointest Res. 2025;25:296-298.
    Abstract

  684. WANG Q, Lu S, Yin Z
    Aloe-emodin Regulates Colon Epithelial Cell Function by Regulating HIF-1alpha to Alleviate Irritable Bowel Syndrome.
    Xenobiotica. 2025 Sep 11:1-16. doi: 10.1080/00498254.2025.2559959.
    Abstract

  685. SATONAGA Y, Kudoh R, Hata M, Shigenaga T, et al
    Ramosetron as a Supportive Agent to Continue Nintedanib in Patients with Interstitial Lung Disease.
    Intern Med. 2025 Sep 11. doi: 10.2169/internalmedicine.5984.
    Abstract

  686. JAIN W, Khaliq M, Wahab A, Laghari M, et al
    Evaluating Vitamin D Deficiency-Linked Digestive Issues by Bridging Endocrinology With Gastrointestinal Disorders.
    Cureus. 2025;17:e89598.
    Abstract

  687. WARRAICH MUT, Shafqat MN, Ajmal U, Choudhary MA, et al
    Frequency of Celiac Disease in Irritable Bowel Syndrome: Insights From a Tertiary Care Hospital.
    Cureus. 2025;17:e89617.
    Abstract

  688. ZHOU Y, Liu S, Zhang Q, Zhang S, et al
    Socioeconomic disparity and risk of irritable bowel syndrome: a cohort study with mediation analysis.
    Clin Gastroenterol Hepatol. 2025 Sep 7:S1542-3565(25)00754.
    Abstract

  689. YUAN J, Pi C, Shen H, Zhou B, et al
    Potential therapeutic benefits of curcumin in depression or anxiety induced by chronic diseases: a systematic review of mechanistic and clinical evidence.
    Front Pharmacol. 2025;16:1638645.
    Abstract

  690. BEZ P, Scapolan M, Ribaldone DG, Caviglia GP, et al
    Antibodies against integrin alphavbeta6 have high diagnostic accuracy for ulcerative colitis.
    Front Immunol. 2025;16:1641329.
    Abstract

  691. HOYER KL, Kornum DS, Baunwall SMD, Klinge MW, et al
    Repeated faecal microbiota transplantation for individuals with type 1 diabetes and gastroenteropathy.
    Diabetologia. 2025 Sep 18. doi: 10.1007/s00125-025-06544.
    Abstract

  692. YAN Q, Wang X, Jiang H, Zhou X, et al
    Decoding Barberry Root's Therapeutic Network: A Synergistic Solution for IBS-D.
    Comb Chem High Throughput Screen. 2025.
    Abstract

  693. WANG Y, Pan T, Hu N, Gao G, et al
    The Role of Ganyu in Formation of Liver Depression and Spleen Deficiency Syndrome: Analysis From Gut Microbiota.
    Gastroenterol Res Pract. 2025;2025:2125189.
    Abstract

  694. HAMMER J, Hammer HF
    Beyond Malabsorption: The Need for Symptom-Based Assessment in Suspected Lactose Intolerance. Lessons From a Test-Specific Symptom Assessment.
    Neurogastroenterol Motil. 2025 Sep 17:e70167. doi: 10.1111/nmo.70167.
    Abstract

  695. BARLOW GM, Pimentel M
    Modern concepts of small intestinal bacterial overgrowth.
    Curr Opin Gastroenterol. 2025 Sep 18. doi: 10.1097/MOG.0000000000001135.
    Abstract

  696. OLBERDING CR, Adili W, Herman M
    Eosinophilic Colitis in an Adult Patient: A Case Report.
    Cureus. 2025;17:e90099.
    Abstract

  697. LI Y, Wang Z, Zhang S, Hua Y, et al
    miR-539-5p Regulates Irritable Bowel Syndrome Pathological Processes by Targeting KDM6A.
    Turk J Gastroenterol. 2025 Sep 10. doi: 10.5152/tjg.2025.24684.
    Abstract

  698. QRMLI AA
    Modeling the Structural Relationships of Irritable Bowel Syndrome Symptom Severity Based on Hostile Attribution, Perceived Stress, and Cognitive Bias With the Mediating Role of Negative Meta-emotion.
    J Psychiatr Pract. 2025;31:245-250.
    Abstract

  699. AL AYOUBI O, Aldakak MA, Alabdullah N, Alabdullah F, et al
    Sigmoid colon endometriosis as an uncommon cause of large bowel obstruction: A case report.
    Int J Surg Case Rep. 2025;135:111927.
    Abstract

  700. DAHLGREN A, Gryback P, Jacobsson H, Hellstrom PM, et al
    Refined Lactulose Hydrogen Breath Test for Small Intestinal Bacterial Overgrowth Subgrouping Irritable Bowel Syndrome With Low and High Breath Hydrogen.
    Gastroenterol Res Pract. 2025;2025:5597071.
    Abstract

  701. FAN Z, Yao J, Zeng X, Zuo J, et al
    Investigation of the biomarkers and mechanism based on endoplasmic reticulum stress in irritable bowel syndrome.
    Arab J Gastroenterol. 2025 Sep 22:S1687-1979(25)00110.
    Abstract

  702. DRAGO L, Corleto VD, Ciprandi G, Brindicci VF, et al
    A multicenter real-world, open-label study assessing the impact of a probiotic mixture on symptoms of irritable bowel syndrome in adults.
    Benef Microbes. 2025 Sep 16:1-12. doi: 10.1163/18762891-bja00097.
    Abstract

  703. SCOTT AJ, Correa AB, Bisby MA, Chandra SS, et al
    Cognitive Behavioral Therapy for Insomnia in People With Chronic Disease: A Systematic Review and Meta-Analysis.
    JAMA Intern Med. 2025 Sep 22:e254610. doi: 10.1001/jamainternmed.2025.4610.
    Abstract

  704. WANG YL, Xu XQ, Long YY, Cheng YL, et al
    Characterization of gut microbiota and metabolites in individuals with constipation-predominant irritable bowel syndrome.
    Front Microbiol. 2025;16:1617288.
    Abstract

  705. QU L, Zhang R, Chu Z, Cai J, et al
    Gut microbiota: A key player for soluble dietary fiber in regulating inflammatory disease.
    J Adv Res. 2025 Sep 17:S2090-1232(25)00732-5. doi: 10.1016/j.jare.2025.
    Abstract

  706. GUEMES-GONZALEZ AM, Arriaga-Pizano LA, Chacon-Salinas R, Wong-Baeza I, et al
    Regulation of Intestinal Permeability in Health and Disease: Possible Therapeutic Applications.
    Arch Med Res. 2025;57:103321.
    Abstract

  707. HOUGHTON LA, Gao S, Gilbert SA, Coffin B, et al
    Clinical Trial: Study to Investigate the Efficacy and Safety of the Alpha-2-Delta Ligand PD-217,014 in Patients With Irritable Bowel Syndrome.
    Aliment Pharmacol Ther. 2025 Jan 15. doi: 10.1111/apt.18487.
    Abstract

  708. SHIN A
    Editorial: Alpha(2)-Delta Ligands in Irritable Bowel Syndrome.
    Aliment Pharmacol Ther. 2025 Jan 30. doi: 10.1111/apt.18528.
    Abstract

  709. CAMILLERI M, Ford AC
    Review Article: Surrogate Endpoints to Assess Treatment Efficacy in Disorders of Gut-Brain Interaction of Lower Gastrointestinal Tract.
    Aliment Pharmacol Ther. 2025 Feb 2. doi: 10.1111/apt.18527.
    Abstract

  710. KHUNSRIRAKSAKUL C, Ziegler O, Liu D, Kulaylat AS, et al
    The Impact of Antispasmodic Use on Abdominal Pain and Opioid Use in Inflammatory Bowel Disease: A Population-Based Study.
    Aliment Pharmacol Ther. 2025 Apr 11. doi: 10.1111/apt.70147.
    Abstract

  711. BAILLIE S, Saxena S, Jayasooriya N, Bottle A, et al
    Pain and Sedative Medication Use Among Individuals With Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study.
    Aliment Pharmacol Ther. 2025 Jul 2. doi: 10.1111/apt.70247.
    Abstract

  712. MEISENHEIMER ES, Carnevale AM
    Chronic Pelvic Pain in Women: Evaluation and Treatment.
    Am Fam Physician. 2025;111:218-229.
    Abstract

  713. GRAD R, Ebell MH
    Top 20 Research Studies of 2024 for Primary Care Physicians.
    Am Fam Physician. 2025;112:34-41.
    Abstract

  714. CAMILLERI M
    When and What to Test for Diarrhea: Focus on Stool Testing.
    Am J Gastroenterol. 2025;120:778-784.
    Abstract

  715. WALLEN H, Ljotsson B, Lindfors P, Forsell E, et al
    Internet-Delivered Exposure-Based Cognitive Behavior Therapy for Irritable Bowel Syndrome: A Clinical Effectiveness Study.
    Am J Gastroenterol. 2025;120:856-863.
    Abstract

  716. LI D, Yang J
    Methodological Challenges and Suggestions for Improvement in the Study of Irritable Bowel Syndrome Flora.
    Am J Gastroenterol. 2025 May 2. doi: 10.14309/ajg.0000000000003489.
    Abstract

  717. WEI J, Zhong Y, Li Y, Li J, et al
    Addressing Mechanistic and Subtype-specific Limitations in the Study on Fecal Proteolytic Bacteria and Staphylococcal Superantigens in Irritable Bowel Syndrome.
    Am J Gastroenterol. 2025 Apr 28. doi: 10.14309/ajg.0000000000003453.
    Abstract

  718. THERRIEN A, Akula S, Galeas-Pena M, Frank E, et al
    Hereditary Alpha-Tryptasemia is Associated with Ongoing Symptoms in Individuals with Celiac Disease Despite Following a Gluten-Free Diet.
    Am J Gastroenterol. 2025 May 14. doi: 10.14309/ajg.0000000000003537.
    Abstract

  719. DUGGAL S, Mahapatra S, Garrison K, Robles A, et al
    Assessing Gastrointestinal Awareness on TikTok: A Content Analysis of Colorectal Cancer, IBS, and IBD Narratives.
    Am J Gastroenterol. 2025 May 14. doi: 10.14309/ajg.0000000000003539.
    Abstract

  720. SAAB O, Al-Obaidi H, Algodi M, Algodi A, et al
    Yoga for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Am J Gastroenterol. 2025 May 13. doi: 10.14309/ajg.0000000000003524.
    Abstract

  721. CALDART F, Gabriel C, Vauquelin B, Riviere P, et al
    Overlap of esophageal disorders of gut-brain interactions (E-DGBIs) and GERD is highly prevalent in patients with refractory reflux symptoms.
    Am J Gastroenterol. 2025 May 22. doi: 10.14309/ajg.0000000000003542.
    Abstract

  722. KARRENTO K, Lu PL, Chumpitazi BP
    Little Patients Big Discoveries: Potential Pediatric to Adult Neurogastroenterology Translation.
    Am J Gastroenterol. 2025 Jun 6. doi: 10.14309/ajg.0000000000003579.
    Abstract

  723. BUSAM JA, Batta N, Shah ED, Joo L, et al
    The Safety of Pharmacotherapy for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2025 Jun 5. doi: 10.14309/ajg.0000000000003572.
    Abstract

  724. AWAD DC, Hubner DM
    The impact of violence and trauma on patient care: What the gastroenterologist needs to know.
    Am J Gastroenterol. 2025 Jun 10. doi: 10.14309/ajg.0000000000003587.
    Abstract

  725. SHIHA MG, Schiepatti A, Manza F, Maimaris S, et al
    Global prevalence of celiac disease in patients with Rome III and Rome IV irritable bowel syndrome: A systematic review and meta-analysis.
    Am J Gastroenterol. 2025 Jun 10. doi: 10.14309/ajg.0000000000003586.
    Abstract

  726. RAO SSC
    Fructose and Lactose Malabsorption or Intolerance or Hypersensitivity: Which Triggers Symptoms and Why?
    Am J Gastroenterol. 2025 Jun 26. doi: 10.14309/ajg.0000000000003577.
    Abstract

  727. PARK CJ, Jones MP, Prott G, Sequeira C, et al
    Rome IV Functional Defecation Disorder: Time for a Change in Symptom Criteria for Improved Clinical Relevance?
    Am J Gastroenterol. 2024;120:2165-2172.
    Abstract

  728. GREER KB, Sultan S
    Irritable Bowel Syndrome.
    Ann Intern Med. 2025 Aug 12. doi: 10.7326/ANNALS-25-01965.
    Abstract

  729. HOLTMANN G, Moniruzzaman MD, Shah A
    Decoding the Gut-Brain Axis: A Journey Towards Targeted Interventions for Disorders-of-Gut-Brain Interaction.
    Dig Dis. 2025 Feb 12:1-14. doi: 10.1159/000543845.
    Abstract

  730. TURSI A, Marinoni B, Privitera AC, Privitera L, et al
    STW 5-II for Treatment of Functional Gastrointestinal Disorders: Mechanism and Clinical Efficacy.
    Dig Dis. 2025;43:266-272.
    Abstract

  731. CHEN LJ, Plantinga AM, Burr R, Cain K, et al
    Exploration of Cytokines and Microbiome Among Males and Females with Diarrhea-Predominant Irritable Bowel Syndrome.
    Dig Dis Sci. 2025 Jan 8. doi: 10.1007/s10620-024-08836.
    Abstract

  732. VARMA S, Scott LL, Sibelli A, Pathipati M, et al
    Digital Gut-Directed CBT May Improve Fecal Incontinence in IBS.
    Dig Dis Sci. 2025 Feb 14. doi: 10.1007/s10620-025-08871.
    Abstract

  733. HEATH MR, Mujagic Z, Luo Y, Keszthelyi D, et al
    It's a Women's World: A New Look at Sex Differences in Patients with the Irritable Bowel Syndrome.
    Dig Dis Sci. 2025 Mar 8. doi: 10.1007/s10620-025-08965.
    Abstract

  734. QUIGLEY EMM
    Dyspepsia-Is the Stomach Half Empty?
    Dig Dis Sci. 2025 Apr 18. doi: 10.1007/s10620-025-09038.
    Abstract

  735. SHARABI E, Busam JA, Mathur K, Rezaie A, et al
    Tracking Anti-cytolethal Distending Toxin B and Anti-vinculin Over Time and Their Roles in Symptoms.
    Dig Dis Sci. 2025 May 4. doi: 10.1007/s10620-025-09068.
    Abstract

  736. HIRAMOTO BA, Lee S, Chan WW
    Looking Beyond the Barrier for Fecal Incontinence: The Brain-Gut Axis and Central Neurosensory Processes as Treatment Targets.
    Dig Dis Sci. 2025 Jun 12. doi: 10.1007/s10620-025-09114.
    Abstract

  737. KHURANA R, Rakhra G
    Assessing the Impact of the Low-FODMAP Diet on IBS Management in Asian Countries: A Systematic Review and Meta-Analysis of Evidence.
    Dig Dis Sci. 2025 Jul 27. doi: 10.1007/s10620-025-09241.
    Abstract

  738. LI L, Xu L, Wang L, Sun Y, et al
    Role of AQP1 in the Ameliorating Effect of Electroacupuncture in a Rodent Model of Visceral Hypersensitivity.
    Dig Dis Sci. 2025 Aug 5. doi: 10.1007/s10620-025-09269.
    Abstract

  739. AHMED T, Lemberg DA, Day AS, Leach ST, et al
    The Interplay Between Immunological Status and Gut Microbial Dysbiosis in the Development of the Symptoms of Irritable Bowel Syndrome: A Systematic Review with Meta-Analysis.
    Dig Dis Sci. 2025 Sep 3. doi: 10.1007/s10620-025-09360.
    Abstract

  740. YAMANE T, Masaoka T, Ishii C, Masuoka H, et al
    Factors contributing to the efficacy of fecal microbiota transplantation for diarrhea-dominant functional bowel disorders.
    Digestion. 2025 Apr 10:1-22. doi: 10.1159/000545183.
    Abstract

  741. MIHARA H, Kuraishi S, Fujinami H, Ando T, et al
    Investigation of Recognition Areas by Explainable AI for Colonoscopy Images of Irritable Bowel Syndrome.
    Digestion. 2025 Apr 29:1-11. doi: 10.1159/000546183.
    Abstract

  742. NGUYEN DC, Gonlachanvit S, Sukaram T, Patcharatrakul T, et al
    Volatile Organic Compounds in Irritable Bowel Syndrome: Microbial Insights into Gut-Brain Dynamics and Clinical Applications.
    Digestion. 2025 Sep 4:1-14. doi: 10.1159/000548310.
    Abstract

  743. ARIF TB, Ali SH, Bhojwani KD, Sadiq M, et al
    Global prevalence and risk factors of irritable bowel syndrome from 2006 to 2024 using the Rome III and IV criteria: a meta-analysis.
    Eur J Gastroenterol Hepatol. 2025 Apr 30. doi: 10.1097/MEG.0000000000002994.
    Abstract

  744. ROKKAS T, Ekmektzoglou K, Tsanou E, Bricca L, et al
    Comparative effectiveness and safety of probiotics with psychotropic potential in mental health benefits in irritable bowel syndrome: a systematic review and network meta-analysis.
    Eur J Gastroenterol Hepatol. 2025 Aug 25. doi: 10.1097/MEG.0000000000003062.
    Abstract

  745. QUIGLEY EMM
    Microbial Influences on Irritable Bowel Syndrome.
    Gastroenterol Clin North Am. 2025;54:351-365.
    Abstract

  746. BUZENSKI J, Davenport S, Glinky A, Edwards PT, et al
    A Practical Guide to Behavioral Treatment for Children with Disorders of Gut-Brain Interaction.
    Gastroenterol Clin North Am. 2025;54:639-649.
    Abstract

  747. DI LORENZO C
    Social Media and Children with Disorders of Gut-Brain Interaction.
    Gastroenterol Clin North Am. 2025;54:627-638.
    Abstract

  748. COHEN A, Wheeler JC
    New Pharmacologic Treatments in Pediatric Neurogastroenterology.
    Gastroenterol Clin North Am. 2025;54:569-587.
    Abstract

  749. ARSLAN E, Kiyak E
    The Effects of Progressive Muscle Relaxation Exercises on Symptom Severity and Quality of Life in Patients With Irritable Bowel Syndrome.
    Gastroenterol Nurs. 2025;48:271-279.
    Abstract

  750. HUNG KW, Leiman DA, Kaza A, Watson R, et al
    AGA Institute Quality Indicator Development for Irritable Bowel Syndrome.
    Gastroenterology. 2025 Jan 15:S0016-5085(24)05666.
    Abstract

  751. SINGH P, Chey WD, Takakura W, Cash BD, et al
    A novel, IBS-specific IgG ELISA-based elimination diet in irritable bowel syndrome: A randomized, sham-controlled trial.
    Gastroenterology. 2025 Jan 31:S0016-5085(25)00328.
    Abstract

  752. AGUILERA-LIZARRAGA J, Lopez-Lopez C, Jaramillo-Polanco J, Florens MV, et al
    Psychological stress-induced local immune response to food antigens increases pain signaling across the gut in mice.
    Gastroenterology. 2025 Feb 18:S0016-5085(25)00371.
    Abstract

  753. TORICES L, Bonfiglio F, Esteban-Blanco C, Zamfir-Taranu A, et al
    Domain-specific effects of sucrase-isomaltase genotype in irritable bowel syndrome.
    Gastroenterology. 2025 Feb 11:S0016-5085(25)00362.
    Abstract

  754. REXWINKEL R, Vermeijden NK, Zeevenhooven J, Kelder J, et al
    Mebeverine and the influence of labeling in adolescents with irritable bowel syndrome or functional abdominal pain-NOS: a 2x2 randomized, placebo-controlled trial.
    Gastroenterology. 2025 Mar 10:S0016-5085(25)00493.
    Abstract

  755. LAMICHHANE R, Gautam M, Fletcher JG, Bailey KR, et al
    Inadequate Propulsion and Pelvic Floor Relaxation in Dyssynergic Defecation: Insights from Synchronous Proctomanometry.
    Gastroenterology. 2025 Apr 30:S0016-5085(25)00651.
    Abstract

  756. YANG JW, Qi LY, Yan SY, She YF, et al
    Efficacy of ACupuncTure in Irritable bOwel syNdrome (ACTION): a multi-centre randomized controlled trial.
    Gastroenterology. 2025 May 27:S0016-5085(25)00826.
    Abstract

  757. GAO J, Lee AA, Abtahi S, Turner JR, et al
    Low FODMAP diet improves colonic barrier function and mast cell activation in patients with IBS-D: A mechanistic trial.
    Gastroenterology. 2025 Jul 18:S0016-5085(25)05771.
    Abstract

  758. FLACK R, Brownlow G, Burton-Murray H, Palsson O, et al
    The Prevalence and Burden of Avoidant/Restrictive Food Intake Disorder (ARFID) Symptoms in Adults with Disorders of Gut-Brain Interaction: A Population-Based Study.
    Gastroenterology. 2025 Aug 20:S0016-5085(25)05896.
    Abstract


  759. Correction: Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis.
    Gut. 2025;74:e12.
    Abstract

  760. WRIGHT-HUGHES A, Ow PL, Alderson SL, Ridd MJ, et al
    Predictors of response to low-dose amitriptyline for irritable bowel syndrome and efficacy and tolerability according to subtype: post hoc analyses from the ATLANTIS trial.
    Gut. 2025 Jan 25:gutjnl-2024-334490. doi: 10.1136/gutjnl-2024-334490.
    Abstract

  761. DECRAECKER L, Cuende Estevez M, Van Remoortel S, Quan R, et al
    Characterisation of MRGPRX2(+) mast cells in irritable bowel syndrome.
    Gut. 2025 Feb 23:gutjnl-2024-334037. doi: 10.1136/gutjnl-2024-334037.
    Abstract

  762. BANNON CA, Walters JRF, Wu T, Kay RG, et al
    Insulin-like peptide 5 is released in response to bile acid in the rectum and is associated with diarrhoea severity in patients with bile acid diarrhoea.
    Gut. 2025 Jul 23:gutjnl-2025-335393. doi: 10.1136/gutjnl-2025-335393.
    Abstract

  763. ZAMFIR-TARANU A, Loscher BS, Franke A, Bonfiglio F, et al
    Sucrase-isomaltase hypomorphic variant Val15Phe affects the response to a sucrose challenge test in patients with IBS.
    Gut. 2025 Sep 10:gutjnl-2025-336393. doi: 10.1136/gutjnl-2025-336393.
    Abstract

  764. JAIN A, Ramchandani S, Bhatia S
    Gastrointestinal symptoms and disorders of gut-brain interaction in pregnancy.
    Indian J Gastroenterol. 2025 Jan 4. doi: 10.1007/s12664-024-01705.
    Abstract

  765. YILDIZ G, Sogut G
    Masked hypertension in patients with irritable bowel syndrome.
    Indian J Gastroenterol. 2025 Mar 24. doi: 10.1007/s12664-025-01745.
    Abstract

  766. GOYAL O, Goyal P, Goyal MK, Jain K, et al
    Overlap of 'disorders of gut-brain interaction' and their impact on quality of life and somatization in a tertiary care center- A cross-sectional study.
    Indian J Gastroenterol. 2025 Apr 15. doi: 10.1007/s12664-025-01770.
    Abstract

  767. BHARADWAJ PK, Simon EG, Dave RG, Geevar T, et al
    Utility of rotational thrombo-elastometry as an objective measure of hypercoagulability in ulcerative colitis.
    Indian J Gastroenterol. 2025 Apr 26. doi: 10.1007/s12664-025-01759.
    Abstract

  768. WANDER GS, Batta A
    Masked hypertension in irritable bowel syndrome: A cause for concern?
    Indian J Gastroenterol. 2025 May 7. doi: 10.1007/s12664-025-01791.
    Abstract

  769. GOYAL MK, Goyal O, Sood A
    The road to Rome IV and beyond: Evolution, refinements and future considerations for the Rome criteria for functional gastrointestinal disorders.
    Indian J Gastroenterol. 2025 Jul 4. doi: 10.1007/s12664-025-01808.
    Abstract

  770. JI TT, Yao YH, Liu L, Li HS, et al
    Masked hypertension in patients with irritable bowel syndrome: A direction worthy of in-depth study.
    Indian J Gastroenterol. 2025 Aug 9. doi: 10.1007/s12664-025-01863.
    Abstract

  771. RAGHAVENDRAN AK, Musunuri B, Rajpurohit S, C GP, et al
    Evaluation of artificial intelligence-based patient education models for irritable bowel syndrome.
    Indian J Gastroenterol. 2025 Sep 20. doi: 10.1007/s12664-025-01872.
    Abstract

  772. JEON SH, Kim M, Choi S, Son S, et al
    Study protocol for a prospective, investigator-initiated clinical trial on the vascular effects of acupuncture in the abdomen and lower limbs for patients with diarrhea-predominant irritable bowel syndrome.
    Int J Colorectal Dis. 2025;40:103.
    Abstract

  773. PISKORZ MM, Stefanolo JP, Ibanez A, Eugenia H, et al
    Gut-brain Axis and Irritable Bowel Syndrome During the Lockdown due to the SARS-CoV-2 Pandemic: A Survey-based Study.
    J Clin Gastroenterol. 2024 Dec 27. doi: 10.1097/MCG.0000000000002123.
    Abstract

  774. ORDAZ-ALVAREZ HR, Priego-Parra BA, Reyes-Diaz SA, Garcia-Zermeno KR, et al
    Prevalence of Eating Disorders Among Adults With Irritable Bowel Syndrome: A Cross-Sectional Study.
    J Clin Gastroenterol. 2024 Nov 12. doi: 10.1097/MCG.0000000000002101.
    Abstract

  775. MAUNEY E, King F 4th, Burton-Murray H, Kuo B, et al
    Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome.
    J Clin Gastroenterol. 2025 Feb 17. doi: 10.1097/MCG.0000000000002149.
    Abstract

  776. HUNT M, Dalvie A, Ipek S, Glinski S, et al
    Efficacy of a CBT Self-Help App (Zemedy) Versus an Education, Relaxation, and Mindfulness App for IBS: Results from Post-Treatment, 3-Month, and 6-Month Follow-Up.
    J Clin Gastroenterol. 2025 Mar 12. doi: 10.1097/MCG.0000000000002164.
    Abstract

  777. TKALCIC M, Toncic M, Pletikosic Toncic S, Troskot Peric R, et al
    Attentional Biases in Irritable Bowel Syndrome Patients: The Role of Interoception and Anxiety.
    J Clin Gastroenterol. 2025 Jun 2. doi: 10.1097/MCG.0000000000002200.
    Abstract

  778. YAN Y, Wang LJ, Shen XJ
    Comment on "Prevalence of Eating Disorders Among Adults With Irritable Bowel Syndrome".
    J Clin Gastroenterol. 2025 Jul 7. doi: 10.1097/MCG.0000000000002223.
    Abstract

  779. KATSUMATA R, Hosokawa T, Manabe N, Mori H, et al
    Brain activity during a public-speaking situation in virtual reality in patients with irritable bowel syndrome and functional dyspepsia.
    J Gastroenterol. 2025 Feb 24. doi: 10.1007/s00535-025-02228.
    Abstract

  780. TALLEY NJ, Duncanson K, Williams GM
    Why are disorders of gut-brain interaction (DGBI) often food-related? Duodenal eosinophils and mast cells, small intestinal bacteria, food allergy and altered food intake in functional dyspepsia and the irritable bowel syndrome: a new paradigm.
    J Gastroenterol. 2025 Jun 30. doi: 10.1007/s00535-025-02268.
    Abstract

  781. YU QX, Wang DD, Dong PJ, Zheng LH, et al
    Probiotics Combined With Trimebutine for the Treatment of Irritable Bowel Syndrome Patients: A Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2025 Jan 8. doi: 10.1111/jgh.16858.
    Abstract

  782. LOO QY, Chuah KH, Hian WX, Khoo XH, et al
    Impact of Positive Glucose, Lactose, and Fructose Hydrogen Breath Tests on Symptoms and Quality of Life in Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2025 Jan 23. doi: 10.1111/jgh.16891.
    Abstract

  783. CHENG L, Wang Q, Wu B, Yan X, et al
    Efficacy of Linaclotide in Functional Dyspepsia and Constipation-Predominant Irritable Bowel Syndrome Overlap: A Randomized Trial.
    J Gastroenterol Hepatol. 2025 Mar 13. doi: 10.1111/jgh.16925.
    Abstract

  784. YAO Y, You X, Yang S, Xie Y, et al
    Associations of Long-Term Night Shift Work With Incident Irritable Bowel Syndrome: A Population-Based Cohort Study.
    J Gastroenterol Hepatol. 2025 Jul 12. doi: 10.1111/jgh.70002.
    Abstract

  785. YAN Y, Liu L, Shen XJ
    Comment on "Impact of Positive Glucose, Lactose, and Fructose Hydrogen Breath Tests on Symptoms and Quality of Life in Irritable Bowel Syndrome".
    J Gastroenterol Hepatol. 2025 Jul 23. doi: 10.1111/jgh.70032.
    Abstract

  786. AHMED A, Chauhan A, Kumari A, Hokari R, et al
    Prevalence of Serologically Defined Celiac Disease in Patients With Irritable Bowel Syndrome in Asia: A Multicountry Hospital-Based Study.
    J Gastroenterol Hepatol. 2025 Sep 13. doi: 10.1111/jgh.70074.
    Abstract

  787. POLACHEK A, Flindt G, Lazar L, Barlow S, et al
    Proctocolitis or TikTok-olitis: The dangers of social media influence on home constipation management.
    J Pediatr Gastroenterol Nutr. 2025 Mar 13. doi: 10.1002/jpn3.70027.
    Abstract

  788. GROEN J, Gordon M, Chogle A, Benninga M, et al
    ESPGHAN/NASPGHAN guidelines for treatment of irritable bowel syndrome and functional abdominal pain-not otherwise specified in children aged 4-18 years.
    J Pediatr Gastroenterol Nutr. 2025 May 30. doi: 10.1002/jpn3.70070.
    Abstract

  789. HU J, Zhang Y, Liu C, Gkaravella A, et al
    Effects of microbiota-based interventions on depression and anxiety in children and adolescents-A systematic review.
    J Pediatr Gastroenterol Nutr. 2025 May 26. doi: 10.1002/jpn3.70092.
    Abstract

  790. GANZEVOORT IN, Berger MY, Vlieger AM, Benninga MA, et al
    Children with disorders of gut-brain interaction in primary care versus hospital care: A comparison of characteristics.
    J Pediatr Gastroenterol Nutr. 2025 Jun 29. doi: 10.1002/jpn3.70129.
    Abstract

  791. CRISTOFORI F, Calabrese FM, Iacobellis I, Santamaria M, et al
    Calcium butyrate efficacy in pediatric irritable bowel syndrome: Randomized placebo-controlled multiomics-based clinical trial.
    J Pediatr Gastroenterol Nutr. 2025 Jul 9. doi: 10.1002/jpn3.70154.
    Abstract

  792. BEINVOGL B, Burch E, Snyder J, Liu E, et al
    Vulnerability factors for pediatric disorders of gut-brain interaction and implications for functional impairment.
    J Pediatr Gastroenterol Nutr. 2025 Jul 14. doi: 10.1002/jpn3.70155.
    Abstract

  793. LACH J, Colombo JM, Schurman JV, Friesen CA, et al
    Variability in stool symptoms in youth with abdominal pain-associated disorders of gut-brain interaction.
    J Pediatr Gastroenterol Nutr. 2025 Sep 1. doi: 10.1002/jpn3.70205.
    Abstract

  794. BAI X, Guo X, Zhou Z, Liu S, et al
    Functional gastrointestinal disorders are highly prevalent in children with short stature and linked to reduced growth velocity.
    J Pediatr Gastroenterol Nutr. 2025 Sep 17. doi: 10.1002/jpn3.70203.
    Abstract

  795. AKBARI R, Salimi Y, Dehghani-Aarani F, Rezayat E, et al
    Attention in irritable bowel syndrome: A systematic review of affected domains and brain-gut axis interactions.
    J Psychosom Res. 2025;191:112067.
    Abstract

  796. PETERSEN MW, Wellnitz KB, Carstensen TBW, Dantoft TM, et al
    Welfare benefit utilization for people with functional somatic disorder. A population-based cohort study.
    J Psychosom Res. 2025;191:112073.
    Abstract

  797. MACKRILL K, Bass C, Petrie K
    Comparing illness perceptions in inflammatory bowel disease and irritable bowel syndrome.
    J Psychosom Res. 2025;196:112337.
    Abstract

  798. CHEN Y, Zhou Y, Liu S, Zhang Q, et al
    Bidirectional Association of Rheumatoid Arthritis and Irritable Bowel Syndrome: A Large-Scale Prospective Cohort Study.
    Mayo Clin Proc. 2025 Aug 2:S0025-6196(25)00282.
    Abstract

  799. CAMILLERI M, Dellon ES
    Year in Review: Selection of Best Papers in Gastroenterology and Hepatology 2024.
    Mayo Clin Proc. 2025 Aug 1:S0025-6196(25)00310.
    Abstract

  800. SANDBERG-JANZON A, Karling P
    Prescription of commonly used drugs in patients with functional bowel disorders. A cross-sectional comparison with the general population.
    Scand J Gastroenterol. 2025 Jan 25:1-9. doi: 10.1080/00365521.2025.2458070.
    Abstract

  801. CYMBAL M, Chatterjee A, Ajayi-Fox P, Lyu R, et al
    Specialty laboratory testing for chronic abdominal pain in irritable bowel syndrome.
    Scand J Gastroenterol. 2025 Jan 24:1-5. doi: 10.1080/00365521.2025.2456491.
    Abstract

  802. SANDBERG-JANZON A, Karling P
    Prescription of NSAIDs and proton pump inhibitors are associated with increased faecal calprotectin levels in patients with functional bowel disorder: an observational study.
    Scand J Gastroenterol. 2025 May 29:1-8. doi: 10.1080/00365521.2025.2512368.
    Abstract

  803. ROTH B, Al-Shareef D, Ohlsson B
    Intake of fiber and micronutrients in patients with IBS.
    Scand J Gastroenterol. 2025 Jul 22:1-12. doi: 10.1080/00365521.2025.2535721.
    Abstract

  804. MADVA EN, Varma S, Small V, Dekel M, et al
    Pharmacologic neuromodulation for bloating.
    Scand J Gastroenterol. 2025 Aug 8:1-5. doi: 10.1080/00365521.2025.2544306.
    Abstract

  805. POPE Q, Varma R, Tataru C, David MM, et al
    Learning a deep language model for microbiomes: The power of large scale unlabeled microbiome data.
    PLoS Comput Biol. 2025;21:e1011353.
    Abstract

  806. AKHLAQ S, Kazmi N, Kazmi SMH, Atiq M, et al
    Somatization symptomology and its association with stress in patients with irritable bowel syndrome.
    PLoS One. 2025;20:e0312506.
    Abstract

  807. TATTAN M, Rosmalen J, Hanssen D
    Factors associated with receiving a Functional Disorder diagnostic label: A systematic review.
    PLoS One. 2025;20:e0317236.
    Abstract

  808. ZHOU J, Lamichhane N, Xu Z, Wang J, et al
    The effect of acupuncture on quality of life in patients with irritable bowel syndrome: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0314678.
    Abstract

  809. EKMAN L, Tufvesson H, Englund E, Dahlin LB, et al
    Symptoms and objective signs of peripheral sensory neuropathy in POTS and correlations to gastrointestinal symptoms.
    PLoS One. 2025;20:e0327549.
    Abstract


  810. Editorial Note: Somatization symptomology and its association with stress in patients with irritable bowel syndrome.
    PLoS One. 2025;20:e0331058.
    Abstract


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.


;